https://health-pharma.ro/question/formularea-medicamentelor-determina/2022-11-23T10:42:38+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-forme-farmaceutice-sunt-critice-din-punct-de-vedere-biofarmaceutic/2022-11-23T10:44:04+02:00https://health-pharma.ro/question/biodisponibilitatea-relativa-se-foloseste-pentru-a/2022-11-23T10:44:44+02:00https://health-pharma.ro/question/recipientul-de-conditionare-primara-are-urmatoarele-roluri-cu-exceptia/2022-11-23T10:45:05+02:00https://health-pharma.ro/question/utilizarea-precursorilor-medicamentosi-are-scopul-de-a-inlatura-urmatoarele-proprietati-nedorite-ale-substantelor-medicamentoase/2022-11-23T10:45:32+02:00https://health-pharma.ro/question/promotorii-de-absorbtie-sunt-substante-auxiliare-care/2022-11-23T10:46:08+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-substante-auxiliare-actioneaza-datorita-tensiunii-superficiale/2022-11-23T10:47:06+02:00https://health-pharma.ro/question/biodisponibilitatea-sau-disponibilitatea-fiziologica-a-medicamentelor-reprezinta/2022-11-23T10:47:54+02:00https://health-pharma.ro/question/echivalenta-farmacologica-a-doua-medicamente-inseamna-ca/2022-11-23T10:48:34+02:00https://health-pharma.ro/question/alegerea-excipientilor-in-formularea-unui-medicament-se-face-in-functie-de/2022-11-23T10:49:05+02:00https://health-pharma.ro/question/determinarea-biodisponibilitatii-unui-medicament-in-sange-se-face-prin-reprezentarea-grafica-a/2022-11-23T10:49:37+02:00https://health-pharma.ro/question/doua-medicamente-prezinta-echivalenta-chimica-atunci-cand/2022-11-23T10:50:14+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-materii-prime-farmaceutice-prezinta-viteza-de-dizolvare-mai-mare-implicit-absorbtie-superioara/2022-11-23T10:50:46+02:00https://health-pharma.ro/question/factorii-care-influenteaza-viteza-de-dizolvare-si-implicit-biodisponibilitatea-conform-ecuatiei-lui-noyes-whitney-sunt/2022-07-06T08:36:05+03:00https://health-pharma.ro/question/promotorii-de-absorbtie-actioneaza-prin-urmatoarele-procedee/2022-07-06T08:36:55+03:00https://health-pharma.ro/question/prodrogurile-sau-precursorii-medicamentosi-sunt-substante-care/2022-07-06T08:38:24+03:00https://health-pharma.ro/question/substituirea-unui-medicament-cu-altul-nu-este-recomandata-in-urmatoarele-cazuri/2022-07-06T08:39:31+03:00https://health-pharma.ro/question/factorii-fizico-chimici-care-influenteaza-biodisponibilitatea-sunt/2022-07-06T08:40:11+03:00https://health-pharma.ro/question/substante-auxiliare-care-pot-influenta-biodisponibilitatea-medicamentelor-sunt/2022-07-06T08:42:13+03:00https://health-pharma.ro/question/permeabilitatea-unei-substante-medicamentoase-prin-membranele-gastrointestinale-depinde-de/2022-11-23T10:51:18+02:00https://health-pharma.ro/question/doua-produse-medicamentoase-sunt-echivalente-terapeutic-atunci-cand/2022-11-23T10:51:40+02:00https://health-pharma.ro/question/pentru-determinarea-biodisponibilitatii-relative-optimale-se-foloseste-ca-termen-de-comparare-pentru-forma-farmaceutica-a-carei-biodisponibilitate-se-apreciaza/2022-11-23T10:52:08+02:00https://health-pharma.ro/question/fenomenele-care-pot-aparea-in-urma-asocierii-unei-substante-medicamentoase-cu-un-excipient-incompatibil-sunt/2022-11-23T10:52:48+02:00https://health-pharma.ro/question/determinarea-biodisponibilitatii-in-urmatoarele-cazuri/2022-11-23T10:53:43+02:00https://health-pharma.ro/question/formularea-medicamentelor-reprezinta-procedeul-prin-care/2022-11-23T10:54:47+02:00https://health-pharma.ro/question/factorii-farmaceutico-tehnologici-care-pot-influenta-biodisponibilitate-sunt/2022-11-23T10:55:30+02:00https://health-pharma.ro/question/punctul-de-plecare-in-formularea-unui-medicament-nou-il-constituie/2022-11-23T10:55:58+02:00https://health-pharma.ro/question/pentru-care-din-urmatoarele-substante-reducerea-dimensiunii-particulelor-poate-determina-micsorarea-biodisponibilitatii/2022-11-23T10:56:33+02:00https://health-pharma.ro/question/viteza-de-eliberare-a-substantei-active-din-formele-farmaceutice-cu-administrare-perorala-scade-in-ordinea/2022-11-23T10:58:04+02:00https://health-pharma.ro/question/optimizarea-absorbtiei-substantei-medicamentoase-se-poate-realiza-prin/2022-11-23T10:58:51+02:00https://health-pharma.ro/question/medicamentele-alternative-terapeutic-sunt-cele-care-contin/2022-11-23T10:59:32+02:00https://health-pharma.ro/question/biodisponibilitatea-unui-medicament-inseamna/2022-11-23T10:59:59+02:00https://health-pharma.ro/question/doua-medicamente-prezinta-echivalenta-farmaceutica-atunci-cand/2022-11-23T11:00:55+02:00https://health-pharma.ro/question/factorii-specifici-substantei-medicamentoase-care-influenteaza-biodisponibilitatea-sunt/2022-11-23T11:02:02+02:00https://health-pharma.ro/question/conform-sistemului-de-clasificare-biofarmaceutica-scb-clasa-i-include-substante-cu/2022-11-23T11:04:46+02:00https://health-pharma.ro/question/excipientii-utilizati-in-formulare-influenteaza-urmatoarele-elemente-de-calitate-a-medicamentelor/2022-11-23T11:05:23+02:00https://health-pharma.ro/question/bioechivalenta-corespunde-medicamentelor/2022-11-23T11:05:41+02:00https://health-pharma.ro/question/formularea-unui-medicament-presupune-alegerea/2022-11-23T11:06:24+02:00https://health-pharma.ro/question/urmatoarele-substante-auxiliare-au-solubilitate-selectiva-in-sucurile-gastrointestinale/2022-11-23T11:07:24+02:00https://health-pharma.ro/question/biodisponibilitatea-absoluta-a-unui-medicament-exprimata-in-procente-reprezinta/2022-11-23T11:08:48+02:00https://health-pharma.ro/question/un-nou-medicament-formulat-si-realizat-la-scara-de-laborator-este-supus-unui-studiu-complex-pentru-stabilirea/2022-11-23T11:10:23+02:00https://health-pharma.ro/question/dosarul-farmaceutic-pentru-un-medicament-cuprinde/2022-11-23T11:11:03+02:00https://health-pharma.ro/question/exista-urmatoarele-tipuri-de-biodisponibilitate-a-medicamentelor/2022-11-23T11:11:37+02:00https://health-pharma.ro/question/capacitatea-de-traversare-a-celulelor-membranare-de-catre-substanta-medicamentoasa-poate-fi-masurata-prin/2022-11-23T11:12:20+02:00https://health-pharma.ro/question/pe-baza-curbei-concentratiei-sangvine-timp-se-pot-stabili-urmatorii-parametri-farmacocinetici-importanti-pentru-studiile-de-biodisponibilitate/2022-11-23T11:12:56+02:00https://health-pharma.ro/question/polimorfii-unei-substante-prezinta-aceeasi/2022-11-23T11:13:30+02:00https://health-pharma.ro/question/micsorarea-dimensiunii-particulelor-determina-cresterea-tolerantei-in-cazul/2022-11-23T11:14:08+02:00https://health-pharma.ro/question/spre-deosebire-de-starea-hidratata-starea-anhidra-a-unei-substante-medicamentoase-prezinta/2022-11-23T11:14:34+02:00https://health-pharma.ro/question/tipul-de-forma-farmaceutica-influenteaza-biodisponibilitatea-prin/2022-11-23T11:15:07+02:00https://health-pharma.ro/question/urmatorul-procedeu-de-fabricare-poate-influenta-cedarea-substantei-medicamentoase-din-comprimate/2022-11-23T11:15:31+02:00https://health-pharma.ro/question/microemulsiile-injectabile-se-diferentiaza-de-emulsii-prin-urmatoarele-caracteristici/2022-11-23T11:16:18+02:00https://health-pharma.ro/question/lichidele-pentru-dializa-peritoneala-se-utilizeaza/2022-07-06T10:42:28+03:00https://health-pharma.ro/question/scopul-asocierii-de-antioxidanti-in-formulele-medicamentelor-injectabile-este-de-protejare-a/2022-11-23T11:18:09+02:00https://health-pharma.ro/question/despre-sterilizarea-cu-vapori-sub-presiune-sunt-adevarate-urmatoarele/2022-11-23T11:18:54+02:00https://health-pharma.ro/question/precizati-care-sunt-solventii-ofici-nall-pentru-preparatele-injectablie/2022-11-23T11:20:45+02:00https://health-pharma.ro/question/concentratia-solutiel-oficinale-per-fuzabili-de-glucoza-este/2022-05-06T13:11:42+03:00https://health-pharma.ro/question/sunt-adevarate-urmatoarele-afirmatii-referitoare-la-caile-de-administrare-parenterale/2022-11-23T11:24:01+02:00https://health-pharma.ro/question/avantajele-radiosterilizarii-sunt/2022-11-23T11:27:23+02:00https://health-pharma.ro/question/conform-monografiel-infundibilia-urmatoarele-categorii-de-substante-auxllare-nu-sunt-admise-la-preparare/2022-11-23T11:28:23+02:00https://health-pharma.ro/question/urmatoarele-afirmatli-referitoare-la-produsul-iniectabile-natril-lodidi-sunt-false/2022-05-06T13:44:14+03:00https://health-pharma.ro/question/timpul-intre-productia-apei-distilate-si-sterilizarea-solutiilor-injectabile-preparate-sa-nu-depaseasca/2022-11-23T11:29:39+02:00https://health-pharma.ro/question/onografia-iniectabilia-prevede-urmatoarele-afirmatii-pentru-parametrul-izotonie/2022-05-06T13:36:16+03:00https://health-pharma.ro/question/la-prepararea-solutiilor-injectabile-cel-mai-folosit-sistem-tampon-este/2022-11-23T11:30:49+02:00https://health-pharma.ro/question/concentratia-solutiei-oficinale-injectabile-de-acid-ascorbic-este/2022-11-23T11:31:11+02:00https://health-pharma.ro/question/agentii-antimicrobieni-folositi-in-formulele-preparatelor-parenterale-sunt/2022-11-23T11:31:36+02:00https://health-pharma.ro/question/un-solvent-anhidru-este-selectat-in-formularea-medicamentelor-parenterale-in-functie-de/2022-11-23T11:32:34+02:00https://health-pharma.ro/question/eliminarea-pirogenelor-se-poate-obtine-prin/2022-11-23T11:33:06+02:00https://health-pharma.ro/question/despre-sterilizatorul-cu-benzi-hidraulice-sunt-adevarate-urmatoarele/2022-11-23T11:33:41+02:00https://health-pharma.ro/question/alegeti-tipurile-de-sali-albe-sterile/2022-11-23T11:34:30+02:00https://health-pharma.ro/question/la-administrarea-solutiilor-peretele-capilar-prezinta-diverse-caracteristici-cu-exceptia/2022-11-23T11:34:59+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-afirmatii-cu-privire-la-substantele-pirogene-sunt-adevarate/2022-11-23T11:35:58+02:00https://health-pharma.ro/question/factorii-de-care-depinde-calitatea-apei-distilate-sunt/2022-11-23T11:36:37+02:00https://health-pharma.ro/question/indicator-biologic-radiosensibil-este/2022-11-23T11:37:00+02:00https://health-pharma.ro/question/perfuziile-pentru-nutritie-parenterala/2022-11-23T11:37:23+02:00https://health-pharma.ro/question/conform-fr-x-indicatorii-biologici-folositi-pentru-controlul-sterilizarii-sunt/2022-11-23T11:38:06+02:00https://health-pharma.ro/question/la-adaugarea-cosolventilor-in-formulele-medicamentelor-parenterale-se-au-in-vedere-urmatoarele-probleme-care-pot-sa-apara/2022-11-23T11:39:05+02:00https://health-pharma.ro/question/afirmatia-corecta-despre-sterilizarea-prin-caldura-umeda-este/2022-11-23T11:39:35+02:00https://health-pharma.ro/question/conditiile-de-lucru-pentru-tehnica-fluxului-laminar-sunt-urmatoarele-cu-exceptia/2022-11-23T11:39:56+02:00https://health-pharma.ro/question/urmatoarele-substante-auxiliare-se-folosesc-ca-agenti-de-suspendare-in-formularea-medicamentelor-injectabile-cu-exceptia/2022-11-23T11:46:46+02:00https://health-pharma.ro/question/urmatoarele-prevederi-referitoare-la-solutiile-uleioase-injectabile-sunt-valabile-cu-exceptia/2022-11-23T11:47:28+02:00https://health-pharma.ro/question/precizati-preparatele-care-nu-sunt-incluse-in-categoria-preparatelor-parenterale/2022-11-23T11:48:18+02:00https://health-pharma.ro/question/plastomerii-utilizati-cel-mai-des-pentru-conditionarea-medicamentelor-parenterale-sunt/2022-11-23T11:48:57+02:00https://health-pharma.ro/question/selectati-afirmatiile-adevarate-referitoare-la-fabricarea-solutiilor-injectabile/2022-11-23T11:50:13+02:00https://health-pharma.ro/question/tipurile-de-inchidere-a-fiolelor-ce-contin-solutii-injectabile-sunt/2022-11-23T11:51:03+02:00https://health-pharma.ro/question/contaminarea-cu-pirogene-trebuie-verificata-la-urmatoarele-grupe-de-substante-active/2022-11-23T11:51:31+02:00https://health-pharma.ro/question/macromoleculele-adaugate-intr-o-solutie-apoasa-injectabila-vor-contribui-la/2022-11-23T11:56:32+02:00https://health-pharma.ro/question/ajustarea-izotoniei-unei-solutii-injectabile-se-poate-realiza-prin/2022-11-23T11:56:59+02:00https://health-pharma.ro/question/la-administrarea-excesiva-intravenoasa-a-unei-solutii-de-clorura-de-sodiu-09-m-v-se-produce-fenomenul-de/2022-11-23T11:57:26+02:00https://health-pharma.ro/question/o-solutie-injectabila-care-are-un-ph-egal-cu-cel-al-serului-sangvin-este-considerata/2022-11-23T11:57:58+02:00https://health-pharma.ro/question/viteza-de-absorbtie-a-unui-medicament-injectabil-administrat-pe-cale-i-m-depinde-de/2022-11-23T11:58:24+02:00https://health-pharma.ro/question/concentratele-pentru-solutii-injeetabile-si-perfuzabile-sunt/2022-07-06T13:20:35+03:00https://health-pharma.ro/question/agentii-stabilizanti-utilizati-pentru-asigurarea-stabilitatii-suspensiilor-injectabile-sunt/2022-07-06T13:21:08+03:00https://health-pharma.ro/question/conditiile-de-pastrare-pentru-majoritatea-preparatelor-injectabile-sunt/2022-07-06T13:21:38+03:00https://health-pharma.ro/question/avantajele-recipientelor-din-materiale-plastice-folosite-la-conditionarea-solutiilor-de-uz-parenteral-sunt/2022-07-06T13:22:12+03:00https://health-pharma.ro/question/izotonia-trebuie-luata-in-considerare-pentru-urmatoarele-forme-farmaceutice/2022-07-06T13:22:41+03:00https://health-pharma.ro/question/nu-sunt-forme-farmaceutice-parenterale-cu-eliberare-modificata/2022-07-06T13:23:09+03:00https://health-pharma.ro/question/endotoxinele-sunt-definite-de-urmatoarele-proprietati/2022-07-06T13:23:43+03:00https://health-pharma.ro/question/selectati-prevederile-monografici-infundibilia-pentru-parametrul-uniformitatea-volumului/2022-11-23T12:01:07+02:00https://health-pharma.ro/question/conform-fr-x-filtrele-folosite-la-sterilizare-pot-fi-confectionate-din/2022-05-06T13:12:08+03:00https://health-pharma.ro/question/senzatia-de-durere-la-administrarea-medicamentelor-parenterale-este-data-de/2022-11-23T12:02:02+02:00https://health-pharma.ro/question/alegerea-solventului-pentru-obtinerea-solutiilor-injectabile-se-face-in-functie-de/2022-11-23T12:02:31+02:00https://health-pharma.ro/question/rolul-ph-ului-in-formularea-medicamentelor-parenterale/2022-11-23T12:02:57+02:00https://health-pharma.ro/question/solutiile-utilizate-pentru-actiunea-dezinfectanta-sunt/2022-11-23T12:03:27+02:00https://health-pharma.ro/question/un-volum-de-1000-ml-solutie-perfuzabila-contine-255-g-kci-cati-meq-k-sunt-prezenti-in-aceasta-solutie-745/2022-05-06T13:43:41+03:00https://health-pharma.ro/question/fr-x-prevede-un-interval-de-ph-pentru-solutiile-injectabile-cu-valori-de/2022-05-06T13:32:38+03:00https://health-pharma.ro/question/care-sunt-conditiile-de-calitate-ale-plastomerilor-folositi-in-conditionarea-medicamentelor-parenterale/2022-07-06T13:46:51+03:00https://health-pharma.ro/question/despre-deshidratarea-hipotonica-putem-afirma-urmatoarele/2022-07-06T13:49:34+03:00https://health-pharma.ro/question/stabilitatea-substantelor-medicamentoase-prelucrate-in-forme-farmaceutice-injectabile-se-va-baza-pe-studii-analitice-care-sa-permita/2022-07-06T13:50:36+03:00https://health-pharma.ro/question/metodele-de-depirogenare-prin-eliminarea-pirogenelor-constau-in/2022-11-23T12:05:10+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-surse-pot-contamina-preparatele-parenterale-cu-substante-pirogene/2022-11-23T12:05:48+02:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-produsul-infundibile-natrii-chloridi-composita/2022-11-23T12:06:12+02:00https://health-pharma.ro/question/produsele-ce-nu-se-pot-steriliza-cu-ajutorul-caldurii-sunt/2022-11-23T12:06:45+02:00https://health-pharma.ro/question/cati-meq-na-se-gasesc-intr-un-litru-de-solutie-perfuzabila-de-nacl-09-myag-5845/2022-11-23T12:07:14+02:00https://health-pharma.ro/question/solventul-cel-mai-frecvent-folosit-pentru-obtinerea-solutiilor-injectabile-este/2022-11-23T12:07:45+02:00https://health-pharma.ro/question/degradarea-proteinelor-se-produce-in-urmatoarele-conditii-de-mediu-cu-exceptia/2022-11-23T12:08:06+02:00https://health-pharma.ro/question/pentru-prepararea-solutiilor-injectabile-substantele-medicamentoase-higroscopice-si-delicvescente-se-vor-usca-la-etuva/2022-07-06T13:56:21+03:00https://health-pharma.ro/question/o-solutie-izotonica-are/2022-07-06T13:56:47+03:00https://health-pharma.ro/question/carbonatul-acid-de-sodiu-prezinta-ca-impuritate-admisa/2022-07-06T13:57:10+03:00https://health-pharma.ro/question/urmatoarele-prevederi-din-fr-x-referitoare-la-uleiurile-vegetale-folosite-in-formularea-medicamentelor-injectabile-sunt-valabile-cu-exceptia/2022-07-06T13:58:05+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-produsul-iniectabile-glyceryli-trinitratis/2022-07-06T13:59:28+03:00https://health-pharma.ro/question/mentionati-tipul-de-sticla-recomandat-de-farmacopei-pentru-conditionarea-solutiilor-injectabile-si-perfuzabile/2022-07-06T14:00:02+03:00https://health-pharma.ro/question/se-vor-prepara-solutii-injectabile-cu-ph-acid-pentru-urmatoarele-substante-medicamentoase/2022-11-23T12:08:47+02:00https://health-pharma.ro/question/despre-substantele-antiseptice-nu-este-adevarata-afirmatia/2022-11-23T12:09:10+02:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-inactivarea-endotoxinelor-prin-hidroliza-acida-sau-alcalina/2022-11-23T12:09:36+02:00https://health-pharma.ro/question/marimea-particulelor-insolubile-prezente-in-solutiile-injectabile-care-pot-provoca-granuloame-si-microtromboze-este-cuprinsa-in-intervalul/2022-11-23T12:10:18+02:00https://health-pharma.ro/question/metoda-de-sterilizare-aleasa-in-cazul-unei-solutii-perfuzabile-cu-glucoza-este/2022-11-23T12:10:45+02:00https://health-pharma.ro/question/cele-mai-folosite-proteine-ca-surse-de-aminoacizi-sunt/2022-11-23T12:11:08+02:00https://health-pharma.ro/question/conservantii-antimicrobieni-se-pot-asocia-cu-urmatoarea-metoda-de-sterilizare/2022-07-06T14:06:39+03:00https://health-pharma.ro/question/solventii-anhidri-utilizati-la-prepararea-medicamentelor-injectabile-sunt/2022-07-06T14:07:35+03:00https://health-pharma.ro/question/gluconatul-de-calciu-prezinta-ca-impuritate-neadmisa/2022-07-06T14:07:56+03:00https://health-pharma.ro/question/selectati-afirmatia-falsa-privind-serul-sangvin/2022-07-06T14:08:29+03:00https://health-pharma.ro/question/metodele-de-depirogenare-prin-inactivarea-endotoxinelor-constau-in/2022-07-06T14:09:09+03:00https://health-pharma.ro/question/la-prepararea-unei-solutii-perfuzabile-de-clorura-de-sodiu-cu-un-continut-de-20-meq-l-se-vor-dizolva-intr-un-litru-de-apa/2022-07-06T14:09:55+03:00https://health-pharma.ro/question/apirogenitatea-este-o-conditie-obligatorie-pentru-urmatoarele-categorii-de-preparate-parenterale/2022-07-06T14:10:20+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-produsul-infundibile-mannitoli-sunt-adevarate/2022-11-23T12:11:46+02:00https://health-pharma.ro/question/in-conditii-fiziologice-normale-valoarea-ph-ului-sangvin-este-de/2022-11-23T12:20:34+02:00https://health-pharma.ro/question/principalele-surse-de-substante-pirogene-sunt/2022-11-23T12:21:02+02:00https://health-pharma.ro/question/din-lista-de-mai-jos-selectati-caile-principale-de-administrare-parenterala-a-medicamentelor/2022-11-23T12:21:55+02:00https://health-pharma.ro/question/controlul-impuritatilor-pirogene/2022-11-23T12:22:26+02:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-particulele-insolubile-din-solutiile-injectabile/2022-11-23T12:23:08+02:00https://health-pharma.ro/question/la-preparatele-injectabile-pot-surveni-alterari-in-timpul-fabricarii-depozitarii-si-transportului/2022-07-06T14:16:57+03:00https://health-pharma.ro/question/prezenta-pirogenelor-nu-este-admisa-in-medicamentele-parenterale-deoarece-sunt/2022-07-06T14:17:32+03:00https://health-pharma.ro/question/din-lista-de-mai-jos-selectati-procedeele-fizice-de-sterilizare/2022-07-06T14:17:59+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-solutii-perfuzabile-sunt-folosite-in-tratamentul-alcalozei-metabolice/2022-11-23T20:13:23+02:00https://health-pharma.ro/question/unul-dintre-factorii-principali-care-asigura-desfasurarea-unei-activitati-biologice-intr-un-mediu-hidroelectrolitic-constant-este/2022-07-06T14:19:26+03:00https://health-pharma.ro/question/in-productia-pulberilor-pentru-solutii-injectabile-sau-perfuzabile-se-efectueaza-urmatoarele-determinari/2022-07-06T14:20:53+03:00https://health-pharma.ro/question/conform-monografiei-infundibilia-preparatele-parenterale-sunt-definite-ca-fiind/2022-07-06T14:23:34+03:00https://health-pharma.ro/question/selectati-filtrele-cu-membrana/2022-11-23T12:23:51+02:00https://health-pharma.ro/question/despre-oxidul-de-etilen-sunt-adevarate-urmatoarele/2022-11-23T12:24:14+02:00https://health-pharma.ro/question/despre-filtrele-de-sticla-sinterizata-sunt-adevarate-urmatoarele/2022-11-23T12:24:46+02:00https://health-pharma.ro/question/contactul-cu-solutiile-hipertone-determina-urmatoarele-fenomene/2022-11-23T12:25:28+02:00https://health-pharma.ro/question/conform-fr-x-prin-valoarea-d-a-indicatorilor-biologici-se-intelege/2022-11-23T12:26:19+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-referitoare-la-calea-de-administrare-intravasculara/2022-11-23T12:27:22+02:00https://health-pharma.ro/question/lonograma-serului-sangvin-indica-un-deficit-de-42-meq-nat-calculati-cantitatea-de-clorura-de-sodiu-necesara-pentru-a-rezolva-acest-deficit-m-5845/2022-05-06T13:35:18+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-produsul-oficinal-infundibile-glucosi/2022-07-06T14:32:25+03:00https://health-pharma.ro/question/alegeti-substantele-medicamentoase-pentru-care-farmacopeile-prevad-sorturi-speciale-la-obtinerea-solutiilor-injectabile/2022-07-06T14:33:03+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-privind-inocuitatea-medicamentelor-injectabile/2022-07-06T14:33:52+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-elemente-pot-fi-surse-de-impurificare-a-solutiilor-injectabile/2022-07-06T14:34:29+03:00https://health-pharma.ro/question/prefiltrarea-aerului-in-spatiul-de-productie-a-medicamentelor-injectabile-se-realizeaza-prin-diverse-tipuri-de-filtre-cu-exceptia-celor-4/2022-07-06T14:34:58+03:00https://health-pharma.ro/question/implanturile-ca-preparate-parenterale-cu-actiune-prelungita-prezinta-o-serie-de-caracteristici-cu-exceptia/2022-11-23T12:28:18+02:00https://health-pharma.ro/question/despre-formaldehida-sunt-adevarate-urmatoarele/2022-11-23T12:28:41+02:00https://health-pharma.ro/question/endotoxinele-prezinta-urmatoarele-proprietati/2022-11-23T12:29:08+02:00https://health-pharma.ro/question/in-cazul-emulsiilor-injectabile-eliberarea-substantei-medicamentoase-depinde-de/2022-11-23T12:29:40+02:00https://health-pharma.ro/question/apa-distilata-este-cel-mai-folosit-solvent-in-formulele-solutiilor-parenterale-pentru-ca/2022-11-23T12:30:07+02:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-produsul-iniectabile-etamsylati-sunt-false/2022-11-23T12:30:34+02:00https://health-pharma.ro/question/conform-monografiei-parenteralia-preparatele-parenterale-sunt/2022-07-06T15:02:58+03:00https://health-pharma.ro/question/despre-ultrasunete-este-adevarata-urmatoarea-afirmatie/2022-07-06T15:03:28+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-excipientii-utilizati-la-obtinerea-preparatelor-parenterale-conform-monografiei-parenteralia/2022-07-06T15:04:55+03:00https://health-pharma.ro/question/din-analiza-serului-sangvin-a-unui-pacient-reiese-ca-prezinta-un-deficit-de-15-meq-k-sa-se-calculeze-cantitatea-de-kcl-necesara-corectarii-acestui-deficit-mkcl745/2022-05-06T13:25:52+03:00https://health-pharma.ro/question/care-sunt-avantajele-cauciucurilor-folosite-la-conditionarea-solutiilor-de-uz-parenteral/2022-07-06T15:05:37+03:00https://health-pharma.ro/question/solubilizantii-folositi-in-formularea-solutiilor-injectabile-sunt/2022-07-06T15:06:04+03:00https://health-pharma.ro/question/proprietatile-coligative-ale-solutiilor-injectabile-sunt-utile-in-determinarea/2022-11-23T12:31:24+02:00https://health-pharma.ro/question/se-folosesc-ca-inlocuitori-de-plasma/2022-11-23T12:31:46+02:00https://health-pharma.ro/question/ionograma-unui-pacient-arata-un-deficit-de-40-meq-nat-ce-volum-exprimat-in-ml-de-solutie-perfuzabila-de-nacl-trebuie-administrat-pentru-reducerea-lui-mnacl-5845/2022-11-23T12:32:49+02:00https://health-pharma.ro/question/in-formularea-medicamentelor-parenterale-sunt-cuprinse/2022-11-23T12:33:14+02:00https://health-pharma.ro/question/mpuritatile-de-sticla-intr-o-solutie-injectabila-pot-avea-originea-in-urmatoarele-procese/2022-05-06T13:35:28+03:00https://health-pharma.ro/question/deficitul-de-potasiu-poate-fi-recunoscut-prin-diverse-manifestari-cu-exceptia/2022-11-23T12:34:21+02:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-produsul-iniectabile-dinatrii-hydrogenophosphatis-2p-sunt-false/2022-11-23T12:34:47+02:00https://health-pharma.ro/question/substantele-tampon-utilizate-pentru-solutiile-injectabile-sunt/2022-07-06T15:23:18+03:00https://health-pharma.ro/question/excesul-de-volum-izotonic-poate-fi-cauzat-de-o-serie-de-factori-cu-exceptia/2022-07-06T15:23:37+03:00https://health-pharma.ro/question/emulgatorii-sintetici-utilizati-in-formulele-emulsiilor-perfuzabile-sunt/2022-07-06T15:24:00+03:00https://health-pharma.ro/question/mecanism-de-sterilizare-prin-alchilare-are/2022-05-06T13:35:21+03:00https://health-pharma.ro/question/0-emulsie-injectabila-prezinta-urmatoarele-cerinte/2022-07-06T15:25:56+03:00https://health-pharma.ro/question/la-alegerea-substantelor-tampon-in-formularea-solutiilor-injectabile-se-va-tine-cont-de-urmatoarele-deziderate/2022-07-06T15:26:27+03:00https://health-pharma.ro/question/impuritatile-chimice-prezente-in-solutiile-injectabile-pot-genera/2022-07-06T15:26:49+03:00https://health-pharma.ro/question/principalele-compartimente-din-spatiul-de-producfle-al-medicamentelor-parenterale/2022-11-23T12:36:08+02:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-solutia-perfuzabila-de-lactat-de-sodiu/2022-11-23T12:36:43+02:00https://health-pharma.ro/question/conform-monografiei-infundibilia-ph-ul-preparatelor-perfuzabile/2022-11-23T12:37:07+02:00https://health-pharma.ro/question/sistemul-perfuzor/2022-11-23T12:37:57+02:00https://health-pharma.ro/question/medicamentele-perfuzabile-prezinta-o-serie-de-avantaje-cu-exceptia/2022-11-23T12:38:57+02:00https://health-pharma.ro/question/conditiile-de-calitate-obligatorii-pentru-medicamentele-perfuzabile-sunt/2022-11-23T12:39:20+02:00https://health-pharma.ro/question/propilenglicolul-se-utilizeaza-in-formularea-medicamentelor-parenterale-pentru-urmatoarele-avantaje-cu-exceptia/2022-07-06T15:32:40+03:00https://health-pharma.ro/question/afirmatiile-corecte-despre-filtrarea-sterilizanta-sunt/2022-07-06T15:33:08+03:00https://health-pharma.ro/question/la-utilizarea-uleiurilor-vegetale-pentru-prepararea-medicamentelor-injectabile-se-vor-lua-in-considerare-urmatoarele-aspecte/2022-07-06T15:33:33+03:00https://health-pharma.ro/question/la-obtinerea-latexurilor-injecta-bile-pot-fi-utilizate/2022-07-06T15:33:55+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-solutia-perfuzabila-de-hidrogenocarbonat-de-sodiu/2022-07-06T15:34:33+03:00https://health-pharma.ro/question/afirmatia-falsa-despre-sterilizarea-in-vapori-fluenti-este/2022-07-06T15:34:58+03:00https://health-pharma.ro/question/punctul-crioscopie-este/2022-11-23T12:44:33+02:00https://health-pharma.ro/question/conform-monografiei-parenteralia-eticheta-trebuie-sa-mentioneze/2022-11-23T13:02:40+02:00https://health-pharma.ro/question/selectati-afirmatiile-adevarate-referitoare-la-recipientele-destinate-preparatelor-parenterale-conform-monografiei-parenteralia/2022-11-23T13:06:41+02:00https://health-pharma.ro/question/concentratia-solutiei-oficinale-injectabile-de-digoxina-este/2022-11-23T13:07:12+02:00https://health-pharma.ro/question/obtinerea-de-medicamente-parenterale-apirogene-este-posibila-in-urmatoarele-conditii/2022-11-23T13:07:54+02:00https://health-pharma.ro/question/exotoxinele-sunt/2022-11-23T13:08:13+02:00https://health-pharma.ro/question/germenul-patogen-cu-sperii-cei-mai-rezistenti-la-calduri-este/2022-11-23T13:11:10+02:00https://health-pharma.ro/question/selectati-avantajele-cailor-parenterale-de-administrare-a-medicamentelor/2022-11-23T13:11:39+02:00https://health-pharma.ro/question/aspeetul-solutiilor-inject-ile-est-urmarit-cu-urmatoarele-aparate/2022-11-23T13:13:24+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-produse-perfuzabile-sunt-oficinale/2022-11-23T13:15:07+02:00https://health-pharma.ro/question/urmatoarele-substante-auxiliare-se-folosesc-ca-agenti-de-suspendare-in-formularea-medicamentelor-injectabile-cu-exceptia-2/2022-11-23T13:15:40+02:00https://health-pharma.ro/question/endotoxinele-au-afinitate-pentru-urmatorii-polimeri-hidrofobi/2022-11-23T13:16:04+02:00https://health-pharma.ro/question/conditiile-pe-care-trebuie-sa-le-indeplineasca-solventii-in-formulele-solutiilor-injectabile-sunt/2022-11-23T13:16:37+02:00https://health-pharma.ro/question/glicofurolul-este-un-solvent-folosit-la-obtinerea-unor-preparate-parenterale-pentru-urmatoarele-proprietati/2022-11-23T13:17:05+02:00https://health-pharma.ro/question/medicamentele-perfuzabile-se-utilizeaza/2022-11-23T13:17:20+02:00https://health-pharma.ro/question/metodele-de-sterilizare-prevazute-de-fr-x-sunt/2022-11-23T13:17:41+02:00https://health-pharma.ro/question/prevenirea-aparitiei-substantelor-pirogene-in-preparatele-parenterale-se-obtine-prin/2022-11-23T13:18:08+02:00https://health-pharma.ro/question/ionograma-serului-sangvin-indica-un-deficit-de-5-meq-na-calculati-cantitatea-de-carbonat-acid-de-sodiu-necesara-pentru-a-rezolva-acest-deficit-mnahco384/2022-11-23T13:18:27+02:00https://health-pharma.ro/question/afirmatiile-corecte-despre-sterilizarea-prin-electroni-accelerati-sunt/2022-11-23T13:19:06+02:00https://health-pharma.ro/question/selectati-afirmatiile-adevarate-pentru-definirea-procesului-de-osmoza/2022-07-06T15:49:48+03:00https://health-pharma.ro/question/conform-monografiei-infundibilia-preparatele-perfuzabile-sunt/2022-07-06T15:50:49+03:00https://health-pharma.ro/question/uleiul-de-floarea-soarelui-folosit-la-prepararea-medicamentelor-injectabile-trebuie-sa-corespunda-urmatoarelor-exigente-de-calitate-cu-exceptia/2022-07-06T15:51:20+03:00https://health-pharma.ro/question/urmatoarele-prevederi-referitoare-la-preparatele-perfuzabile-sunt-valabile-cu-exceptia/2022-07-06T15:51:49+03:00https://health-pharma.ro/question/selectati-solventul-care-indeplineste-conditia-de-inocuitate-in-formularea-medicamentelor-injectabile/2022-07-06T15:52:11+03:00https://health-pharma.ro/question/la-curatarea-dopurilor-de-cauciuc-se-foloseste/2022-07-06T15:52:36+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-substante-nu-este-folosita-la-sterilizare-prin-gaze/2022-11-23T13:19:42+02:00https://health-pharma.ro/question/urmatoarele-substante-pot-fi-utilizate-ca-adsorbanti-fizici-pentru-eliminarea-pirogenelor/2022-11-23T13:20:03+02:00https://health-pharma.ro/question/sterilizarea-cu-aer-cald-se-realizeaza-in/2022-11-23T13:20:26+02:00https://health-pharma.ro/question/conform-monografiei-infundibilia-urmatoarele-afirmatii-sunt-adevarate-pentru-prepararea-preparatelor-perfuzabile/2022-11-23T13:21:20+02:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-produsul-iniectabile-calcii-chloridi/2022-11-23T13:21:41+02:00https://health-pharma.ro/question/nu-reprezinta-o-calitate-obligatorie-a-solutiilor-parenterale/2022-11-23T13:22:00+02:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-produsul-iniectabilemagnesii-sulfatis-sunt-adevarate/2022-07-06T15:58:09+03:00https://health-pharma.ro/question/apartin-categoriei-formelor-farmaceutice-parenterale-cu-eliberare-controlata/2022-07-06T15:58:40+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-suspensiile-injectabile/2022-07-06T15:59:07+03:00https://health-pharma.ro/question/precizati-care-dintre-afirmatiile-referitoare-la-pudrele-sterile-este-falsa/2022-07-06T15:59:30+03:00https://health-pharma.ro/question/mecanismele-de-actiune-intalnite-in-procedeele-de-sterilizare-sunt/2022-07-06T15:59:59+03:00https://health-pharma.ro/question/substantele-inlocuitoare-de-volum-sangvin-trebuie-sa-indeplineasca-urmatoarele-conditii/2022-11-23T13:28:52+02:00https://health-pharma.ro/question/selectati-procedeul-folosit-pentru-produsele-care-nu-pot-fi-sterilizate-dupa-conditionarea-definitiva/2022-11-23T13:29:19+02:00https://health-pharma.ro/question/care-din-urmatoarele-afirmatii-referitoare-la-fenomenul-de-primaj-sunt-false/2022-11-23T13:29:39+02:00https://health-pharma.ro/question/oleatul-de-etil-este-folosit-ca-solvent-in-formularea-medicamentelor-parenterale-deoarece/2022-11-23T13:29:58+02:00https://health-pharma.ro/question/limita-de-conservare-este-atunci-cand-un-produs-injectabil-a-pierdut-din-activitatea-sa/2022-11-23T13:30:19+02:00https://health-pharma.ro/question/conservarea-preparatelor-perfuzabile-conform-monografiei-infundibilia-se-realizeaza-in/2022-11-23T19:46:22+02:00https://health-pharma.ro/question/un-solvent-anhidru-este-selectat-in-formularea-medicamentelor-parenterale-in-functie-de-2/2022-11-23T19:50:10+02:00https://health-pharma.ro/question/substantele-medicamentoase-trebuie-sa-fie-conditionate-in-recipiente-care-sa-le-asigure/2022-11-23T19:50:36+02:00https://health-pharma.ro/question/reconstituirea-proteinelor-din-aminoacizi-esentiali-are-loc-in-urmatoarele-conditii/2022-11-23T19:51:03+02:00https://health-pharma.ro/question/pulberile-pentru-solutii-injectabile-si-perfuzabile-sunt/2022-11-23T19:51:29+02:00https://health-pharma.ro/question/emulsiile-perfuzabile-prezinta-urmatoarele-exigente-de-calitate/2022-11-23T19:51:59+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-afirmatii-sunt-adevarate-pentru-produsul-iniectabile-digoxini/2022-11-23T19:54:04+02:00https://health-pharma.ro/question/substantele-straine-care-pot-fi-prezente-in-suspensie-intr-o-solutie-injectabila-pot-fi-aduse-de/2022-11-23T19:46:45+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-afirmatii-referitoare-la-endotoxine-sunt-adevarate/2022-11-23T19:47:08+02:00https://health-pharma.ro/question/pentru-prepararea-medicamentelor-parenterale-si-a-solutiilor-pentru-dializa-se-foloseste-conform-fr-x-suplim-2006-si-ph-eur-6th/2022-11-23T19:47:37+02:00https://health-pharma.ro/question/cu-referire-la-formele-farmaceutice-parenterale-cu-actiune-prelungita-care-afirmatii-sunt-corecte/2022-11-23T19:48:05+02:00https://health-pharma.ro/question/acidoza-metabolica-este-definita-prin-urmatoarele/2022-11-23T19:48:32+02:00https://health-pharma.ro/question/microorganismele-contaminante-ale-apei-pentru-preparate-injectabile-sunt/2022-11-23T19:49:43+02:00https://health-pharma.ro/question/urmatoarea-substanta-tampon-este-utilizata-pentru-tamponarea-solufiilor-injectabile/2022-11-23T19:59:26+02:00https://health-pharma.ro/question/caracteristicile-polietilenglicolilor-folositi-la-prepararea-solutiilor-injectabile-sunt/2022-11-23T19:59:49+02:00https://health-pharma.ro/question/despre-sterilizarea-prin-caldura-sunt-adevarate/2022-11-23T20:00:25+02:00https://health-pharma.ro/question/depirogenarea-apei-distilate-se-poate-efectua-prin-urmatoarele-metode-cu-exceptia/2022-11-23T20:00:43+02:00https://health-pharma.ro/question/conform-monografiei-parenteralia-implanturile-sunt/2022-11-23T20:01:26+02:00https://health-pharma.ro/question/conform-fr-x-suplim-2006-si-ph-eur-6-limita-admisa-pentru-impuritati-pirogene-microorganisme-la-apa-pentru-preparate-injectabile-este-de/2022-11-23T20:01:48+02:00https://health-pharma.ro/question/pentru-prepararea-unei-solutii-perfuzabile-de-nacl-cu-un-continut-de-1-meq-l-se-vor-dizolva-intr-un-litru-de-apa-m-nacl-5845/2022-11-23T19:55:16+02:00https://health-pharma.ro/question/despre-sterilizarea-cu-aer-cald-sunt-adevarate-urmatoarele/2022-11-23T19:55:43+02:00https://health-pharma.ro/question/monografia-iniectabilia-prevede-urmatoarele-afirmatii-pentru-parametrul-culoare/2022-11-23T19:56:28+02:00https://health-pharma.ro/question/ph-ul-euhidric-asigura-solutiei-injectabile/2022-11-23T19:56:53+02:00https://health-pharma.ro/question/sterilizarea-cu-aer-cald-se-aplica/2022-11-23T19:57:22+02:00https://health-pharma.ro/question/urmatoarele-enunturi-sunt-adevarate-cu-privire-la-proprietatile-farmacocinetice-ale-medicamentelor-parenterale/2022-11-23T19:58:50+02:00https://health-pharma.ro/question/la-obtinerea-unui-preparat-injectabil/2022-11-23T20:04:54+02:00https://health-pharma.ro/question/conform-fr-x-parametrii-pentru-sterilizarea-cu-vapori-de-apa-sub-presiune-sunt/2022-11-23T20:06:11+02:00https://health-pharma.ro/question/sistemele-tampon-intalnite-in-lichidele-intra-si-extravasculare-sunt/2022-11-23T20:06:39+02:00https://health-pharma.ro/question/efectele-globale-ale-endotoxinelor-constau-in/2022-11-23T20:07:01+02:00https://health-pharma.ro/question/urmele-de-cupru-din-apa-distilata-sunt-un-bun-catalizator-al-oxidarii-urma-toarelor-substante-medicamentoase/2022-11-23T20:07:20+02:00https://health-pharma.ro/question/particulele-insolubile-care-trebuie-indepartate-prin-filtrarea-clarifianta-a-solutiilor-injectabile-pot-fi/2022-11-23T20:07:44+02:00https://health-pharma.ro/question/daca-natura-substantei-medicamentoase-permite-in-formularea-solutiilor-injectabile-se-vor-asigura-urmatoarele-conditii/2022-11-23T20:08:13+02:00https://health-pharma.ro/question/conform-fr-x-diametrul-porilor-membranelor-filtrante-trebuie-sa-fie/2022-11-23T20:02:17+02:00https://health-pharma.ro/question/contactul-cu-solutiile-hipotone-determina-urmatoarele-fenomene/2022-11-23T20:02:42+02:00https://health-pharma.ro/question/alcoolul-etilic-utilizat-ca-solvent-pentru-medicamentele-parenterale-prezinta-urmatoarele-dezavantaje/2022-11-23T20:03:02+02:00https://health-pharma.ro/question/despre-filtrele-cu-membrana-sunt-adevarate/2022-11-23T20:03:22+02:00https://health-pharma.ro/question/agentii-de-oxidare-solubili-in-apa-folositi-in-medicamentele-injectabile-sunt-urmatoarele-substante-cu-exceptia/2022-11-23T20:03:43+02:00https://health-pharma.ro/question/conservantii-antimicrobieni-nu-se-adauga-in-preparatele-injectabile-atunci-cand-acestea-sunt-destinate-administrarii-pe-cale/2022-11-23T20:04:12+02:00https://health-pharma.ro/question/dezavantajele-oxidului-de-etilen-sunt/2022-11-23T20:04:34+02:00https://health-pharma.ro/question/alcoolul-benzilie-utilizat-ea-solvent-pentru-medicamentele-parenterale-prezinta-urmatoarele-avantaje/2022-11-23T20:12:03+02:00https://health-pharma.ro/question/produsele-injectabile-care-contin-ulei-ca-vehicul-sunt/2022-11-23T20:12:26+02:00https://health-pharma.ro/question/solventii-anhidri-miscibili-eu-apa-utilizati-la-prepararea-medicamentelor-injectabile-sunt/2022-11-23T20:12:45+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-solutii-perfuzabile-sunt-folosite-in-tratamentul-acidozei-metabolice/2022-11-23T20:13:34+02:00https://health-pharma.ro/question/in-realizarea-formelor-de-transport-si-eliberare-la-tinta-se-folosese-ca-suporturi-pentru-substanta-medicamentoasa-urmatoarele-particule/2022-11-23T20:14:08+02:00https://health-pharma.ro/question/conform-monografiei-parenteralia-conservantii-antimicrobieni-pot-fi-introdusi-in-formula-unui-preparat-injectabil-atunci-cand/2022-11-23T20:14:37+02:00https://health-pharma.ro/question/mecanismele-de-actiune-ale-agentilor-antioxidanti-sunt-valabile-cu-exceptia/2022-11-23T20:15:31+02:00https://health-pharma.ro/question/izoosmoza-solutiilor-injectabile-se-determina-pe-baza/2022-11-23T20:15:49+02:00https://health-pharma.ro/question/selectati-informatia-falsa-privind-solutia-oficinala-de-metronidazol/2022-11-23T20:16:14+02:00https://health-pharma.ro/question/depirogenarea-materialului-medico-chirurgical-se-realizeaza-prin/2022-11-23T20:16:39+02:00https://health-pharma.ro/question/pentru-a-evita-impurificarea-solutiilor-injectabile-cantarirea-substantelor-trebuie-sa-se-efectueze/2022-11-23T20:16:59+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-solutii-perfuzabile-asigura-aportul-energetic-dupa-administrare/2022-11-23T20:17:45+02:00https://health-pharma.ro/question/preparatele-parenterale-nu-sunt/2022-11-23T20:18:14+02:00https://health-pharma.ro/question/inlocuirea-apei-distilate-cu-un-solvent-anhidru-se-face-in-urmatoarele-situatii-cu-exceptia/2022-11-23T20:18:38+02:00https://health-pharma.ro/question/afirmatiile-corecte-despre-radiatiile-infrarosii-sunt/2022-11-23T20:19:05+02:00https://health-pharma.ro/question/parafina-lichida-solvent-lipofil-nu-se-poate-folosi-in-formularea-preparatelor-parenterale-deoarece/2022-11-23T20:19:37+02:00https://health-pharma.ro/question/indicati-care-dintre-metodele-ce-se-folosesc-pentru-prelungirea-actiunii-unui-preparat-injectabil-nu-sunt-de-natura-fizica/2022-11-23T20:21:17+02:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-afirmatii-referitoare-la-metodele-curative-de-depirogenare-sunt-adevarate/2022-11-23T20:21:49+02:00https://health-pharma.ro/question/afirmatiile-corecte-despre-razele-gamma-sunt/2022-11-23T20:40:56+02:00https://health-pharma.ro/question/afirmatia-corecta-despre-sterilizarea-prin-caldura-uscata-este/2022-11-23T20:41:24+02:00https://health-pharma.ro/question/inocuitatea-medicamentului-injectabil-reprezinta/2022-11-23T20:41:52+02:00https://health-pharma.ro/question/senzatia-de-durere-la-injectarea-unei-solutii-este-data-de-urmatoarele-caracteristici-cu-exceptia/2022-11-23T20:42:20+02:00https://health-pharma.ro/question/valoarea-ph-ului-solutiilor-injeetabile-trebuie-sa-fie-in-limite/2022-11-23T20:42:42+02:00https://health-pharma.ro/question/urmatoarele-substante-se-folosese-in-formularea-inlocuitorilor-de-plasma/2022-11-23T20:43:48+02:00https://health-pharma.ro/question/solutiile-injectabile-trebuie-sa-prezinte-un-ph/2022-07-06T17:33:46+03:00https://health-pharma.ro/question/pentru-solutiile-injectabile-fr-x-prevede-un-interval-de-ph/2022-07-06T17:34:23+03:00https://health-pharma.ro/question/tamponul-extracelular-cel-mai-important-la-nivelul-plasmei-este/2022-07-06T17:34:42+03:00https://health-pharma.ro/question/la-administrarea-solutiilor-injectabile-pe-cale-i-v/2022-07-06T17:35:05+03:00https://health-pharma.ro/question/in-formularea-solutiilor-parenterale-se-pot-folosi-ca-solubilizanti/2022-07-06T17:35:29+03:00https://health-pharma.ro/question/in-formularea-solutiilor-perfuzabile-cerintele-de-calitate-sunt-urmatoarele-cu-exceptia/2022-07-10T14:49:04+03:00https://health-pharma.ro/question/salile-albe-sterile-sunt/2022-07-06T17:36:09+03:00https://health-pharma.ro/question/urmatoarea-precizare-este-valabila-pentru-operatiile-de-preparare-ale-solutiilor-perfuzabile/2022-07-06T17:36:35+03:00https://health-pharma.ro/question/administrarea-lenta-a-perfuziilor-asigura/2022-07-06T17:37:01+03:00https://health-pharma.ro/question/numarul-de-particule-pe-unitatea-de-volum-care-nu-pot-difuza-printr-o-membrana-semipermeabila-este-exprimat-prin/2022-07-06T17:37:22+03:00https://health-pharma.ro/question/prevederile-fr-x-pentru-ph-ul-solutiilor-injectabile-sunt/2022-07-06T17:37:54+03:00https://health-pharma.ro/question/caracteristicile-solutiilor-perfuzabile-sunt-urmatoarele/2022-07-06T17:38:20+03:00https://health-pharma.ro/question/viteza-de-absorbtie-a-unui-medicament-injectabil-pe-cale-i-m-depinde-de/2022-07-06T17:38:45+03:00https://health-pharma.ro/question/eliberarea-substantei-medicamentoase-dintr-o-solutie-injectabila-administrata-i-m/2022-07-06T17:39:29+03:00https://health-pharma.ro/question/emulsiile-multiple-cu-administrare-parenterala/2022-07-06T17:39:54+03:00https://health-pharma.ro/question/sigilarea-fiolelor-se-realizeaza/2022-07-06T17:40:16+03:00https://health-pharma.ro/question/seringile-autoinjectabile/2022-07-06T17:40:35+03:00https://health-pharma.ro/question/mecanismul-de-actiune-al-antisepticelor-gazoase-utilizate-ca-agenti-sterilizanti-este/2022-07-06T17:40:53+03:00https://health-pharma.ro/question/alegeti-afirmatia-corecta-referitoare-la-flambare/2022-07-06T17:42:34+03:00https://health-pharma.ro/question/urmatoarele-reprezinta-calitati-dorite-dar-nu-obligatorii-pentru-preparatele-parenterale/2022-07-06T17:43:01+03:00https://health-pharma.ro/question/nu-face-parte-din-clasa-procedeelor-de-sterilizare-prin-caldura-umeda/2022-07-06T17:43:27+03:00https://health-pharma.ro/question/reprezinta-un-procedeu-chimic-de-sterilizare/2022-07-06T17:43:57+03:00https://health-pharma.ro/question/precizati-care-sunt-metodele-de-control-fizic-utilizate-pentru-masurarea-temperaturii-si-presiunii-in-cursul-sterilizarii/2022-07-06T17:44:23+03:00https://health-pharma.ro/question/alegeti-enunturile-corecte/2022-05-06T13:09:58+03:00https://health-pharma.ro/question/filtrele-cu-membrana-sunt-confectionate-din/2022-07-06T17:52:51+03:00https://health-pharma.ro/question/afirmatiile-corecte-referitoare-la-asepsie-sunt/2022-07-06T17:53:11+03:00https://health-pharma.ro/question/alegeti-afirmatia-corecta-referitoare-la-metodele-termice-de-sterilizare/2022-07-06T17:53:35+03:00https://health-pharma.ro/question/conform-fr-x-suplim-2006-concentratele-pentru-solutii-injectabile-sau-perfuzabile-sunt/2022-07-06T17:54:43+03:00https://health-pharma.ro/question/selectati-afirmatia-corecta-referitoare-la-emulsiile-perfuzabile-conform-monografiei-parenteralia-preparate-perfuzabile-fr-x-suplim-2004/2022-07-06T17:55:16+03:00https://health-pharma.ro/question/selectati-determinarile-prevazute-de-fr-x-suplim-2004-la-monografia-parenteralia-pulberi-pentru-solutii-injectabile-sau-perfuzabile/2022-07-06T17:56:06+03:00https://health-pharma.ro/question/selectati-afirmatia-adevarata-referitoare-la-etichetarea-pulberilor-pentru-solutii-injectabile-si-perfuzabile-conform-monografiei-parenteralia-din-fr-x-suplim-2004/2022-07-06T17:56:33+03:00https://health-pharma.ro/question/selectati-afirmatia-falsa-referitoare-la-implanturi-conform-monografiei-parenteralia-din-fr-x-suplim-2004/2022-07-06T17:57:23+03:00https://health-pharma.ro/question/conform-fr-x-suplim-2004-pulberile-pentru-solutii-injectabile-sau-perfuzabile/2022-07-06T17:58:50+03:00https://health-pharma.ro/question/sunt-adevarate-urmatoarele-afirmatii-referitoare-la-productia-preparatelor-parenterale-conform-monografiei-parenteralia-fr-x-suplim-2004/2022-07-06T17:59:17+03:00https://health-pharma.ro/question/conform-monografiei-parenteralia-fr-x-suplim-2004-excipientii-folositi-la-obtinerea-preparatelor-parenterale-trebuie-sa-indeplineasca-urmatoarele-caracteristici/2022-07-06T17:59:40+03:00https://health-pharma.ro/question/selectati-categoria-de-excipienti-care-se-pot-utiliza-la-obtinerea-preparatelor-parenterale-conform-monografiei-parenteralia-fr-x-suplim-2004/2022-07-06T18:00:06+03:00https://health-pharma.ro/question/selectati-afirmatia-corecta-referitoare-la-emulsiile-injectabile-conform-monografiei-parenteralia-preparate-injectabile-fr-x-suplim-2004/2022-07-06T18:00:32+03:00https://health-pharma.ro/question/pentru-preparatele-oftalmice-este-falsa-urmatoarea-afirmatie/2022-07-06T19:26:09+03:00https://health-pharma.ro/question/masina-bottle-pack-se-foloseste/2022-07-06T19:26:33+03:00https://health-pharma.ro/question/agentii-tensioactivi-din-colire-actioneaza-prin-mai-multe-mecanisme/2022-07-06T19:27:03+03:00https://health-pharma.ro/question/lentilele-de-contact-suple/2022-07-06T19:27:59+03:00https://health-pharma.ro/question/conform-fr-x-pieturile-pentru-ochi-ce-contin-mai-putin-de-1-m-m-substanta-activa-se-prepara-prin-dizolvarea-acesteia-in/2022-07-06T19:28:19+03:00https://health-pharma.ro/question/toate-substantele-active-enumerate-dau-reactii-alergizante-la-nivel-ocular-cu-exceptia/2022-07-06T19:28:49+03:00https://health-pharma.ro/question/referitor-la-alcoolul-polivinilic-apv-nu-este-adevarata-urmatoarea-afirmatie/2022-07-06T19:29:14+03:00https://health-pharma.ro/question/urmatoarele-filtre-bacteriene-nu-sunt-reutilizabile/2022-07-06T19:30:06+03:00https://health-pharma.ro/question/pentru-colire-multidoza-perioada-limita-de-utilizare-dupa-deschiderea-recipientelor-nu-trebuie-sa-depaseasca/2022-07-06T19:30:33+03:00https://health-pharma.ro/question/insertele-oftalmice-sunt/2022-07-06T19:30:55+03:00https://health-pharma.ro/question/cel-mai-periculos-agent-patogen-la-nivel-ocular-este/2022-07-06T19:31:19+03:00https://health-pharma.ro/question/izohidria-este-obligatorie-pentru-urmatoarele-solutii-oftalmice/2022-07-06T19:31:40+03:00https://health-pharma.ro/question/solutiile-pentru-bai-oculare-oculobalnea/2022-07-06T19:32:10+03:00https://health-pharma.ro/question/alegerea-unui-ph-ul-optim-pentru-colire-tine-cont-de/2022-07-06T19:32:57+03:00https://health-pharma.ro/question/valorile-ph-ului-tolerate-de-ochi-variaza-intre/2022-07-06T19:33:20+03:00https://health-pharma.ro/question/operatia-de-sterilizare-este-obligatorie-pentru/2022-07-06T19:33:56+03:00https://health-pharma.ro/question/referitor-la-mertiolat-o-afirmatie-este-falsa/2022-07-06T19:34:18+03:00https://health-pharma.ro/question/referitor-la-lacrisert-sunt-adevarate-urmatoarele-afirmatii/2022-07-06T19:34:53+03:00https://health-pharma.ro/question/preparatele-oftalmice-semisolide-sunt/2022-05-06T13:37:42+03:00https://health-pharma.ro/question/solutiile-de-lubrifiere-pentru-lentilele-de-contact/2022-07-06T19:37:20+03:00https://health-pharma.ro/question/lentilele-de-contact-sunt/2022-07-06T19:38:22+03:00https://health-pharma.ro/question/formele-oftalmice-de-transport-si-eliberare-la-tinta-sunt-reprezentate-de/2022-07-06T19:38:46+03:00https://health-pharma.ro/question/sodi-sunt-sisteme-terapeutice/2022-07-06T19:39:44+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-enunturi-nu-este-un-dezavantaj-al-medicamentelor-oftalmice/2022-07-06T19:40:20+03:00https://health-pharma.ro/question/valoarea-euhidrica-a-ph-ului-unei-solutii-oftalmice-reprezinta/2022-07-06T19:40:41+03:00https://health-pharma.ro/question/suspensiile-oftalmice/2022-07-06T19:41:23+03:00https://health-pharma.ro/question/in-preparatele-oftalmice-nu-se-foloseste-drept-conservant-antimicrobian/2022-07-06T19:41:50+03:00https://health-pharma.ro/question/nu-exprima-un-avantaj-al-medicamentelor-oftalmice-urmatoarea-afirmatie/2022-07-06T19:42:17+03:00https://health-pharma.ro/question/nu-e-permisa-adaugarea-de-conservanti-antimicrobieni-la/2022-07-06T19:42:44+03:00https://health-pharma.ro/question/despre-sistemul-occusert-sunt-adevarate-urmatoarele-enunturi/2022-07-06T19:43:32+03:00https://health-pharma.ro/question/pentru-suspensiile-oftalmice-fr-x-prevede-ca-marimea-particulelor-sa-prezinte-un-diametru/2022-07-06T19:44:01+03:00https://health-pharma.ro/question/referitor-la-prodroguri-sunt-adevarate-urmatoarele-afirmatii/2022-07-06T19:44:33+03:00https://health-pharma.ro/question/sterilitatea-colirelor-unidoza-este-asigurata-prin-urmatoarele-procedee/2022-07-06T19:45:09+03:00https://health-pharma.ro/question/nu-este-o-componenta-a-lichidului-lacrimal-urmatoarea-proteina/2022-07-06T19:45:31+03:00https://health-pharma.ro/question/in-functie-de-viteza-de-eliberare-a-substantei-medicamentoase-preparatele-oftalmice-nu-pot-fi/2022-07-06T19:45:50+03:00https://health-pharma.ro/question/criteriile-de-selectie-a-substantelor-tensioactive-folosite-in-formularea-colirelor-sunt/2022-07-06T19:46:10+03:00https://health-pharma.ro/question/referitor-la-sistemele-tampon-folosite-in-solutii-oftalmice-nu-este-adevarat-urmatorul-enunt/2022-07-06T19:46:36+03:00https://health-pharma.ro/question/preparate-oftalmice-neoficializate-de-suplimentul-2004-al-fr-x-sunt-urmatoarele/2022-07-06T19:47:03+03:00https://health-pharma.ro/question/care-dintre-enunturile-mentionate-despre-agentii-de-viscozitate-folositi-in-colire-este-fals/2022-07-06T19:47:29+03:00https://health-pharma.ro/question/conform-fr-x-masa-de-izotonizant-pentru-colirele-hipotone-cu-substanta-activa-peste-1-m-m-se-calculeaza-folosind/2022-07-06T19:47:46+03:00https://health-pharma.ro/question/volumul-ideal-de-colir-instilat-in-sacul-conjunctival-este-de/2022-07-06T19:48:04+03:00https://health-pharma.ro/question/referitor-la-colirul-cu-sulfat-de-atropina-oficinal-in-fr-x-una-dintre-afirmatii-este-falsa/2022-07-06T19:48:30+03:00https://health-pharma.ro/question/cu-privire-la-colirul-cu-pilocarpina-unul-dintre-enunturile-mentionate-este-fals/2022-07-06T19:49:00+03:00https://health-pharma.ro/question/despre-pseudo-latexurile-oculare-putem-afirma-ca/2022-07-06T19:49:18+03:00https://health-pharma.ro/question/referitor-la-unguentul-oftalmic-cu-pilocarpina-nu-este-adevarata-urmatoarea-afirmatie/2022-07-06T19:53:28+03:00https://health-pharma.ro/question/agentii-viscozifianti-trebuie-sa-indeplineasca-urmatoarele-conditii-cu-exceptia-uneia/2022-07-06T19:54:16+03:00https://health-pharma.ro/question/factorii-fizico-chimici-care-influenteaza-penetratia-si-absorbtia-oculara-sunt/2022-07-06T19:54:45+03:00https://health-pharma.ro/question/referitor-la-metilcelulozi-un-agent-de-viscozitate-pentru-colire-o-afirmatie-este-falsa/2022-07-06T19:56:29+03:00https://health-pharma.ro/question/referitor-la-agentii-tensioactivi-folositi-in-colire-una-dintre-afirmatii-este-falsa/2022-07-06T19:56:51+03:00https://health-pharma.ro/question/ca-agenti-izotonizanti-pentru-solutiile-oftalmice-se-folosesc-urmatoarele-substante-cu-o-exceptie/2022-07-06T19:57:08+03:00https://health-pharma.ro/question/sunt-promotori-de-absorbtie-in-colire/2022-07-06T19:57:58+03:00https://health-pharma.ro/question/solutiile-oftalmice-pot-contine-urmatorii-adjuvanti-cu-o-exceptie/2022-07-06T19:58:59+03:00https://health-pharma.ro/question/conservantii-antimicrobieni-folositi-in-colire-trebuie-sa-indeplineasca-urmatoarele-conditii/2022-07-06T19:59:29+03:00https://health-pharma.ro/question/sistemele-terapeutice-oftalmice-osmotice-sunt/2022-07-06T19:59:48+03:00https://health-pharma.ro/question/caracteristicile-produsului-occusertpilo-20-sunt-urmatoarele/2022-07-06T20:00:12+03:00https://health-pharma.ro/question/prin-cornee-pot-penetra-usor-substante-active/2022-07-06T20:00:33+03:00https://health-pharma.ro/question/cresterea-permeabilitatii-corneene-a-substantelor-se-poate-realiza-prin/2022-07-06T20:00:58+03:00https://health-pharma.ro/question/ce-substante-pot-fi-formulate-sub-forma-de-prodroguri/2022-07-06T20:01:29+03:00https://health-pharma.ro/question/plastomerii-utilizati-la-obtinerea-recipientelor-pentru-colire-prezinta-urmatoarele-inconveniente/2022-07-06T20:01:55+03:00https://health-pharma.ro/question/conform-fr-x-ph-ul-picaturilor-pentru-nas-trebuie-sa-fie-cuprins-intre/2022-05-06T13:12:09+03:00https://health-pharma.ro/question/solutiile-pentru-spalari-nazale/2022-07-07T08:43:21+03:00https://health-pharma.ro/question/pulberile-nazale/2022-07-07T08:43:59+03:00https://health-pharma.ro/question/monografia-rhinoguttae-din-fr-x-cuprinde-preparate-farmaceutice-sub-forma-de/2022-07-07T08:44:25+03:00https://health-pharma.ro/question/nu-se-utilizeaza-pentru-cresterea-viscozitatii-solutiilor-nazale/2022-07-07T08:44:51+03:00https://health-pharma.ro/question/se-administreaza-pe-mucoasa-nazala-pentru-actiune-sistemica/2022-07-07T08:45:53+03:00https://health-pharma.ro/question/una-dintre-afirmatiile-referitoare-la-agentii-de-crestere-a-viscozitatii-solutiilor-nazale-nu-este-adevarata/2022-07-07T08:46:22+03:00https://health-pharma.ro/question/solventii-care-pot-fi-folositi-la-prepararea-picaturilor-nazale-sunt/2022-07-07T08:46:53+03:00https://health-pharma.ro/question/categoriile-de-preparate-nazale-prevazute-in-suplimentul-2004-al-fr-x-sunt/2022-07-07T08:47:22+03:00https://health-pharma.ro/question/picaturile-pentru-nas/2022-07-07T08:47:47+03:00https://health-pharma.ro/question/administrarea-endonazala-pentru-efect-sistemic-prezinta-urmatoarele-avantaje/2022-07-07T08:48:15+03:00https://health-pharma.ro/question/care-dintre-urmatoarele-substante-poate-fi-folosita-pentru-ajustarea-tonicitatii-solutiilor-nazale/2022-07-07T08:48:40+03:00https://health-pharma.ro/question/marirea-biodisponibilitatii-substantelor-active-administrate-pe-cale-nazala-se-realizeaza-prin-urmatoarele-modalitati-cu-exceptia/2022-07-07T08:49:10+03:00https://health-pharma.ro/question/picaturile-pentru-nas-cu-clorhidrat-de-nafazolina-01-prevazute-in-fr-x-nu-au-in-compozitie/2022-07-07T08:49:45+03:00https://health-pharma.ro/question/sunt-considerate-forme-farmaceutice-moderne-pentru-administrare-pe-cale-nazala-urmatoarele/2022-07-07T08:50:09+03:00https://health-pharma.ro/question/caile-de-transport-transnazal-al-substantelor-medicamentoase-sunt/2022-07-07T08:50:38+03:00https://health-pharma.ro/question/se-administreaza-pe-mucoasa-nazala-pentru-efect-local-urmatoarele-substante-cu-exceptia/2022-07-07T08:51:22+03:00https://health-pharma.ro/question/precizati-substantele-cu-care-se-pot-izotoniza-solutiile-nazale/2022-07-07T08:51:47+03:00https://health-pharma.ro/question/referitor-la-solutiile-macromoleculare-utilizate-pentru-cresterea-timpului-de-contact-cu-mucoasa-nazala-este-fals-ca/2022-07-07T08:52:19+03:00https://health-pharma.ro/question/la-prepararea-picaturilor-pentru-nas-se-recomanda-folosirea-urmatoarelor-vehicule-cu-exceptia/2022-07-07T08:52:45+03:00https://health-pharma.ro/question/la-prepararea-solutiilor-nazale-se-pot-folosi-urmatoarele-substante-auxiliare/2022-07-07T08:53:10+03:00https://health-pharma.ro/question/printre-factorii-care-influenteaza-absorbtia-nazala-si-sunt-dependenti-de-forma-farmaceutica-se-numara/2022-07-07T08:53:39+03:00https://health-pharma.ro/question/pentru-ajustarea-ph-ului-solutiilor-nazale-se-utilizeaza/2022-07-07T08:54:01+03:00https://health-pharma.ro/question/picaturile-oficinale-pentru-nas-cu-clorhidrat-de-nafazolina/2022-07-07T08:56:12+03:00https://health-pharma.ro/question/izotonizarea-solutiilor-pentru-aplicare-endonazala/2022-07-07T08:55:14+03:00https://health-pharma.ro/question/preparatele-nazale-nu-se-pot-administra-sub-forma-de/2022-07-07T08:56:37+03:00https://health-pharma.ro/question/una-dintre-urmatoarele-substante-nu-este-promotor-de-absorbtie-pe-cale-nazala/2022-07-07T08:57:02+03:00https://health-pharma.ro/question/solutia-nazala-prevazuta-in-fr-x-contine/2022-07-07T08:57:24+03:00https://health-pharma.ro/question/pentru-conservarea-preparatelor-nazale-se-utilizeaza/2022-07-07T08:58:05+03:00https://health-pharma.ro/question/precizati-substanta-care-poate-fi-folosita-pentru-ajustarea-tonicitatii-solutiilor-nazale/2022-07-07T08:58:35+03:00https://health-pharma.ro/question/se-administreaza-pe-mucoasa-nazala-pentru-actiune-sistemica-2/2022-07-07T08:59:23+03:00https://health-pharma.ro/question/spray-urile-nazale/2022-07-07T08:59:40+03:00https://health-pharma.ro/question/lizofosfatidilcolina-se-poate-utiliza-pentru-cresterea-biodisponibilitatii-pe-cale-nazala-a/2022-07-07T09:00:03+03:00https://health-pharma.ro/question/mucusul-tisular-nazal-contine/2022-07-07T09:00:30+03:00https://health-pharma.ro/question/una-dintre-urmatoarele-substante-auxiliare-nu-poate-fi-prezenta-in-formularea-produselor-apoase-nazale/2022-07-07T09:00:56+03:00https://health-pharma.ro/question/pentru-conservarea-preparatelor-nazale-se-pot-utiliza-urmatoarele-substante-cu-exceptia/2022-07-07T09:01:26+03:00https://health-pharma.ro/question/dintre-partile-componente-ale-unei-pompe-nazale-nu-face-parte/2022-07-07T09:01:44+03:00https://health-pharma.ro/question/agentii-de-crestere-a-viscozitatii-utilizati-in-formularea-solutiilor-nazale-indeplinesc-urmatoarele-conditii/2022-07-07T09:02:09+03:00https://health-pharma.ro/question/sistemele-bioadezive-nazale/2022-07-07T09:02:31+03:00https://health-pharma.ro/question/una-dintre-afirmatiile-referitoare-la-ph-ul-picaturilor-pentru-nas-este-falsa/2022-07-07T09:02:54+03:00https://health-pharma.ro/question/una-dintre-urmatoarele-substante-nu-se-administreaza-pe-mucoasa-sazala-pentru-efect-vasoconstrictor/2022-07-07T09:03:24+03:00https://health-pharma.ro/question/unul-dintre-urmatorii-solventi-nu-poate-fi-prezent-in-formularea-picaturilor-nazale/2022-07-07T09:04:29+03:00https://health-pharma.ro/question/referitor-la-uleiul-de-floarea-soarelui-folosit-ca-solvent-pentru-picaturile-de-nas-nu-este-adevarata-afirmatia/2022-07-07T09:04:54+03:00https://health-pharma.ro/question/medicamente-din-urmatoarele-clase-se-pot-administra-transmucozal-pentru-actiune-sistemica/2022-07-07T09:05:34+03:00https://health-pharma.ro/question/printre-factorii-fiziologici-care-influenteaza-absorbtia-nazala-se-pot-enumera/2022-07-07T09:06:54+03:00https://health-pharma.ro/question/produsele-apoase-nazale-pot-fi-conservate-cu-urmatoarele-substante-cu-o-exceptie/2022-07-07T09:07:17+03:00https://health-pharma.ro/question/pentru-a-evita-degradarea-insulinei-de-catre-aminopeptidaza-prezenta-in-celulele-mucoasei-nazale/2022-07-07T09:07:55+03:00https://health-pharma.ro/question/pentru-marirea-biodisponibilitatii-substantelor-active-administrate-pe-cale-nazala-se-recurge-la/2022-07-07T09:08:23+03:00https://health-pharma.ro/question/substantele-active-solide-insolu-bile-folosite-pentru-erinele-sub-forma-de-suspensii-trebuie-sa-prezinte-particule-cu-dimensiunea-de-cel-mult/2022-07-07T09:08:49+03:00https://health-pharma.ro/question/absorbtia-nazala-este-influentata-de-urmatorii-parametri-fizico-chimici-ai-substantei-medicamentoase/2022-07-07T09:09:28+03:00https://health-pharma.ro/question/referitor-la-suspensiile-lichide-preparate-ex-tempore-in-farmacie-din-forme-farmaceutice-industriale-solide-sunt-ade-varate-urmatoarele-afirmatii/2022-07-07T09:22:44+03:00https://health-pharma.ro/question/starea-floculata-prezinta-urmatoarele-caracteristici-cu-exceptia/2022-07-07T09:24:03+03:00https://health-pharma.ro/question/selectati-afirmatia-falsa-referitoare-la-colorantii-folositi-la-obtinerea-suspensiilor/2022-07-07T09:24:28+03:00https://health-pharma.ro/question/in-cazul-suspensiilor-particulele-solide-dispersate-intr-o-faza-lichida-pot-fi-incar-cate-electrie-prin/2022-07-07T09:25:11+03:00https://health-pharma.ro/question/pentru-fabricarea-suspensiilor-solide-orale-sub-forma-de-granule-se-utilizeaza-mai-rar-ca-substanta-auxiliara/2022-07-07T09:25:48+03:00https://health-pharma.ro/question/comportarea-reologica-proprietatile-de-curgere-si-viscozitatea-a-unei-suspensii-are-rol-determinant-in/2022-07-07T09:26:11+03:00https://health-pharma.ro/question/fata-de-suspensiile-lichide-suspenstile-solide-prezinta-urmatoarele-avantaje/2022-07-07T09:26:36+03:00https://health-pharma.ro/question/instabilitatea-fizica-a-suspensiilor-se-manifesta-prin-urmatoarele-fenomene-cu-exceptia/2022-07-07T09:27:06+03:00https://health-pharma.ro/question/conform-fr-x-suspensiile-farmaceutice-se-conserva/2022-07-07T09:27:36+03:00https://health-pharma.ro/question/metoda-de-precipitare-prin-modificarea-ph-ului-mediului-de-dispersie-se-poate-aplica-pentru-prepararea-industriali-a-urmatoarelor-suspensii/2022-07-07T09:28:03+03:00https://health-pharma.ro/question/selectati-enuntul-adevarat-referitor-la-stabilitatea-microbiologica-a-suspensiilor/2022-07-07T09:28:24+03:00https://health-pharma.ro/question/in-formularea-suspensiilor-polimerii-hidrofili-nu-se-utilizeaza-pentru-rolul-de/2022-07-07T09:28:52+03:00https://health-pharma.ro/question/suspensiile-prezinta-urmatoarele-dezavantaje/2022-07-07T09:29:24+03:00https://health-pharma.ro/question/conform-fr-x-suspensiile-farmaceutice-trebuie-sa-prezinte-urmatoarele-caractere-vizuale-cu-exceptia/2022-07-07T09:35:04+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-enunturi-referitoare-la-pulberile-suspendabile-este-adevarat/2022-07-07T09:36:51+03:00https://health-pharma.ro/question/substantele-auxiliare-care-se-utilizeaza-in-formularea-suspensiilor-pentru-favorizarea-umectarii-ca-agenti-de-umectare-includ/2022-07-07T09:38:20+03:00https://health-pharma.ro/question/in-cazul-suspensiilor-procesul-de-cimentare/2022-07-07T09:46:43+03:00https://health-pharma.ro/question/selectati-enunturile-adevarate-referitoare-la-procesul-de-cimentare-a-sedimentului-dintr-o-suspensie/2022-07-07T09:47:22+03:00https://health-pharma.ro/question/alegeti-enuntul-fals-referitor-la-potentialul-zeta/2022-07-07T09:47:44+03:00https://health-pharma.ro/question/ideal-in-suspensiile-floculate-volumul-de-sediment/2022-07-07T09:49:12+03:00https://health-pharma.ro/question/in-functie-de-stabilitate-si-natura-sedimentului-suspensiile-se-clasifica-in/2022-07-07T09:50:10+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-categorii-de-substante-auxiliare-din-formularea-suspensiilor-defloculate-se-foloseste-ca-peptizant-defloculant/2022-07-07T09:50:35+03:00https://health-pharma.ro/question/alegeti-afirmatiile-adevarate-referitoare-la-suspensiile-defloculate/2022-07-07T09:51:04+03:00https://health-pharma.ro/question/asocierile-de-granule-cu-pulberi-suspendabile-prezinta-ca-principal-dezavantaj/2022-07-07T09:51:26+03:00https://health-pharma.ro/question/in-functie-de-capacitatea-de-umectare-si-dispersare-in-mediul-lichid-substantele-solide-insolubile-se-pot-clasifica-in/2022-07-07T09:54:15+03:00https://health-pharma.ro/question/viteza-de-sedimentare-a-particulelor-unei-suspensii/2022-07-07T09:54:37+03:00https://health-pharma.ro/question/produsele-sub-forma-de-suspensii-trebuie-sa-indeplineasca-urmatoarele-conditii-cu-exceptia/2022-07-07T09:54:57+03:00https://health-pharma.ro/question/la-formularea-suspensiilor-trebuie-evitata-folosirea-formelor-polimorfe-metastabile-ale-substantelor-insolubile-deoarece-pot-produce-urmatoarele-consecinte-cu-exceptia/2022-07-07T09:55:49+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-proprietati-fizice-si-chimice-ale-unei-suspensii-nu-este-influentata-de-dimensiunea-particulelor/2022-07-07T09:56:16+03:00https://health-pharma.ro/question/la-prepararea-suspensiilor-orale-densitatea-unui-vehicul-apes-poate-fi-marita-prin-adaos-de/2022-07-07T09:56:51+03:00https://health-pharma.ro/question/conform-fr-x-marimea-particulelor-solide-din-suspensiile-farmaceutice-se-determina/2022-07-07T09:57:50+03:00https://health-pharma.ro/question/pentru-flocularea-controlata-a-particulelor-solide-ale-unei-suspensii-se-utilizeaza/2022-07-07T09:59:11+03:00https://health-pharma.ro/question/alegeti-caile-parenterale-de-administrare-a-suspensiilor/2022-07-07T09:59:38+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-afirmatii-referitoare-la-suspensiile-parenterale-este-falsa/2022-07-07T10:00:05+03:00https://health-pharma.ro/question/stabilitatea-chimica-a-suspensiilor-este-asigurata-prin/2022-07-07T10:00:26+03:00https://health-pharma.ro/question/granulele-pentru-suspensil/2022-07-07T10:01:50+03:00https://health-pharma.ro/question/alegeti-anuntul-fals-referitor-la-volumul-de-sedimentare-a-unei-suspensii/2022-07-07T10:02:34+03:00https://health-pharma.ro/question/referitor-la-bentonita-folosita-ca-agent-de-suspensie-sunt-adevarate-urmatoarele-afirmat/2022-07-07T10:02:54+03:00https://health-pharma.ro/question/in-industrie-pentru-conditionarea-suspensiilor-unidoza-se-utilizeaza/2022-07-07T10:03:24+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-afirmatii-se-refera-la-dispersabilitatea-suspensiilor-pentru-reconstituire/2022-07-07T10:03:51+03:00https://health-pharma.ro/question/in-cazul-suspensiilor-fenomenul-de-modificare-a-cristalelor/2022-07-07T10:04:24+03:00https://health-pharma.ro/question/surfactantii-utilizati-ca-agenti-umectanti-pentru-formularile-de-suspensii-parenterale-sunt/2022-07-07T10:04:51+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatorii-factori-ce-pot-modifica-eliberarea-substantei-medicamentoase-dintr-o-suspensie-orala-nu-depind-de-forma-farmaceutica/2022-07-07T10:05:13+03:00https://health-pharma.ro/question/pentru-realizarea-suspensiilor-farmaceutice-substantele-medicamentoase-vor-fi-selectate-in-functie-de-urmatoarele-considerente/2022-07-07T10:05:41+03:00https://health-pharma.ro/question/referitor-la-substantele-auxiliare-care-se-pot-folosi-la-prepararea-suspensiilor-farmaceutice-fr-x-nu-prevede/2022-07-07T10:06:15+03:00https://health-pharma.ro/question/metodele-de-preparare-prin-dispersare-a-suspensiilor-lichide-defloculate-si-floculate-in-vehicul-structurat-au-in-comun-urmatoarele-etape/2022-07-07T10:06:41+03:00https://health-pharma.ro/question/la-formularea-suspensiilor-in-selectia-unui-aromatizant-formulatorul-va-tine-seama-de-urmatoarele-aspecte/2022-07-07T10:07:24+03:00https://health-pharma.ro/question/metodele-care-pot-diminua-tendinta-de-crestere-a-cristalelor-de-substanta-medicamentoasa-in-suspensii-sunt-urmatoarele-cu-exceptia/2022-07-07T10:07:49+03:00https://health-pharma.ro/question/modificarile-fizice-ale-suspensiilor-produse-de-contaminarea-microbiana-constau-in/2022-07-07T10:08:09+03:00https://health-pharma.ro/question/agentii-de-dispersare-utilizati-la-prepararea-suspensiilor-farmaceutice-se-clasifica-in-urmatoarele-grupe/2022-07-07T10:08:29+03:00https://health-pharma.ro/question/fenomenul-de-fotare/2022-07-07T10:09:36+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatorii-polimeri-hidrofili-fac-parte-din-grupul-agentilor-de-suspensie-naturali/2022-07-07T10:10:08+03:00https://health-pharma.ro/question/selectati-solventii-utilizati-ca-agenti-umectanti-in-formularea-suspensiilor-care-retardeaza-cristalizarea-solidelor-solubilizate/2022-07-07T10:10:42+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatorii-surfactanti-neionici-se-utilizeaza-cel-mai-frecvent-ea-agenti-umectanti-in-suspensii-pentru-uz-intern-si-extern/2022-07-07T10:11:04+03:00https://health-pharma.ro/question/marimea-particulelor-solide-dispersate-in-suspensiile-oftalmice-corespunde-prevederilor-fr-x-daca-90-respectiv-10-din-particulele-examinate-la-microscop-prezinta-un-diametru-de-cel-mult/2022-07-07T10:11:27+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-prevederi-ale-fr-x-referitoare-la-prepararea-suspensiilor-este-falsa/2022-07-07T10:13:23+03:00https://health-pharma.ro/question/suspensiile-antiacide-contin-cantitati-de-substante-neutralizante/2022-07-07T10:13:45+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatorii-polimeri-hidrofili-fac-parte-din-grupul-agentilor-de-suspensie-de-sinteza/2022-07-07T10:14:19+03:00https://health-pharma.ro/question/despre-prepararea-vehiculului-structurat-ca-faza-a-procesului-tehnologic-de-fabricare-a-suspensiilor-sunt-adevarate-urmatoarele-afirmatii-cu-exceptia/2022-07-07T10:16:39+03:00https://health-pharma.ro/question/fata-de-pulberile-suspendabile-granulele-suspendabile-prezinta-urmatoarele-avantaje/2022-07-07T10:17:00+03:00https://health-pharma.ro/question/valoarea-zero-a-unghiului-de-contact-al-unui-lichid-cu-un-solid-0-0-denota-ca-umectarea-particulelor-solide-este/2022-07-07T10:18:20+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-stratori-nu-se-regaseste-intr-o-suspensie-defloculata/2022-07-07T10:18:49+03:00https://health-pharma.ro/question/in-prezent-in-farmacie-se-prepara-urmatoarele-tipuri-de-suspensii/2022-07-07T10:19:12+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-reguli-recomandate-a-fi-respectate-la-fabricarea-unei-suspensii-floculate-in-vehicul-structurat-nu-este-corecta/2022-07-07T10:19:36+03:00https://health-pharma.ro/question/precizati-care-sunt-calitati-eerste-pentru-un-agent-de-suspensie-ideal/2022-07-07T10:20:09+03:00https://health-pharma.ro/question/din-ecuatia-lui-stokes-reiese-ca-stabilitatea-unui-sistem-dispers-va-fi-cu-atat-mai-mare-cu-cat/2022-07-07T10:20:26+03:00https://health-pharma.ro/question/printre-caracteristicile-datorita-carora-celuloza-microcristalina-este-un-agent-de-suspensie-excelent-se-numara/2022-07-07T10:20:58+03:00https://health-pharma.ro/question/care-dintre-urmatorii-agenti-floculanti-pentru-suspensii-face-parte-din-clasa-electrolitilor/2022-07-07T10:21:20+03:00https://health-pharma.ro/question/conform-ecuatiei-lui-stokes-urmatorii-factori-influenteaza-viteza-de-sedimentare-a-particulelor-solide-in-suspensie-cu-exceptia/2022-07-07T10:44:34+03:00https://health-pharma.ro/question/procesul-de-divizare-a-substantei-solide/2022-07-07T10:22:07+03:00https://health-pharma.ro/question/comprimatele-pentru-suspensii/2022-07-07T10:22:30+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-procese-nu-constituie-o-etapa-principala-a-fabricarii-pastelor-de-dinti/2022-07-07T10:22:58+03:00https://health-pharma.ro/question/o-suspensie-de-buna-calitate-trebuie-sa-indeplineasca-urmatoarele-conditii/2022-07-07T10:23:18+03:00https://health-pharma.ro/question/un-vehicul-structurat-folosit-la-formularea-suspensiilor/2022-07-07T10:23:43+03:00https://health-pharma.ro/question/pentru-prepararea-suspensiilor-radioopace-sulfatul-de-bariu-se-utilizeaza-in-concentratii-de/2022-07-07T10:24:06+03:00https://health-pharma.ro/question/etapele-de-obtinere-a-suspensiilor-defloculate-includ/2022-07-07T10:24:27+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatorii-polimeri-hidrofili-fac-parte-din-grupul-agentilor-de-suspensie-de-semisinteza/2022-07-07T10:25:13+03:00https://health-pharma.ro/question/alegeti-enuntul-fals-cu-privire-la-avantajele-suspensiilor/2022-07-07T10:26:52+03:00https://health-pharma.ro/question/eliberarea-substantei-medicamentoase-dintr-o-suspensie-orala-cu-faza-externa-hidromiscibila-este-controlata-de/2022-07-07T10:27:17+03:00https://health-pharma.ro/question/selectati-parametrul-prevazut-de-fr-x-la-controlul-calitatii-suspensiilor-farmaceutice/2022-07-07T10:27:47+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-surfactanti-utilizati-ca-agenti-de-umectare-la-prepararea-suspensiilor-sunt-adevarate/2022-07-07T10:29:17+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-lichide-se-pot-folosi-ca-vehicule-lipofile-pentru-prepararea-suspensiilor-de-uz-extern/2022-07-07T10:29:42+03:00https://health-pharma.ro/question/selectati-factorul-care-nu-intervine-in-stabilizarea-suspensiilor/2022-07-07T10:30:29+03:00https://health-pharma.ro/question/suspensiile-farmaceutice-prezinta-urmatoarele-avantaje/2022-07-07T10:31:30+03:00https://health-pharma.ro/question/diametrul-maxim-al-particulelor-solide-din-suspensii-admis-de-fr-x-pentru-90-din-particulele-examinate-este/2022-07-07T10:31:49+03:00https://health-pharma.ro/question/la-formularea-suspensiilor-se-urmareste-indeplinirea-urmatoarelor-conditii/2022-07-07T10:32:26+03:00https://health-pharma.ro/question/selectati-factorul-care-nu-intervine-in-obtinerea-de-suspensii-floculate-sau-defloculate/2022-07-07T10:32:57+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-lichide-se-pot-folosi-ca-vehicule-pentru-prepararea-suspensiilor-orale/2022-07-07T10:33:30+03:00https://health-pharma.ro/question/referitor-la-modificarea-viscozitatii-suspensiei-sunt-adevarate-urmatoarele-afirmatii/2022-07-07T10:33:52+03:00https://health-pharma.ro/question/din-considerente-tehnologice-pentru-realizarea-suspensiilor-reconstituibile-se-recomanda-urmatorii-edulcoranti-naturali-cu-exceptia/2022-07-07T10:34:15+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-pentru-solufille-coloidale-apoase-de-metilceluloza-05-2-folosite-ca-agenti-de-suspensie/2022-07-07T10:34:43+03:00https://health-pharma.ro/question/la-fabricarea-suspensiilor-farmaceutice-pulverizarea-substantelor-medicamentoase-se-poate-efectua-prin-diferite-metode-mecanice-care-nu-includ/2022-07-07T10:35:10+03:00https://health-pharma.ro/question/gradul-de-floculare/2022-07-07T10:35:43+03:00https://health-pharma.ro/question/suspenslite-foarte-concentrate-sunt-denumite-impropriu/2022-07-07T10:36:03+03:00https://health-pharma.ro/question/stabilitatea-fizica-a-unei-suspensii-farmaceutice-poate-fi-evaluata-prin-masurarea-urmatorilor-parametri-cu-exceptia/2022-07-07T10:36:43+03:00https://health-pharma.ro/question/alegeti-afirmatiile-adevarate-referitoare-la-sistemele-disperse-floculate/2022-07-07T10:37:04+03:00https://health-pharma.ro/question/dezavantajele-agentilor-de-suspendare-din-grupul-hidrocoloizilor-sunt/2022-07-07T10:37:28+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatorii-antioxidanti-pentru-suspensii-este-solubil-in-apa/2022-07-07T10:37:57+03:00https://health-pharma.ro/question/in-stabilizarea-suspensiilor-apoase-ph-ul-acestora-poate-interveni-astfel/2022-07-07T10:38:23+03:00https://health-pharma.ro/question/masurarea-potentialului-zeta-pentru-evaluarea-stabilitatii-suspensiilor-ofera-informatii-referitoare-la/2022-07-07T10:38:55+03:00https://health-pharma.ro/question/in-cazul-suspensiilor-limita-minima-de-marime-a-particulelor-solide-dispersate-este-de/2022-07-07T10:39:13+03:00https://health-pharma.ro/question/suspensiile-prezinta-urmatoarele-avantaje/2022-07-07T10:39:46+03:00https://health-pharma.ro/question/alegeti-enuntul-fals-cu-privire-la-dezavantajele-suspensiilor/2022-07-07T10:40:20+03:00https://health-pharma.ro/question/suspensiile-pot-fi-clasificate-in-functie-de-dimensiunea-particulelor-solide-suspendate-in/2022-07-07T10:43:11+03:00https://health-pharma.ro/question/alegeti-calea-nonmucozala-de-administrare-a-suspensiilor/2022-07-07T10:43:43+03:00https://health-pharma.ro/question/n-formularea-suspensiilor-dimensiunile-relativ-mari-ale-particulelor-solide-determina/2022-07-07T10:44:06+03:00https://health-pharma.ro/question/in-ecuatia-lui-g-stokes-care-exprima-viteza-de-sedimentare-a-particulelor-solide-intr-o-suspensie-intervin-urmatorii-factori-cu-exceptia/2022-07-07T10:21:45+03:00https://health-pharma.ro/question/proprietatile-superficiale-solid-lichid-care-prezinta-interes-major-peatru-tehnologia-de-preparare-a-suspensiilor-farmaceutice-sunt-legate-de/2022-07-07T10:45:16+03:00https://health-pharma.ro/question/suspensiile-deflocolate-pot-fi-imbunatatite-reducandu-se-posibilitatea-de-cimentare-prin/2022-07-07T10:46:34+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa-referitoare-la-fenomenul-de-modificare-a-cristalelor-ce-poate-aparea-in-cazul-suspensiilor/2022-07-07T10:47:23+03:00https://health-pharma.ro/question/in-formularea-pastelor-de-dinti-se-pot-utiliza-ea-agenti-abrazivi-urmatoarele-substante/2022-07-07T10:47:46+03:00https://health-pharma.ro/question/ca-agenti-antigelificanti-si-contra-cimentarii-sedimentului-in-suspensiile-farmaceutice-se-utilizeaza-urmatoarele-substante-cu-exceptia/2022-07-07T10:48:16+03:00https://health-pharma.ro/question/in-vehiculul-apos-pentru-suspensiile-orale-se-poate-adauga-glicerol-si-alcool-cu-scopul-de-a-controla-urmatoarele-caracteristici/2022-07-07T10:48:56+03:00https://health-pharma.ro/question/in-suspensiile-orale-apa-utilizata-ca-vehicul-pentru-substanta-medicamentoasa-insolubila-indeplineste-urmatoarele-roluri/2022-07-07T10:49:31+03:00https://health-pharma.ro/question/care-dintre-urmatoarele-afirmatii-se-refera-la-agentii-de-suspensie/2022-07-07T10:49:53+03:00https://health-pharma.ro/question/pentru-suspensiile-care-contin-substante-puternic-active-sau-toxice-fr-x-prevede/2022-07-07T10:50:13+03:00https://health-pharma.ro/question/ca-agent-de-suspensie-guma-arabica/2022-07-07T10:50:30+03:00https://health-pharma.ro/question/referitor-la-tragacanta-ca-agent-de-suspensie-sunt-adevarate-urmatoarele-afirmatii-cu-exceptia/2022-07-07T10:50:54+03:00https://health-pharma.ro/question/veegumul-ca-agent-de-suspensie/2022-07-07T10:51:09+03:00https://health-pharma.ro/question/carboximetilceluloza-sodica-se-utilizeaza-ca-agent-de-suspensie-datorita-urmatoarelor-proprietati/2022-07-07T10:51:34+03:00https://health-pharma.ro/question/pentru-a-conferi-suspensiilor-orale-o-rezistenta-mare-la-sedimentare-carboximetilceluloza-sodica-se-poate-asocia-cu-polimeri-tixotropi-ca/2022-07-07T10:54:17+03:00https://health-pharma.ro/question/manitolul-utilizat-ca-edulcorant-in-suspensiile-cu-administrare-orala/2022-07-07T10:56:55+03:00https://health-pharma.ro/question/in-suspensiile-orale-cu-antibiotice-concentratia-de-substanta-medicamentoasa-este-de/2022-07-07T10:57:20+03:00https://health-pharma.ro/question/pentru-a-dezvolta-o-suspensie-farmaceutica-stabila-si-de-calitate-adjuvantii-si-aditivii-se-aleg-pe-baza-urmatoarelor-caracteristici-principale-cu-exceptia/2022-07-07T10:57:42+03:00https://health-pharma.ro/question/surfactantii-utilizati-ca-agenti-de-umectare-in-formularea-suspensiilor-au-valoarea-hlb-cuprinsa-in-intervalul/2022-07-07T11:00:34+03:00https://health-pharma.ro/question/selectati-care-dintre-urmatorii-agenti-defloculanti-utilizati-in-suspensli-de-uz-intern-actioneaza-prin-stabilizare-entalpica/2022-07-07T11:00:57+03:00https://health-pharma.ro/question/concentratiile-in-care-agentii-de-viscozitate-se-pot-utiliza-in-suspensii-pentru-actiunea-de-coloizi-protectori-sunt/2022-07-07T11:01:28+03:00https://health-pharma.ro/question/cel-mai-utilizat-agent-de-stabilitate-pentru-fabricarea-suspensiilor-industriale-este/2022-07-07T11:01:50+03:00https://health-pharma.ro/question/fata-de-alti-agenti-viscozifianti-carbomerii-ofera-urmatorul-avantaj/2022-07-07T11:02:11+03:00https://health-pharma.ro/question/care-dintre-urmatoarele-substante-se-utilizeaza-ca-agent-antispumant-in-suspensiile-farmaceutice/2022-07-07T11:03:54+03:00https://health-pharma.ro/question/hidrogelurile-de-cmc-sodica/2022-05-06T13:32:42+03:00https://health-pharma.ro/question/determinarea-tipului-de-emulsie-a-unguentelor-emulsie-se-poate-face-prin-metoda/2022-07-07T11:44:10+03:00https://health-pharma.ro/question/absorbtia-percutanata-este-definita-ca-suma-urmatoarelor-fenomene/2022-07-07T11:44:31+03:00https://health-pharma.ro/question/penetratia-si-absorbtia-substantelor-medicamentoase-dintr-un-unguent-depind-de-urmatorii-factori-fiziologici/2022-07-07T11:45:44+03:00https://health-pharma.ro/question/principalele-proprietati-structurale-care-faciliteaza-interpenetrarea-unui-polimer-bloadeziv-intr-un-substrat-biologic-includ/2022-07-07T11:46:21+03:00https://health-pharma.ro/question/la-prepararea-unguentelor-in-farmacie-se-pot-folosi-ustensile-metalice-in-cazul-prezentei/2022-07-07T11:46:47+03:00https://health-pharma.ro/question/pentru-a-asigura-o-consistenta-normala-moderata-a-unguentelor-limita-maxima-in-care-pot-fi-incorporate-extractele-moi-si-fluide-este/2022-07-07T11:47:14+03:00https://health-pharma.ro/question/cremele-cu-stearati/2022-07-07T11:48:20+03:00https://health-pharma.ro/question/dintre-caile-enumerate-alegeti-caile-transepidermice-de-penetratie-prin-piele/2022-07-07T11:48:40+03:00https://health-pharma.ro/question/hidrogelurile-se-caracterizeaza-prin-urmatoarele/2022-07-07T11:49:00+03:00https://health-pharma.ro/question/procesele-sau-leziunile-cutanate-acute/2022-07-07T11:49:19+03:00https://health-pharma.ro/question/avantaje-ale-tuburilor-din-aluminiu-pentru-conditionarea-unguentelor/2022-07-07T11:49:39+03:00https://health-pharma.ro/question/pentru-a-asigura-o-consistenta-normala-moderata-a-unguentelor-limita-maxima-in-care-pot-fi-incorporate-uleiurile-volatile-este/2022-07-07T11:50:06+03:00https://health-pharma.ro/question/pentru-hidrogeluri-urmatoarele-afirmatii-sunt-adevarate/2022-07-07T11:50:45+03:00https://health-pharma.ro/question/pentru-fabricarea-diferitelor-tipuri-de-unguente-se-utilizeaza-urmatoarele-substante-medicamentoase-cu-actiune-citostatica-locala-cu-exceptia/2022-07-07T11:51:08+03:00https://health-pharma.ro/question/antioxidantii-adaugati-in-unguente-trebuie-sa-indeplineasca-urmatoarele-conditii/2022-07-07T11:51:38+03:00https://health-pharma.ro/question/stratul-cornos/2022-07-07T11:52:07+03:00https://health-pharma.ro/question/alegeti-afirmatiile-corecte-referitoare-la-incorporarea-ihtiolului-in-bazele-de-unguent/2022-07-07T11:52:28+03:00https://health-pharma.ro/question/dezavantajele-tuburilor-din-aluminiu-pentru-conditionarea-unguentelor-constau-in-faptul-ca/2022-07-07T11:53:07+03:00https://health-pharma.ro/question/pastele-prezinta-din-punct-de-vedere-reologie-o-curgere-comportare/2022-07-07T11:53:26+03:00https://health-pharma.ro/question/bazele-de-unguent-cu-macrogoli/2022-07-07T11:53:44+03:00https://health-pharma.ro/question/produsele-mucoadezive/2022-07-07T11:54:01+03:00https://health-pharma.ro/question/supl-2004-al-fr-x-prevede-ca-preparatele-semisolide-pentru-aplicatii-cutanate-si-corespunda-determinarii-masei-sau-volumului-eliberat/2022-07-07T11:54:49+03:00https://health-pharma.ro/question/hidrogelurile/2022-07-07T11:55:07+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-cold-creme-sunt-adevarate-cu-exceptia/2022-07-07T11:56:38+03:00https://health-pharma.ro/question/degradarea-unguentelor-din-cauza-contaminarii-microbiene-se-manifesta-prin-urmatoarele-modificari-chimice/2022-07-07T11:56:57+03:00https://health-pharma.ro/question/pe-eticheta-ambalajelor-care-contin-preparate-semisolide-pentru-aplicatii-cutanate-trebuie-sa-existe-urmatoarele-mentiuni-conform-supl-2004-al-fr-x/2022-07-07T11:57:39+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-hidrogelul-de-chitosan-sunt-adevarate/2022-07-07T11:58:45+03:00https://health-pharma.ro/question/avantajele-prepararii-unguentelor-prin-metoda-fuziunii-sunt/2022-07-07T12:00:01+03:00https://health-pharma.ro/question/sunt-factori-dependenti-de-substanta-medicamentoasa-care-influenteaza-penetratia-prin-piele/2022-07-07T12:00:22+03:00https://health-pharma.ro/question/comportamentul-reologic-al-formelor-farmaceutice-semisolide-influenteaza/2022-07-07T12:00:43+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-despre-lanolina-de-calitate-buna-sunt-adevarate-cu-exceptia/2022-07-07T12:00:57+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa-referitoare-la-promotorii-de-absorbtie-a-substantelor-medicamentoase-din-unguente/2022-07-07T12:01:35+03:00https://health-pharma.ro/question/analiza-reologica-a-unguentelor-medicamentoase-cuprinde-urmatoarele-determinari/2022-07-07T12:01:58+03:00https://health-pharma.ro/question/componenta-majoritara-a-factorului-natural-de-umectare-nmf-din-stratul-cornos-este-reprezentata-de/2022-07-07T12:02:22+03:00https://health-pharma.ro/question/cel-mai-frecvent-se-folosesc-la-conditionarea-unguentelor-dermatologice-tuburi-din/2022-07-07T12:02:43+03:00https://health-pharma.ro/question/testul-de-acantoza-pentru-preparate-topice-semisolide/2022-07-07T12:03:02+03:00https://health-pharma.ro/question/unguentul-cu-macrogoli/2022-07-07T12:03:19+03:00https://health-pharma.ro/question/conform-fr-x-pastele-sunt/2022-07-07T12:03:49+03:00https://health-pharma.ro/question/urmatoarele-substante-medieamen-tonse-se-utilizeaza-tople-pentru-actiunea-keratolitica/2022-07-07T12:04:12+03:00https://health-pharma.ro/question/oleogelurile-sunt-preparate-care-pot-contine/2022-07-07T12:04:27+03:00https://health-pharma.ro/question/glicerolatele/2022-07-07T12:04:44+03:00https://health-pharma.ro/question/urmatoarea-afirmatie-referitoare-ia-alcoolul-cetostearille-este-fals/2022-07-07T12:05:02+03:00https://health-pharma.ro/question/determina-acantoza-cea-mai-pronuntata/2022-07-07T12:05:36+03:00https://health-pharma.ro/question/din-categoria-unguentelor-sterile-incluse-in-categoria-1-fip-fac-parte/2022-07-07T12:05:56+03:00https://health-pharma.ro/question/in-functie-de-consistenta-unguentele-pot-fi-clasificate-in-urmatoarele-trei-categorii/2022-07-07T12:06:20+03:00https://health-pharma.ro/question/sunt-emulgatori-care-stabilizeaza-unguentele-emulsii-de-tipul-ulei-in-apa/2022-07-07T12:06:40+03:00https://health-pharma.ro/question/determinarea-ph-ului-unguentelor-se-realizeaza/2022-07-07T12:07:14+03:00https://health-pharma.ro/question/vaselina-prezinta-urmatoarele-dezavantaje-cu-exceptia/2022-07-07T12:07:33+03:00https://health-pharma.ro/question/dintre-urmatorii-excipienti-folositi-la-prepararea-unguentelor-are-punctul-de-topire-cel-mai-ridicat/2022-07-07T12:07:56+03:00https://health-pharma.ro/question/selectati-excipientul-solid-utilizat-la-prepararea-unguentelor/2022-07-07T12:08:14+03:00https://health-pharma.ro/question/in-preparatele-topice-semisolide-se-folosesc-pentru-un-efect-de-profunzime-substante-cu-actiune/2022-07-07T12:08:49+03:00https://health-pharma.ro/question/metodele-de-studiu-a-cedarii-substantelor-medicamentoase-din-preparate-topice-semisolide-in-vitro-fara-membrane-sunt/2022-07-07T12:09:13+03:00https://health-pharma.ro/question/unguentele-pentru-care-se-prevede-o-anumita-incarcatura-microbiana-sunt/2022-07-07T12:09:29+03:00https://health-pharma.ro/question/referitor-la-penetratia-si-absorbtia-unei-substante-medicamentoase-dintr-un-unguent-sunt-adevarate-urmatoarele-afirmatii-cu-exceptia/2022-07-07T12:10:10+03:00https://health-pharma.ro/question/selectati-metodele-fizice-care-pot-modifica-penetratia-si-absorbtia-prin-piele/2022-07-07T12:11:04+03:00https://health-pharma.ro/question/esterii-acizilor-grasi-cu-alcoolii/2022-07-07T12:11:22+03:00https://health-pharma.ro/question/stocarea-intermediara-a-preparatelor-topice-semisolide-se-face-in/2022-07-07T12:11:55+03:00https://health-pharma.ro/question/bazele-de-unguent-mixte/2022-07-07T12:12:11+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-substante-sunt-folosite-ca-promotori-de-absorbtie-a-substantelor-medicamentoase-din-unguente/2022-07-07T12:12:58+03:00https://health-pharma.ro/question/alegeti-ordinea-corecta-de-cedare-a-substantelor-medicamentoase-din-unguente-in-functie-de-natura-bazei-de-unguent/2022-07-07T12:13:59+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-prepararea-unguentului-de-glicerol-sunt-adevarate-cu-exceptia/2022-07-07T12:14:19+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-bazele-de-absorbtie-tip-h-l-sunt-false-cu-exceptia/2022-07-07T12:32:49+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-cu-privire-la-unguentele-medicamentoase/2022-07-07T12:33:11+03:00https://health-pharma.ro/question/studiile-de-sterilitate-sunt-obligatorii-pentru-preparatele-topice-semisolide/2022-07-07T12:33:36+03:00https://health-pharma.ro/question/interpretand-curbele-de-viscozitate-semisolidele-pot-fi-considerate-ca-avand-o-comportare/2022-07-07T12:33:56+03:00https://health-pharma.ro/question/o-baza-de-unguent-trebuie-sa-prezinte-urmatoarele-caractere-specifice/2022-07-07T12:34:15+03:00https://health-pharma.ro/question/bazele-de-unguent-cu-uleiuri-de-silicone/2022-07-07T12:34:37+03:00https://health-pharma.ro/question/in-preparatele-topice-semisolide-se-folosesc-pentru-un-efect-regional-substante-cu-actiune/2022-07-07T12:35:44+03:00https://health-pharma.ro/question/principalii-factori-care-influenteaza-stabilitatea-fizico-chimica-a-unguentelor-in-timp-sunt/2022-07-07T12:36:23+03:00https://health-pharma.ro/question/nu-sunt-recipiente-cu-deschidere-larga-folosite-pentru-ambalarea-unguentelor-in-farmacie/2022-07-07T12:36:42+03:00https://health-pharma.ro/question/promotorii-de-absorbtie-nepolari-utilizati-la-formularea-unguentelor-sunt/2022-07-07T12:36:59+03:00https://health-pharma.ro/question/guma-guar-prezinta-urmatoarele-caracteristici/2022-07-07T12:37:14+03:00https://health-pharma.ro/question/referitor-la-etozomi-sunt-corecte-urmatoarele-afirmatii/2022-07-07T12:37:29+03:00https://health-pharma.ro/question/aprecierea-consistentei-unguentelor-se-poate-realiza/2022-07-10T08:21:23+03:00https://health-pharma.ro/question/determinarea-caracteristicilor-reologice-ale-unui-unguent-se-face-cu/2022-07-10T08:21:49+03:00https://health-pharma.ro/question/in-grupa-lipogelurilor-intra-diferiti-excipienti-ca/2022-07-10T08:22:13+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-stratul-bazal-sunt-false-cu-exceptia/2022-07-10T08:22:32+03:00https://health-pharma.ro/question/surfactantii-ca-promotori-de-absorbtie-prin-piele-pot-actiona-prin-urmatoarele-mecanisme/2022-07-10T08:27:26+03:00https://health-pharma.ro/question/urmatoarea-afirmatie-referitoare-la-cetaceu-este-falsa/2022-07-10T08:28:24+03:00https://health-pharma.ro/question/in-formularea-unguentelor-substantele-cu-rol-de-ameliorare-a-consistentei/2022-07-10T08:29:15+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa/2022-07-10T08:29:58+03:00https://health-pharma.ro/question/urmatoarele-substante-se-folosesc-ca-promotori-de-absorbtie-polari-cu-exceptia/2022-07-10T08:30:43+03:00https://health-pharma.ro/question/promotorii-de-absorbtie-pentru-produsele-topice/2022-07-10T08:31:24+03:00https://health-pharma.ro/question/absorbtia-prin-piele-poate-fi-eres-cuta-astfel/2022-07-10T08:32:15+03:00https://health-pharma.ro/question/urmatorii-polimeri-pot-fi-utilizati-pentru-formele-bioadezive-cu-exceptia/2022-07-10T08:32:40+03:00https://health-pharma.ro/question/urmatorii-polimeri-formeaza-geluri-dependent-de-ph-ul-mediului/2022-07-10T08:33:00+03:00https://health-pharma.ro/question/carbopolul-este-un-polimer-gelin-ant-eu-urmatoarele-caracteristici/2022-07-10T08:33:23+03:00https://health-pharma.ro/question/filmul-superficial-hidrolipidic-al-pielii/2022-07-10T08:33:42+03:00https://health-pharma.ro/question/urmatoarea-afirmatie-referitoare-la-bazele-de-absorbtie-tip-l-h-este-adevarata/2022-07-10T08:34:11+03:00https://health-pharma.ro/question/urmatorii-factori-care-influenteaza-mucoadeziunea-sunt-factori-care-depind-de-mediu-cu-exceptia/2022-07-10T08:34:35+03:00https://health-pharma.ro/question/bazele-de-unguent-oleaginoase/2022-07-10T08:34:54+03:00https://health-pharma.ro/question/unguentele-diadermice/2022-07-10T08:35:13+03:00https://health-pharma.ro/question/bazele-de-absorbtie-de-tip-h-l/2022-07-10T08:36:00+03:00https://health-pharma.ro/question/in-preparatele-topice-semisolide-se-folosesc-pentru-un-efect-de-suprafata-substante-cu-actiune/2022-07-10T08:36:35+03:00https://health-pharma.ro/question/utilizarea-formelor-topice-prezinta-urmatoarele-avantaje/2022-07-10T08:36:57+03:00https://health-pharma.ro/question/cremele-lipofile-pot-contine-emulgatori-de-tipul/2022-07-10T08:37:17+03:00https://health-pharma.ro/question/penetratia-si-absorbtia-cutanata-pot-fi-modificate-de-urmatorii-factori-fizici-cu-exceptia/2022-07-10T08:37:57+03:00https://health-pharma.ro/question/vaselina/2022-07-10T08:38:14+03:00https://health-pharma.ro/question/aspectul-granulos-al-bazei-de-unguent-indica/2022-07-10T08:38:34+03:00https://health-pharma.ro/question/urmatoarele-substante-se-utilizeaza-ca-antioxidanti-in-unguente/2022-07-10T08:39:04+03:00https://health-pharma.ro/question/din-faza-biofarmaceutica-a-penetratiei-prin-piele-face-parte/2022-07-10T08:39:34+03:00https://health-pharma.ro/question/la-inchiderea-tuburilor-ce-contin-anguente-medicamentoase-se-pot-intalni-procese-de/2022-07-10T08:39:54+03:00https://health-pharma.ro/question/care-dintre-urmatoarele-substante-dau-o-acantoza-puternica-dupa-aplicarea-pe-piele/2022-07-10T08:41:04+03:00https://health-pharma.ro/question/pot-scadea-permeabilitatea-pielii/2022-07-10T08:41:26+03:00https://health-pharma.ro/question/unguentele-pot-fi-conditionate-in/2022-07-10T08:41:47+03:00https://health-pharma.ro/question/maturarea-unguentelor-se-realizeaza-in-scopul/2022-07-10T08:42:10+03:00https://health-pharma.ro/question/cremele-hidrofile-pot-contine-emulgatori-de-tipul/2022-07-10T08:43:07+03:00https://health-pharma.ro/question/sunt-factori-fiziologici-care-influenfenza-penetratia-prin-piele/2022-07-10T08:43:32+03:00https://health-pharma.ro/question/prin-resorbtie-se-intelege/2022-07-10T08:43:49+03:00https://health-pharma.ro/question/bazele-de-unguent-hidrofobe/2022-07-10T08:44:14+03:00https://health-pharma.ro/question/pentru-polimerii-care-formeaza-geluri-independent-de-ph-ul-mediului-sau-de-temperatura-urmatoarea-afirmatie-este-falsa/2022-07-10T08:44:37+03:00https://health-pharma.ro/question/preparatul-final-in-cazul-unguentelor-trebuie-sa-corespunda-urmatoarelor-cerinte-specifice/2022-07-10T08:45:15+03:00https://health-pharma.ro/question/in-cazul-unei-inflamatii-acute-unguentul-trebuie/2022-07-10T08:45:41+03:00https://health-pharma.ro/question/supl-2004-al-fr-x-prevede-ca-preparatele-semisolide-sterile-pentru-aplicatii-cutanate-sa-fie-conditionate/2022-07-10T08:46:06+03:00https://health-pharma.ro/question/cremele-amfifile/2022-07-10T08:46:31+03:00https://health-pharma.ro/question/determinarea-consistentei-unui-unguent-medicamentos-releva-urmatoarele-caractere-ale-respectivului-preparat/2022-07-10T08:46:51+03:00https://health-pharma.ro/question/proprietatile-fizico-chimice-ale-substantei-medicamentoase-care-influenteaza-penetratia-prin-piele-sunt-urmatoarele-cu-exceptia/2022-07-10T08:47:24+03:00https://health-pharma.ro/question/urmatoarea-afirmatie-referitoare-la-epiderm-este-adevarata/2022-07-10T08:47:47+03:00https://health-pharma.ro/question/hidrogelul-de-bentonita/2022-07-10T08:48:04+03:00https://health-pharma.ro/question/stratul-granulos/2022-07-10T08:48:37+03:00https://health-pharma.ro/question/gelurile-de-macrogoli/2022-07-10T08:48:54+03:00https://health-pharma.ro/question/controlul-includerii-aerului-in-unguente-se-face-prin/2022-07-10T08:49:14+03:00https://health-pharma.ro/question/agentii-umectanti-utilizati-in-formularea-unguentelor/2022-07-10T08:49:35+03:00https://health-pharma.ro/question/urmatoarele-substante-medicamentoase-au-rolul-de-a-stimula-pigmentarea/2022-07-10T08:50:05+03:00https://health-pharma.ro/question/nu-sunt-promotori-ai-absorbtiei-prin-piele/2022-07-10T08:50:25+03:00https://health-pharma.ro/question/hidrogelul-de-metilceluloza/2022-07-10T08:50:53+03:00https://health-pharma.ro/question/dintre-probele-de-control-mentionate-de-fr-x-in-monografia-unguentelor-nu-face-parte/2022-07-10T08:51:19+03:00https://health-pharma.ro/question/dezavantajele-includerii-aerului-in-preparatele-topice-semisolide-sunt/2022-07-10T08:51:40+03:00https://health-pharma.ro/question/polisiloxanii/2022-07-10T08:52:01+03:00https://health-pharma.ro/question/marirea-permeabilitatii-pielii-poate-fi-realizata-prin/2022-07-10T08:52:22+03:00https://health-pharma.ro/question/gelurile-care-prezinta-o-curgere-dilatanta-au-urmatoarele-proprietati-eu-exceptia/2022-07-10T08:52:41+03:00https://health-pharma.ro/question/tratamentul-suprafetei-pielii-si-mucoaselor/2022-07-10T08:52:59+03:00https://health-pharma.ro/question/substantele-frecvent-implicate-in-acneea-cosmetica-sunt/2022-07-10T08:53:19+03:00https://health-pharma.ro/question/o-baza-de-unguent-indeplineste-urmatoarele-roluri/2022-07-10T08:53:42+03:00https://health-pharma.ro/question/in-unguentele-emulsii-de-tip-l-h-se-asociaza-urmatoarele-substante-reducatoare-solubile-in-apa/2022-07-10T08:54:17+03:00https://health-pharma.ro/question/alegeti-afirmatiile-corecte/2022-07-10T08:54:54+03:00https://health-pharma.ro/question/pentru-aprecierea-consistentei-unguentelor-se-pot-efectua-urmatoarele-determinari-cu-exceptia/2022-07-10T08:55:17+03:00https://health-pharma.ro/question/urmatorii-factori-care-influenteaza-mucoadeziunea-sunt-factori-care-depind-de-polimerul-bioadeziv-cu-exceptia/2022-07-10T08:55:40+03:00https://health-pharma.ro/question/urmatoarea-afirmatie-referitoare-la-hidrogeluri-este-falsa/2022-07-10T08:56:11+03:00https://health-pharma.ro/question/hidrogelurile-eu-retea-reticular-dependente-de-ph-prezinta-urmatoarele-caracteristici-cu-exceptia/2022-07-10T08:56:28+03:00https://health-pharma.ro/question/alegeti-afirmatiile-corecte-despre-bazele-de-unguent/2022-07-10T08:56:52+03:00https://health-pharma.ro/question/din-faza-farmacocinetica-a-penetratiei-prin-piele-nu-face-parte/2022-07-10T08:57:16+03:00https://health-pharma.ro/question/clieerogelol-de-amidon/2022-07-10T08:58:16+03:00https://health-pharma.ro/question/conform-fr-x-cremele-sunt/2022-07-10T08:58:32+03:00https://health-pharma.ro/question/urmatoarea-afirmatie-referitoare-la-derm-este-adevarata/2022-07-10T08:59:07+03:00https://health-pharma.ro/question/alegeti-afirmatiile-corecte-referitoare-la-emplastrele-medicamentoase/2022-07-10T08:59:28+03:00https://health-pharma.ro/question/in-formularea-unguentelor-se-asociaza-urmatorii-antioxidanti/2022-07-10T08:59:50+03:00https://health-pharma.ro/question/cilindrii-morii-cu-valturi-folosita-la-omogenizarea-unguentelor-trebuie-sa-fie/2022-07-10T09:00:16+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa-referitoare-la-cataplasme/2022-07-10T09:00:34+03:00https://health-pharma.ro/question/in-cadrul-examinarii-caracterelor-macroscopice-ale-unguentelor-se-urmaresc-urmatoarele-elemente/2022-07-10T09:00:58+03:00https://health-pharma.ro/question/pentru-a-utiliza-extensiometrul-ojeda-arbussa-este-necesara-existenta-urmatoarelor-elemente-cu-exceptia/2022-07-10T09:01:17+03:00https://health-pharma.ro/question/procedeul-de-fabricare-a-unguentelor-la-rece-se-numeste/2022-07-10T09:01:40+03:00https://health-pharma.ro/question/difuzia-prin-stratul-cornos-pe-cale-transcelulara-a-substantelor-cu-masa-moleculara-mica-are-loc-prin/2022-07-10T09:02:08+03:00https://health-pharma.ro/question/pentru-studierea-proprietatilor-reologice-ale-unguentelor-se-utilizeaza/2022-07-10T09:02:44+03:00https://health-pharma.ro/question/urmatoarele-enunturi-sunt-corecte-referitoare-la-prepararea-hidrogelurilor/2022-07-10T09:03:07+03:00https://health-pharma.ro/question/se-pot-utiliza-ustensile-de-metal-la-prepararea-unguentelor-ce-contin/2022-07-10T09:03:32+03:00https://health-pharma.ro/question/sunt-substante-medicamentoase-cu-caracter-lipofil/2022-07-10T09:03:51+03:00https://health-pharma.ro/question/sunt-substante-medicamentoase-insolubile-in-baze-de-unguent-grase/2022-07-10T09:04:14+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa-referitoare-ia-metodele-folosite-la-prepararea-unguentelor-emulsil-in-industrie/2022-07-10T09:05:08+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-urmatoarele-afirmatii-referitoare-la-preparatele-semisolide-pentru-aplicatii-cutanate-sunt-adevarate/2022-07-10T09:05:40+03:00https://health-pharma.ro/question/supl-2004-al-fr-x-inscrie-urmatoarele-categorii-de-preparate-semisolide-pentru-aplicare-cutanata-cu-exceptia/2022-07-10T09:06:41+03:00https://health-pharma.ro/question/ceratele/2022-07-10T09:06:57+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-paste-sunt-adevarate/2022-07-10T09:07:21+03:00https://health-pharma.ro/question/cataplasmele/2022-07-10T09:07:38+03:00https://health-pharma.ro/question/urmatoarea-afirmatie-referitoare-la-organogeluri-este-falsa/2022-07-10T09:08:04+03:00https://health-pharma.ro/question/urmatoarele-substante-medicamentoase-antifungice-utilizate-pentru-prepararea-unguentelor-fac-parte-din-clasa-de-antibiotice-cu-structura-polienica/2022-07-10T09:08:25+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-derivatii-imidazolici-utilizati-la-prepararea-unguentelor-sunt-adevarate/2022-07-10T09:08:46+03:00https://health-pharma.ro/question/urmatoarele-substante-medicamemtoase-utilizate-la-prepararea-unguentelor-depigmenteaza-epidermul-cu-exceptia/2022-07-10T09:09:04+03:00https://health-pharma.ro/question/la-prepararea-unguentelor-se-pot-utiliza-urmatoarele-substante-cu-actiune-fotoprotectoare-cu-exceptia/2022-07-10T09:09:29+03:00https://health-pharma.ro/question/urmatoarele-baze-de-unguent-sunt-baze-hidrocarbonate/2022-07-10T09:09:49+03:00https://health-pharma.ro/question/uleiurile-hidrogenate-din-compozitia-bazelor-de-unguent/2022-07-10T09:10:08+03:00https://health-pharma.ro/question/cerezina/2022-07-10T09:10:26+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-unguentul-emolient-sunt-adevarate-cu-exceptia/2022-07-10T09:10:47+03:00https://health-pharma.ro/question/stearina/2022-07-10T09:11:17+03:00https://health-pharma.ro/question/diferitele-tipuri-de-silicone-ca-excipienti-la-prepararea-ungmentelor-urmatoarele-proprietati/2022-07-10T09:12:12+03:00https://health-pharma.ro/question/alcoolii-de-lanolina/2022-07-10T09:12:37+03:00https://health-pharma.ro/question/unguentul-hidroabsorbant/2022-07-10T09:12:58+03:00https://health-pharma.ro/question/lanolina-acetilati/2022-07-10T09:13:37+03:00https://health-pharma.ro/question/hidregelurile-anorganice-pot-fi-preparate-autoarele-opuri-de-agenti-gelifianti-cu-exceptia/2022-07-10T09:14:25+03:00https://health-pharma.ro/question/la-formularea-stt-urilor-se-adauga-ca-promotori-de-absorbtie/2022-07-10T09:24:10+03:00https://health-pharma.ro/question/stt-urile-reprezinta-forme-farmaceutice/2022-07-10T09:24:54+03:00https://health-pharma.ro/question/scaderea-fortei-coezive-a-adezivului-unui-stt-are-ca-efecte-nedorite/2022-07-10T09:25:14+03:00https://health-pharma.ro/question/stt-urile-sunt-utilizate-deoarece/2022-07-10T09:25:41+03:00https://health-pharma.ro/question/eliberarea-substantei-medicamentoase-din-dispozitivul-transdermic-poate-fi-realizata-efectiv-prin/2022-07-10T09:26:10+03:00https://health-pharma.ro/question/testul-important-utilizat-in-controlul-de-calitate-al-stt-urilor-este/2022-07-10T09:26:26+03:00https://health-pharma.ro/question/stt-urile-au-la-baza-structuri-polimerice-complexe-ai-caror-constituenti-trebuie-sa-asigure/2022-07-10T09:26:50+03:00https://health-pharma.ro/question/membrana-utilizata-pentru-testul-de-dizolvare-efectuat-in-cazul-stt-urilor-conform-supl-2004-al-fr-x/2022-07-10T09:27:10+03:00https://health-pharma.ro/question/ambalarea-sistemelor-terapeutice-transdermice-conform-supl-2004-al-fr-x-se-face-astfel/2022-07-10T09:27:31+03:00https://health-pharma.ro/question/blondezivul-unui-stt-trebuie-sa-indeplineasca-urmatoarele-cerinte/2022-07-10T09:28:56+03:00https://health-pharma.ro/question/clasificarea-stt-urilor-se-face-in-functie-de/2022-07-10T09:29:23+03:00https://health-pharma.ro/question/obiectivele-formularii-stt-urilor-au-ca-scop-urmatoarele-aspecte/2022-07-10T09:29:44+03:00https://health-pharma.ro/question/aplicarea-de-stt-uri-pe-suprafata-pielii-este-un-procedeu/2022-07-10T09:30:03+03:00https://health-pharma.ro/question/poliacrilatii-sunt-mult-utilizati-ca-adezivi-pentru-stt-uri-datorita-urma-toarei-proprietati/2022-07-10T09:30:32+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-testul-de-dizolvare-specific-sistemelor-terapeutice-transdermice-presupune-utilizarea-urmatoarelor-metode/2022-07-10T09:30:51+03:00https://health-pharma.ro/question/pentru-actiunea-sistemica-a-unor-substante-medicamentoase-pe-cale-cutanata-o-necesitate-primordiala-o-constituie/2022-07-10T09:31:11+03:00https://health-pharma.ro/question/referitor-la-etichetarea-sistemelor-terapeutice-transdermice-supl-2004-al-fr-x-prevede-urmatoarele/2022-07-10T09:31:33+03:00https://health-pharma.ro/question/pentru-formularea-si-fabricarea-unui-stt-proprietatea-esentiala-a-substantelor-active-este/2022-07-10T09:32:03+03:00https://health-pharma.ro/question/sistemele-terapeutice-transdermice-sunt/2022-07-10T09:32:45+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-sistemele-terapeutice-transdermice-prezinta-un-suport-extern-care/2022-07-10T09:33:12+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-sunt-indepartate-cu-usurinta-sistemele-terapeutice-care-au-fost-aplicate/2022-07-10T09:33:30+03:00https://health-pharma.ro/question/designul-unui-stt-cuprinde-urmatorul-element-structural-important/2022-07-10T09:33:58+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-sistemele-terapeutice-transdermice/2022-07-10T09:34:43+03:00https://health-pharma.ro/question/utilizarea-stt-ului-ofera-posibilitatea/2022-07-10T09:35:18+03:00https://health-pharma.ro/question/referitor-la-conservarea-sistemelor-terapeutice-transdermice-supl-2004-al-fr-x-prevede-urmatoarele/2022-07-10T09:35:53+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-sistemele-terapeutice-transdermice-sunt-conditionate/2022-07-10T09:36:41+03:00https://health-pharma.ro/question/la-baza-stt-urilor-se-afla-strue-turi-polimerice-complexe-care-asigura-urmatoarea-functie/2022-07-10T09:37:03+03:00https://health-pharma.ro/question/precizati-care-afirmatii-privind-stt-rile-sunt-corecte-conform-supl-2004-al-fr-x/2022-07-10T09:37:48+03:00https://health-pharma.ro/question/proprietatea-ideala-ceruta-pentru-selectionarea-unui-promotor-de-absorbtie-intr-o-formulare-de-stt-este/2022-07-10T09:38:06+03:00https://health-pharma.ro/question/stt-urile-tip-rezervor-sunt-alcatuite-din/2022-07-10T09:38:22+03:00https://health-pharma.ro/question/stt-tip-matrita-nu-sunt-alcatuite-din/2022-07-10T09:38:40+03:00https://health-pharma.ro/question/dispozitivele-transdermice-tip-rezervor-in-stare-solida-sau-lichida-utilizeaza-adezivul-ca-o-matrita-ce-contine/2022-07-10T09:39:13+03:00https://health-pharma.ro/question/cele-mai-importante-proprietati-ale-substantelor-active-utilizate-pentru-formularea-si-fabricarea-de-stt-urilor-sunt/2022-07-10T09:39:48+03:00https://health-pharma.ro/question/stt-ul-poate-fi-constituit-dintr-o-forma-farmaceutica-semisolida-gel-fabricata-din/2022-07-10T09:40:31+03:00https://health-pharma.ro/question/cand-sistemele-terapeutice-transdermice-sunt-aplicate-pe-pielea-curata-si-fara-leziuni/2022-07-10T09:41:11+03:00https://health-pharma.ro/question/conform-suplimentului-2004-al-fr-x-sistemele-terapeutice-transdermice-sunt-preparate-farmaceutice/2022-07-10T09:41:56+03:00https://health-pharma.ro/question/determinarea-dizolvarii-sistemelor-terapeutice-transdermice-se-poate-face-conform-suplimentului-2004-al-fr-x-utilizand/2022-07-10T09:42:23+03:00https://health-pharma.ro/question/dezavantajele-sistemelor-de-eliberare-transdermica-sunt/2022-07-10T09:43:13+03:00https://health-pharma.ro/question/selectarea-promotorilor-de-absorbtie-pentru-stt-uri-se-poate-baza-pe/2022-07-10T09:43:41+03:00https://health-pharma.ro/question/sistemele-terapeutice-transdermice-conform-suplimentului-2004-al-fr-x-contin/2022-07-10T09:44:20+03:00https://health-pharma.ro/question/precizati-care-excipient-din-cei-enumerati-mai-jos-este-recomandabil-pentru-supozitoarele-realizate-prin-modelare-manuala/2022-07-10T09:45:40+03:00https://health-pharma.ro/question/bazele-liposolubile-utilizate-la-prepararea-supozitoarelor-sunt-caracterizate-de/2022-07-10T09:46:41+03:00https://health-pharma.ro/question/factorii-influenteaza-cinetica-de-eliberare-a-substantei-medicamentoase-la-supozitoare-sunt-determinati-de/2022-07-10T09:47:06+03:00https://health-pharma.ro/question/conform-fr-x-supozitoarele-sunt-preparate-farmaceutice/2022-07-10T09:47:37+03:00https://health-pharma.ro/question/ca-forma-farmaceutica-supozitoarele-prezinta-urmatoarele-avantaje-oferite-de/2022-07-10T09:50:03+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-afirmatii-cu-privire-la-solutiile-emulsiile-si-suspensiile-rectale-sunt-false-conform-supl-2004-al-fr-x/2022-07-10T09:50:26+03:00https://health-pharma.ro/question/substantele-auxiliare-utilizate-la-prepararea-supozitoarelor-sunt-reprezentate-de/2022-07-10T09:51:10+03:00https://health-pharma.ro/question/clasificarea-supozitoarelor-dupa-gradul-de-dispersie-al-substantei-active-include-urmatoarele-tipuri-de-supozitoare-cu-o-exceptie/2022-07-10T09:51:31+03:00https://health-pharma.ro/question/selectati-substantele-medicamentoase-care-scad-punctul-de-topire-al-supozitoarelor/2022-07-10T09:51:51+03:00https://health-pharma.ro/question/gliceridele-semisintetice-prezinta-urmatoarele-avantaje-la-formularea-supozitoarelor/2022-07-10T09:52:16+03:00https://health-pharma.ro/question/metoda-de-modelare-manuala-a-supozitoarelor/2022-07-10T09:52:41+03:00https://health-pharma.ro/question/ce-procedeu-nu-se-recomanda-la-incorporarea-substantelor-active-in-baza-de-supozitoare/2022-07-10T09:53:05+03:00https://health-pharma.ro/question/excipientii-folositi-la-prepararea-supozitoarelor-prin-metodele-de-topire-si-turnare-trebuie-sa-indeplineasca-urmatoarele-caracteristici-cu-o-exceptie/2022-07-10T09:53:23+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-faze-nu-se-aplica-la-metoda-de-modelare-manuala-a-supozitoarelor/2022-07-10T09:53:43+03:00https://health-pharma.ro/question/selectati-factorul-extern-care-nu-influenteaza-calitatea-supozitoarelor-in-timpul-depozitarii/2022-07-10T09:54:02+03:00https://health-pharma.ro/question/excipientii-utilizati-la-prepararea-supozitoarelor-pot-fi/2022-07-10T09:54:38+03:00https://health-pharma.ro/question/gelatina-ca-excipient-hidrosolubil-trebuie-sa-corespunda-unor-cerinte-de-calitate-privind/2022-07-10T09:55:02+03:00https://health-pharma.ro/question/selectati-substantele-folosite-ca-adjuvanti-pentru-imbunatatirea-dispersarii-substantei-medicamentoase-in-cazul-supozitoarelor/2022-07-10T09:57:30+03:00https://health-pharma.ro/question/precizati-tipul-de-supozitoare-care-nu-se-incadreaza-in-categoria-sistemelor-disperse-eterogene-bi-sau-polifazice/2022-07-10T09:57:49+03:00https://health-pharma.ro/question/supozitoarele-sunt-preparate-farmaceutice-solide-care-contin-doze-unitare-din-una-sau-mai-multe-substante-active-dispersate-intr-o/2022-07-10T09:58:20+03:00https://health-pharma.ro/question/supozitoarele-sunt-administrate-pentru-obtinerea-urmatoarelor-efecte-sistemice-cu-o-exceptie/2022-07-10T09:58:36+03:00https://health-pharma.ro/question/supozitoarele-sunt-dispersii-de-substante-medicamentoase-incorporate-intr-un-mediu/2022-07-10T09:58:55+03:00https://health-pharma.ro/question/supozitoarele-destinate-tratamentului-mucoasei-rectale-fac-parte-din-categoria-supozitoarelor/2022-07-10T09:59:10+03:00https://health-pharma.ro/question/urmatoarele-forme-farmaceutice-sunt-clasificate-ca-preparate-rectale/2022-07-10T09:59:38+03:00https://health-pharma.ro/question/in-cazul-metodei-de-topire-si-turnare-in-forme-dispersarea-substantelor-medicamentoase-se-face-prin/2022-07-10T10:00:01+03:00https://health-pharma.ro/question/la-prepararea-supozitoarelor-tip-suspensie-suspendarea-substantelor-medicamentoase-in-baza-de-supozitor-este-caracterizata-de/2022-07-10T10:00:35+03:00https://health-pharma.ro/question/refacerea-troficitatii-in-efectul-local-al-supozitoarelor-in-regiunea-anorectala-consta-in/2022-07-10T10:00:52+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-urmatoarele-afirmatii-cu-privire-la-preparatele-rectale-semisolide-sunt-adevarate-cu-o-singura-exceptie/2022-07-10T10:01:24+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-capsulele-moi-rectale-prezinta-urmatoarele-caracteristici/2022-07-10T10:01:54+03:00https://health-pharma.ro/question/prepararea-industriala-a-supozitoarelor-prin-metoda-topirii-turnarii-se-poate-efectua-in-urmatoarele-moduri/2022-07-10T10:02:18+03:00https://health-pharma.ro/question/precizati-plasticizantii-folositi-la-prepararea-supozitoarelor-in-farmacie/2022-07-10T10:02:41+03:00https://health-pharma.ro/question/selectati-bazele-hidrosolubile-pentru-supozitoare/2022-07-10T10:03:01+03:00https://health-pharma.ro/question/procedeul-de-liofilizare-folosit-la-prepararea-supozitoarelor-in-industrie-urmareste/2022-07-10T10:03:23+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-urmatoarele-afirmatii-cu-privire-la-capsulele-moi-rectale-sunt-adevarate-cu-exceptia-faptului-ca/2022-07-10T10:03:46+03:00https://health-pharma.ro/question/fenomenul-de-polimorfism-al-gliceridelor-poate-fi-evitat-prin-asocierea-cu/2022-07-10T10:04:15+03:00https://health-pharma.ro/question/precizati-care-este-dezavantajul-substantelor-active-incorporate-in-supozitoare/2022-07-10T10:04:43+03:00https://health-pharma.ro/question/prepararea-supozitoarelor-in-farmacie-se-face-prin-urmatoarele-metode/2022-07-10T10:05:23+03:00https://health-pharma.ro/question/diferenta-intre-densitatea-substantei-active-si-cea-a-excipientului-poate-fi-rezolvata-prin/2022-07-10T10:05:42+03:00https://health-pharma.ro/question/ca-forma-farmaceutica-supozitoarele-prezinta-urmatoarele-dezavantaje/2022-07-10T10:06:09+03:00https://health-pharma.ro/question/in-scopul-prepararii-supozitoarelor-excipientii-trebuie-sa-prezinte-urmatoarele-proprietati/2022-07-10T10:06:44+03:00https://health-pharma.ro/question/dispersia-substantei-active-in-baza-de-supozitoare-intr-un-sistem-de-dispersie-omogen-determina/2022-07-10T10:06:59+03:00https://health-pharma.ro/question/avantajele-untului-de-cacao-sunt-urmatoarele-cu-o-exceptie/2022-07-10T10:07:18+03:00https://health-pharma.ro/question/precizati-aspectul-farmaceuticotehnologic-care-este-evitat-in-formularea-supozitoarelor/2022-07-10T10:07:59+03:00https://health-pharma.ro/question/supozitoarele-antihemoroidale-nu-contin/2022-07-10T10:08:24+03:00https://health-pharma.ro/question/la-prepararea-supozitoarelor-in-functie-de-caracteristicile-substantelor-active-si-de-efectul-terapeutic-urmarit-se-folosesc/2022-07-10T10:09:12+03:00https://health-pharma.ro/question/supozitoarele-nu-trebuie-sa-contina/2022-07-10T10:10:21+03:00https://health-pharma.ro/question/avantajele-divizarii-directe-in-tipareambalaje-includ/2022-07-10T10:11:12+03:00https://health-pharma.ro/question/precizati-care-este-dezavantajul-supozitoarelor-administrate-pentru-a-obtine-o-actiune-generala/2022-07-10T10:11:37+03:00https://health-pharma.ro/question/precizati-factorii-care-nu-influenteaza-tratamentul-la-administrarea-supozitoarelor/2022-07-10T10:12:18+03:00https://health-pharma.ro/question/din-punctul-de-vedere-al-formularii-supozitoarele-rectale-trebuie-sa-indeplineasca-urmatoarele-conditii/2022-07-10T10:12:48+03:00https://health-pharma.ro/question/in-procedeul-de-turnare-individuala-a-masei-fluide-sunt-necesare/2022-07-10T10:13:27+03:00https://health-pharma.ro/question/pe-eticheta-pulberilor-si-comprimatelor-pentru-solutii-sau-suspensii-rectale-trebuie-sa-se-precizeze-urmatoarele/2022-07-10T10:14:02+03:00https://health-pharma.ro/question/selectati-afirmatiile-adevarate-referitoare-la-untul-de-cacao/2022-07-10T10:14:30+03:00https://health-pharma.ro/question/la-formularea-supozitoarelor-in-alegerea-substantei-medicamentoase-se-va-tine-cont-de/2022-07-10T10:14:58+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-forme-de-conditionare-a-supozitoarelor-este-cea-mai-recomandata/2022-05-06T13:37:36+03:00https://health-pharma.ro/question/baza-de-supozitoare-este-o-substanta/2022-07-10T10:15:46+03:00https://health-pharma.ro/question/selectati-substantele-care-pot-fi-folosite-ca-lubrifianti-la-prepararea-supozitoarelor-rectale-cu-masa-glicero-gelatinoasa/2022-07-10T10:16:08+03:00https://health-pharma.ro/question/precizati-categoria-de-substante-medicamentoase-care-nu-este-inclusa-in-supozitoarele-antihemoroidale/2022-07-10T10:16:33+03:00https://health-pharma.ro/question/precizati-parametrul-care-nu-influenteaza-alegerea-excipientilor-pentru-supozitoare/2022-07-10T10:16:50+03:00https://health-pharma.ro/question/selectati-factorul-care-a-determinat-diversificarea-formei-farmaceutice-de-supozitoare/2022-07-10T10:17:17+03:00https://health-pharma.ro/question/in-functie-de-tehnologia-de-preparare-supozitoarele-se-clasifica-astfel/2022-07-10T10:17:44+03:00https://health-pharma.ro/question/conform-fr-x-formula-de-preparare-a-masei-gelatinoase-folosita-ca-baza-pentru-supozitoarele-vaginale-este-urmatoarea/2022-07-10T10:18:22+03:00https://health-pharma.ro/question/selectati-forma-farmaceutica-rectala-neoficializata-de-supl-2004-al-fr-x/2022-07-10T10:19:04+03:00https://health-pharma.ro/question/supl-2004-la-fr-x-include-urmatoarele-preparate-rectale/2022-07-10T10:19:33+03:00https://health-pharma.ro/question/calea-de-administrare-rectala-prezinta-urmatoarele-avantaje/2022-07-10T10:19:59+03:00https://health-pharma.ro/question/in-cazul-utilizarii-untului-de-cacao-ca-baza-de-supozitoare-formele-metalice-se-lubrifiaza-cu/2022-07-10T10:20:36+03:00https://health-pharma.ro/question/dezavantajul-untului-de-cacao-utllizat-ca-baza-pentru-supozitoare-este/2022-07-10T10:21:17+03:00https://health-pharma.ro/question/sorturile-de-witepsol-utilizate-la-prepararea-supozitoarelor-sunt-urmatoarele/2022-07-10T10:21:32+03:00https://health-pharma.ro/question/precizati-etapa-care-nu-este-inclusa-in-fazele-procesului-tehnologie-indus-trial-de-obtinere-a-supozitoarelor/2022-05-06T13:37:40+03:00https://health-pharma.ro/question/baza-de-supozitor-poate-fi-de-origine/2022-07-10T10:22:45+03:00https://health-pharma.ro/question/promotoril-care-amelioreaza-eliberarea-substantelor-medicamentoase-la-nivelul-caii-rectale-sunt-urmatorii/2022-07-10T10:24:22+03:00https://health-pharma.ro/question/stabilitatea-supozitoarelor-presupune-evitarea-urmatoarelor-interactiuni-cu-o-exceptie/2022-07-10T10:25:06+03:00https://health-pharma.ro/question/din-punctul-de-vedere-al-tipului-bazel-de-supozitor-acestea-se-clasifica/2022-07-10T10:26:05+03:00https://health-pharma.ro/question/modificarile-care-pot-aparea-in-timpul-depozitarii-supozitoarelor-se-pot-manifesta-prin/2022-07-10T10:26:26+03:00https://health-pharma.ro/question/excipientil-hidrosolubili-utilizati-la-prepararea-supozitoarelor-au-urmatoarele-caracteristici-mai-putin/2022-07-10T10:27:10+03:00https://health-pharma.ro/question/pentru-a-creste-punctul-de-topire-a-untului-de-cacao-se-pot-utiliza-urmatoarele-substante-auxiliare/2022-07-10T10:27:40+03:00https://health-pharma.ro/question/conform-fr-x-untul-de-cacao-prezinta-urmatoarele-proprietati/2022-07-10T10:28:02+03:00https://health-pharma.ro/question/dezavantajele-untului-de-cacao-sunt-urmatoarele-cu-o-exceptie/2022-07-10T10:28:31+03:00https://health-pharma.ro/question/principalele-gliceride-semisintetice-de-tip-adeps-solidus-utiliate-ca-baze-de-supozitor-sunt-urmatoarele-mai-putin/2022-07-10T10:28:58+03:00https://health-pharma.ro/question/factorii-care-influenteaza-cinetica-absorbtiei-substantei-medicamentoase-la-supozitoare-sunt-urmatorii-cu-o-exceptie/2022-07-10T10:29:42+03:00https://health-pharma.ro/question/sunt-lubrifianti-insolubili-utilizati-la-fabricarea-comprimatelor-cu-exceptia/2022-07-10T10:41:14+03:00https://health-pharma.ro/question/urmatoarele-substante-sunt-diluanti-in-formularea-pulberilor-pentru-capsulele-operculate/2022-07-10T10:41:41+03:00https://health-pharma.ro/question/la-prepararea-capsulelor-fr-x-prevede-ca-in-formulare-limita-maxima-de-stearat-de-magneziu-trebuie-sa-fie-de/2022-07-10T14:05:09+03:00https://health-pharma.ro/question/referitor-la-porozitatea-comprimatelor-sunt-adevarate-urmatoarele-afirmatii/2022-07-10T10:42:18+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-tipuri-de-comprimate-sunt-comprimate-cu-eliberare-accelerata/2022-07-10T10:42:39+03:00https://health-pharma.ro/question/la-prepararea-comprimatelor-frx-prevede-ca-in-formulare-limita-maxima-de-tale-trebuie-sa-fie-de/2022-07-10T10:43:21+03:00https://health-pharma.ro/question/referitor-la-tehnologia-de-fabricare-a-capsulelor-moi-versus-cea-a-capsulelor-operculate-sunt-adevarate-urmatoarele/2022-07-10T10:43:38+03:00https://health-pharma.ro/question/manitolul/2022-07-10T10:43:53+03:00https://health-pharma.ro/question/referitor-la-dezagregarea-comprimatelor-efervescente-frx-prevede-ca-acestea-trebuie-sa-se-dizolve-sau-sa-se-disperseze-in-apa-cu-efervescenta-in-cel-mult/2022-07-10T10:44:29+03:00https://health-pharma.ro/question/procedeul-globex-de-preparare-a-capsulelor-moi/2022-07-10T10:44:43+03:00https://health-pharma.ro/question/peg-4000-si-peg-6000/2022-07-10T10:45:11+03:00https://health-pharma.ro/question/in-metoda-de-sigilare-a-capsulelor-operculate-la-temperatura-scazuta-se-executa-urmatoarele-operatii-cu-exceptia/2022-07-10T10:45:33+03:00https://health-pharma.ro/question/factorii-care-influenteaza-procesul-de-dezagregare-produs-de-un-superdezagregant-sunt/2022-07-10T10:46:05+03:00https://health-pharma.ro/question/prevederile-monografiei-compressi-din-fr-x-supl-2004/2022-07-10T10:46:22+03:00https://health-pharma.ro/question/capsulele-gelatinoase-dure-umplute-cu-lichide-au-urmatoarele-caracteristici-cu-exceptia/2022-07-10T10:47:10+03:00https://health-pharma.ro/question/alimentele-din-tractul-gastrointestinal-pot-reduce-absorbtia-unor-substante-active-din-comprimate-prin-diferite-mecanisme-cum-ar-fi/2022-07-10T10:47:30+03:00https://health-pharma.ro/question/prin-acoperirea-enterica-a-capsulelor-se-elimina-actiunea-iritanta-pentru/2022-07-10T10:47:50+03:00https://health-pharma.ro/question/alegeti-afirmatiile-adevarate-referitoare-la-avantajele-utilizarii-capsulelor-gelatinoase-moi/2022-07-10T10:48:25+03:00https://health-pharma.ro/question/nu-este-un-excipient-superdezagregant-utilizat-la-fabricarea-comprimatelor/2022-07-10T10:48:57+03:00https://health-pharma.ro/question/selectati-afirmatia-adevarata-despre-capsulele-gelatinoase-moi-rasucite/2022-07-10T10:49:14+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-surfactantii-in-formularea-pulberilor-pentru-introducerea-in-capsulele-operculate-sunt-false/2022-07-10T10:49:36+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa-referitoare-la-procesul-de-comprimare/2022-07-10T10:50:05+03:00https://health-pharma.ro/question/selectati-afirmatiile-corecte-referitoare-la-caracterele-dimensionale-ale-comprimatelor/2022-07-10T10:50:35+03:00https://health-pharma.ro/question/despre-aglutinanti-sunt-adevarate-urmatoarele-afirmatii/2022-07-10T10:52:14+03:00https://health-pharma.ro/question/la-prepararea-comprimatelor-fr-x-prevede-ca-in-formulare-limita-maxima-de-aerosil-trebuie-sa-fie-de/2022-07-10T10:52:46+03:00https://health-pharma.ro/question/la-umplerea-capsulelor-in-farmacii-si-laboratoare/2022-07-10T10:53:53+03:00https://health-pharma.ro/question/conform-fr-x-supl-2004-determinarea-timpului-de-dezagregare-a-comprimatelor-se-efectueaza-cu-urmatoarele-tipuri-de-aparate/2022-07-10T10:54:32+03:00https://health-pharma.ro/question/alegeti-afirmatiile-corecte-referitoare-la-indicele-carr/2022-07-10T10:54:50+03:00https://health-pharma.ro/question/dupa-administrarea-orala-a-unui-comprimat-substanta-activa-pe-care-o-contine-parcurge-in-faza-biofarmaceutica-urmatoarele-etape/2022-07-10T10:55:09+03:00https://health-pharma.ro/question/sunt-excipienti-utilizati-pentru-eliberare-controlata-dependenti-de-ph-cu-exceptia/2022-07-10T10:55:31+03:00https://health-pharma.ro/question/referitor-la-dezagregarea-capsulelor-gelatinoase-enterosolubile-fr-x-prevede-ca-acestea-trebuie-sa-se-dezagrege-in-cel-mult-60-minute-in/2022-07-10T10:56:04+03:00https://health-pharma.ro/question/factorii-dependenti-de-material-si-de-formulare-care-influenteaza-rezistenta-mecanica-a-comprimatelor-sunt/2022-07-10T10:56:29+03:00https://health-pharma.ro/question/selectati-afirmatiile-care-se-refera-la-timpul-de-rezidenta-gastrica-a-comprimatelor-dupa-administrare-orala/2022-07-10T10:56:58+03:00https://health-pharma.ro/question/urmatorii-parametri-pot-fi-inregistrati-la-masinile-de-comprimat-instrumentate-cu-exceptia/2022-07-10T10:57:21+03:00https://health-pharma.ro/question/lubrifiantii-laminari-ca-excipienti-la-capsulele-operculate/2022-07-10T10:57:38+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-cu-privire-la-produsele-cu-pulberi-pentru-inhalare-introduse-in-capsule-sunt-false/2022-07-10T10:58:04+03:00https://health-pharma.ro/question/urmatoarele-categorii-de-comprimate-sunt-administrate-in-cavitatea-bucala-cu-exceptia/2022-07-10T10:58:27+03:00https://health-pharma.ro/question/scopurile-pentru-care-se-folosesc-colorantii-in-unele-formulari-de-comprimate-sunt/2022-07-10T10:59:27+03:00https://health-pharma.ro/question/acoperirea-comprimatelor-se-face-in-scopul/2022-07-10T10:59:52+03:00https://health-pharma.ro/question/selectati-varianta-incorecta-dintre-urmatoarele-perechi-parametru-testat-metoda-de-testare-utilizata-pentru-controlul-calitatii-comprimatelor/2022-07-10T11:01:07+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-piesele-principale-ale-unei-masini-de-comprimat-sunt-false/2022-07-10T11:01:59+03:00https://health-pharma.ro/question/capsulele-gelatinoase-moi-prezinta-urmatoarele-dezavantaje-cu-exceptia/2022-07-10T11:02:38+03:00https://health-pharma.ro/question/urmatoarele-substante-cristaline-pot-fi-procesate-singure-prin-comprimare-directa/2022-07-10T13:27:25+03:00https://health-pharma.ro/question/selectati-formele-farmaceutice-administrate-pe-cale-orala-care-prezinta-o-biodisponibilitate-mai-mica-decat-comprimatele-neacoperite-cu-eliberare-conventionala/2022-07-10T13:28:08+03:00https://health-pharma.ro/question/conform-fr-x-supl-2004-nu-sunt-supuse-testului-de-dezagregare/2022-07-10T13:28:33+03:00https://health-pharma.ro/question/conform-procedeului-prevazut-in-fr-x-determinarea-uniformitatii-masei-se-efectueaza-pe-urmatorul-numar-de-comprimate/2022-07-10T13:28:56+03:00https://health-pharma.ro/question/despre-excipientii-coprocesati-utilizati-la-formularea-comprimatelor-sunt-adevarate-urmatoarele-afirmatii/2022-07-10T13:29:54+03:00https://health-pharma.ro/question/conform-farmacopeii-europene-ed-a-4-a-ph-eur-4-capsulele-gastrorezistente/2022-07-10T13:30:21+03:00https://health-pharma.ro/question/procedeul-prin-presare-de-obtinere-a-capsulelor-gelatinoase-moi/2022-07-10T13:30:46+03:00https://health-pharma.ro/question/conform-fr-x-casetele-sunt-preparate-din/2022-07-10T13:31:21+03:00https://health-pharma.ro/question/potentialul-de-diluare/2022-07-10T13:31:40+03:00https://health-pharma.ro/question/urmatoarele-substante-auxiliare-au-fluiditate-buna-cu-exceptia/2022-07-10T13:32:02+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-amidonul-pregelatinizat-sunt-adevarate-cu-exceptia/2022-07-10T13:32:41+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-corecte-cu-privire-la-excipientii-coprocesati/2022-07-10T13:33:05+03:00https://health-pharma.ro/question/unghiul-de-repaus-reprezinta/2022-07-10T13:33:24+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-cu-privire-la-poansoane-sunt-adevarate/2022-07-10T13:33:46+03:00https://health-pharma.ro/question/selectati-afirmatia-falsa-cu-privire-la-capsulele-gelatinoase-moi/2022-07-10T13:34:35+03:00https://health-pharma.ro/question/din-punctul-de-vedere-al-pacientului-folosirea-comprimatelor-ca-principala-forma-farmaceutica-dozata-orala-se-justifica-prin-urmatoarele-aspecte/2022-07-10T13:35:02+03:00https://health-pharma.ro/question/dependent-de-tipul-si-marimea-particulelor-rezultate-in-fiecare-etapa-dezagregarea-comprimatelor-este-numita/2022-07-10T13:35:21+03:00https://health-pharma.ro/question/in-functie-de-modul-de-eliberare-a-substantei-active-fr-x-si-ph-eur-4th-impart-capsulele-gelatinoase-moi-astfel/2022-07-10T13:35:45+03:00https://health-pharma.ro/question/gliceridele-semisintetice-ca-excipienti-pentru-capsulele-operculate/2022-07-10T13:36:26+03:00https://health-pharma.ro/question/continutul-capsulelor-gelatinoase-moi-poate-fi-reprezentat-de-urmatoarele-formulari/2022-07-10T13:36:59+03:00https://health-pharma.ro/question/comparativ-cu-capsulele-gelatinoase-moi-capsulele-moi-fara-gelatina-pe-baza-de-amidon-prezinta-urmatoarele-avantaje-cu-exceptia/2022-07-10T13:37:17+03:00https://health-pharma.ro/question/celuloza-microcristalina/2022-07-10T13:37:45+03:00https://health-pharma.ro/question/in-ceea-ce-priveste-substantele-auxiliare-utilizate-la-fabricarea-capsulelor-moi/2022-07-10T13:38:26+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-capsulele-moi-sunt-definite-ca-fiind/2022-07-10T13:38:52+03:00https://health-pharma.ro/question/masini-de-umplere-a-capsulelor-care-comprima-o-cantitate-masurata-de-pulbere-pentru-a-forma-un-dop-plug-sunt/2022-07-10T13:39:16+03:00https://health-pharma.ro/question/dispozitivele-propuse-de-firma-erweka-pentru-determinarea-friabilitatii-comprimatelor-modelul-tdr-100-si-modelul-tar-permit-inregistrarea-urmatorilor-parametri/2022-07-10T13:39:45+03:00https://health-pharma.ro/question/in-procesul-de-legare-a-particulelor-din-granularea-umeda-sunt-implicate-urmatoarele-fenomene/2022-07-10T13:40:06+03:00https://health-pharma.ro/question/adaugarea-intragranulara-a-dezagregantului-la-fabricarea-comprimatelor-va-produce/2022-07-10T13:40:29+03:00https://health-pharma.ro/question/agentul-plasticizant-din-formularea-capsulelor-moi/2022-07-10T13:40:52+03:00https://health-pharma.ro/question/alegeti-afirmatiile-adevarate/2022-07-10T13:41:44+03:00https://health-pharma.ro/question/agentii-antifrictionali-care-faciliteaza-curgerea-granulatului-in-matrita-poarta-denumirea-de/2022-07-10T13:42:08+03:00https://health-pharma.ro/question/viteza-de-dezagregare-a-comprimatelor-orale-este-influentata-de/2022-07-10T13:42:25+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-cu-privire-la-variatia-dozei-comprimatului-si-a-masei-comprimatelor-in-timpul-comprimarii-sunt-adevarate-cu-exceptia/2022-07-10T13:42:49+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-capsulele-operculate-sunt-adevarate/2022-07-10T13:43:54+03:00https://health-pharma.ro/question/conform-supl-2004-al-fr-x-capsulele-gastrorezistente/2022-07-10T13:44:19+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-sisteme-utilizate-pentru-testarea-dizolvarii-comprimatelor-si-capsulelor-realizeaza-dozarea-interna-a-probelor-in-stare-de-lucru/2022-07-10T13:44:42+03:00https://health-pharma.ro/question/procedeul-de-granulare-umeda/2022-07-10T13:45:08+03:00https://health-pharma.ro/question/urmatorii-excipienti-se-adauga-in-faza-de-amestecare-a-granulelor-selectionate-din-procesul-de-fabricare-a-comprimatelor-prin-metoda-de-granulare-umeda-cu-exceptia/2022-07-10T13:45:29+03:00https://health-pharma.ro/question/aparatul-utilizat-pentru-determinarea-friabilitatii-comprimatelor-opereaza-cu-o-viteza-de-rotatie-de/2022-07-10T13:45:51+03:00https://health-pharma.ro/question/option-1agentii-antifrictionali-care-previn-lipirea-materialului-de-comprimat-de-matrita-si-ponsoane-poarta-denumirea-de/2022-07-10T13:46:23+03:00https://health-pharma.ro/question/la-prepararea-capsulelor-fr-x-prevede-ca-in-formulare-limita-maxima-de-aerosil-trebuie-sa-fie-de/2022-07-10T13:47:33+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privitoare-la-fenomenul-de-gripare-in-matrita-a-comprimatelor-sunt-adevarate-cu-exceptia/2022-07-10T13:47:52+03:00https://health-pharma.ro/question/referitor-la-continutul-capsulelor-gelatinoase-moi-sistemele-de-tip-nanosi-microemulsie-concentrata/2022-07-10T13:48:17+03:00https://health-pharma.ro/question/urmatoarele-substante-pot-fi-diluanti-destinati-comprimarii-directe-cu-exceptia/2022-07-10T13:48:42+03:00https://health-pharma.ro/question/urmatoarele-prevederi-ale-supl-2004-al-fr-x-referitoare-la-dezagregarea-capsulelor-moi-sunt-corecte-cu-o-exceptie/2022-07-10T13:49:03+03:00https://health-pharma.ro/question/prezenta-amestecurilor-eutectice-in-pulberile-care-se-introduc-in-capsulele-opereulate/2022-07-10T13:49:41+03:00https://health-pharma.ro/question/cresterea-ph-ului-gastric-in-prezenta-alimentelor-poate-reduce-biodisponibilitatea-unor-substante-active-printre-care/2022-07-10T13:50:10+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-referitoare-la-umplerea-capsulelor-cu-pulbere-sunt-adevarate-cu-exceptia/2022-07-10T13:50:47+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-proprietati-ale-substantelor-medicamentoase-sunt-cele-mai-importante-pentru-clasificarea-biofarmaceutica-biopharmaceutics-drug-classification-system-bcs/2022-07-10T13:51:26+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-cu-privire-la-controlul-calitatii-capsulelor-operculate-sunt-adevarate-cu-exceptia/2022-07-10T13:51:59+03:00https://health-pharma.ro/question/substantele-medicamentoase-din-clasa-a-iii-a-a-sistemului-de-clasificare-biofarmaceutica-prezinta/2022-07-10T13:52:19+03:00https://health-pharma.ro/question/striurile-verticale-eventual-prezente-pe-marginea-comprimatelor-sunt-cauzate-de/2022-07-10T13:52:46+03:00https://health-pharma.ro/question/supl-2004-al-fr-x-prevede-ca-in-compozitia-continutului-capsulelor-se-pot-utiliza-urmatorii-excipienti-cu-exceptia/2022-07-10T13:53:11+03:00https://health-pharma.ro/question/supl-2004-al-fr-x-prevede-ca-finetea-de-dispersare-a-comprimatelor-pentru-dispersii-orale-sa-se-determine-in-urmatoarele-conditii-experimentale-cu-exceptia/2022-07-10T13:53:39+03:00https://health-pharma.ro/question/obiectivele-granularii-umede-sunt-urmatoarele-cu-exceptia/2022-07-10T13:54:01+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatorii-excipienti-se-utilizeaza-sub-forma-de-solutie-ca-liant-in-granularea-umeda/2022-07-10T13:54:24+03:00https://health-pharma.ro/question/selectati-substantele-care-nu-functioneaza-ca-dezagreganti-prin-mecanismul-de-gonflare-cu-apa/2022-07-10T13:55:11+03:00https://health-pharma.ro/question/alegeti-afirmatia-corecta-despre-glicerol-ca-agent-plasticizant-pentru-prepararea-capsulelor-moi/2022-07-10T13:55:39+03:00https://health-pharma.ro/question/urmatoarele-substante-medicamentoase-prezinta-atat-solubilitate-cat-si-permeabilitate-scazuta/2022-07-10T13:56:03+03:00https://health-pharma.ro/question/rezistenta-mecanica-a-comprimatelor-poate-fi-descrisa-ca/2022-07-10T13:56:24+03:00https://health-pharma.ro/question/alegeti-afirmatia-corecta-referitoare-la-amidon-ca-excipient-la-fabricarea-comprimatelor/2022-07-10T13:56:49+03:00https://health-pharma.ro/question/urmatoarele-afimatii-cu-privire-la-capsulele-operculate-sunt-false/2022-07-10T13:58:30+03:00https://health-pharma.ro/question/precizati-tipurile-de-comprimate-pentru-care-fr-x-prevede-ca-pot-prezenta-pigmentari-sau-particule-diferit-colorate-dar-omogen-repartizate/2022-07-10T13:58:52+03:00https://health-pharma.ro/question/la-masina-de-comprimat-rotativa/2022-07-10T13:59:19+03:00https://health-pharma.ro/question/la-prepararea-capsulelor-fr-x-prevede-ca-in-formulare-limita-maxima-de-talc-trebuie-sa-fie-de/2022-07-10T13:59:55+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa-despre-lactoza/2022-07-10T14:00:27+03:00https://health-pharma.ro/question/despre-agentii-superdezagreganti-sunt-adevarate-afirmatiile/2022-07-10T14:00:50+03:00https://health-pharma.ro/question/controlul-oficial-de-calitate-privind-uniformitatea-continutului-comprimatelor-se-aplica-pentru/2022-07-10T14:01:13+03:00https://health-pharma.ro/question/in-principal-capsulele-moi-sunt-destinate-administrarii-orale-dar-pot-fi-folosite-si-pe-alte-cai-cu-exceptia-celei/2022-07-10T14:01:32+03:00https://health-pharma.ro/question/precizati-pentru-care-dintre-urmatoarele-categorii-de-capsule-prevede-supl-2004-al-fr-x-ca-eticheta-trebuie-sa-specifice-modul-de-administrare/2022-07-10T14:01:56+03:00https://health-pharma.ro/question/identificati-dezavantajele-care-limiteaza-utilizarea-gelatinei-la-fabricarea-capsulelor-gelatinoase-moi/2022-07-10T14:02:17+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-masinile-de-comprimat-cu-excentric-sunt-false/2022-07-10T14:02:41+03:00https://health-pharma.ro/question/alegeti-substanta-care-poate-fi-adaugata-in-formularea-invelisului-capsulelor-pentru-ajustarea-consistentei-conform-supl-2004-al-fr-x/2022-07-10T14:03:11+03:00https://health-pharma.ro/question/alegeti-afirmatia-corecta/2022-07-10T14:03:52+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-granularea-uscata-sunt-false/2022-07-10T14:04:20+03:00https://health-pharma.ro/question/rezistenta-pe-care-o-opune-comprimatul-unor-forte-externe-care-actioneaza-pe-partile-laterale-diametral-opuse-pana-la-rupere-este-numita/2022-07-10T14:04:45+03:00https://health-pharma.ro/question/la-prepararea-comprimatelor-fr-x-prevede-e-in-formulare-limita-maxima-de-stearat-de-magnetu-trebuie-sa-fie-de/2022-05-06T13:34:42+03:00https://health-pharma.ro/question/stabilitatea-produsului-final-la-formularea-capsulelor-moi-se-datoreaza-compatibilitatii-dintre/2022-07-10T14:05:32+03:00https://health-pharma.ro/question/precizati-tipul-de-capsule-pentru-care-supl-2004-al-fr-x-prevede-ca-inveligul-poate-contine-o-substanta-activa/2022-07-10T14:06:23+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-capsulele-amilacee-sunt-adevarate/2022-07-10T14:06:48+03:00https://health-pharma.ro/question/factorii-care-influenteaza-biodisponibilitatea-substantei-active-din-capsule-gelatinoase-moi-umplute-cu-formulari-lichide-includ/2022-07-10T14:07:13+03:00https://health-pharma.ro/question/fr-x-admite-adaugarea-corectorilor-de-gust-si-miros-la-prepararea-urmatoarelor-tipuri-de-comprimate/2022-07-10T14:07:34+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-folia-de-aluminiu-ca-material-de-confectionare-a-blisterelor-pentru-comprimate-sunt-false-cu-exceptia/2022-07-10T14:07:56+03:00https://health-pharma.ro/question/la-masina-de-comprimat-cu-excentric/2022-07-10T14:08:24+03:00https://health-pharma.ro/question/conform-fr-x-supl-2004-aparatul-a-utilizat-pentru-determinarea-timpului-de-dezagregare-a-comprimatelor-este-dotat-cu-o-sita-din-sarma-de-otel-inoxidabil-cu-latura-interioara-a-ochiurilor-de/2022-07-10T14:09:11+03:00https://health-pharma.ro/question/alegeti-afirmaflile-adevarate-referitoare-la-efectele-prin-care-diluantii-pot-influenta-biodisponibilitatea-substantel-active-din-comprimatele-neacoperitei/2022-07-10T14:09:30+03:00https://health-pharma.ro/question/masele-semisolide-din-continutul-capsulelor-gelatinoase-moi-sunt-reprezentate-de/2022-07-10T14:09:54+03:00https://health-pharma.ro/question/alegeti-afirmatiile-corecte-referitoare-la-friabilitatea-comprimatelor/2022-07-10T14:10:12+03:00https://health-pharma.ro/question/conform-fr-x-capsulele-oper-culate-contin-obieci-amestecuri-de-substante-sub-forma-de/2022-07-10T14:10:57+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-conditii-experimentale-nu-sunt-prevazute-de-fr-x-supl-2004-pentru-dezagregarea-comprimatelor-efervescente/2022-07-10T14:11:30+03:00https://health-pharma.ro/question/procedeul-scherer-de-preparare-a-capsulelor-gelatinoase-moi/2022-07-10T14:11:54+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privitoare-la-uscarea-granulelor-umede-sunt-false-cu-exceptia/2022-07-10T14:12:19+03:00https://health-pharma.ro/question/alegeti-afirmatiile-adevarate-despre-formularile-termomaleabile-ca-matrite-semisolide-pentru-umplerea-capsulelor-moi/2022-07-10T14:12:55+03:00https://health-pharma.ro/question/dezagregarea-comprimatelor-este-influentata-de-urmatorii-factori-tehnologici/2022-07-10T14:13:21+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-biodisponibilitatea-capsulelor-tari-sunt-false-cu-exceptia/2022-07-10T14:13:50+03:00https://health-pharma.ro/question/rezistenta-la-rupere-a-comprimatului/2022-07-10T14:14:27+03:00https://health-pharma.ro/question/acoperirea-enterica-a-capsulelor-gelatinoase-moi-ofera-urmatoarele-avantaje/2022-07-10T14:14:53+03:00https://health-pharma.ro/question/conform-fr-x-casetele-contin-substante-sau-amestecuri-de-substante-sub-forma-de/2022-07-10T14:15:12+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-afirmatii-se-refera-la-duritatea-comprimatelor/2022-07-10T14:15:32+03:00https://health-pharma.ro/question/option-1uniformitatea-masei-este-un-test-impus-de-farmacopei-la-controlul-calitatii-comprimatelor-deoarece/2022-07-10T14:15:54+03:00https://health-pharma.ro/question/la-granularea-umeda-in-malaxorul-agitator-cu-con-dublu/2022-07-10T14:16:19+03:00https://health-pharma.ro/question/selectati-mecanismele-prin-care-alimentele-din-tractul-gastrointestinal-pot-mari-biodisponibilitatea-unor-substante-active-din-comprimate/2022-07-10T14:16:44+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-substante-sunt-agenti-lianti-folositi-pentru-granularea-uscata-si-comprimarea-directa/2022-07-10T14:17:03+03:00https://health-pharma.ro/question/surfactantii-pot-creste-biodisponibilitatea-substantei-active-greu-solubile-din-comprimatele-neacoperite-prin/2022-07-10T14:17:33+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-hidroxipropilmetilceluloza-hpmc-ca-substanta-auxiliara-la-fabricarea-peretilor-capsulelor-sunt-adevarate/2022-07-10T14:18:08+03:00https://health-pharma.ro/question/la-formularea-pulberilor-care-se-introduc-in-capsulele-operculate-urmatoarele-afirmatii-sunt-adevarate-cu-exceptia/2022-07-10T14:18:35+03:00https://health-pharma.ro/question/limita-maxima-de-friabilitate-admisa-pentru-comprimate-este-de/2022-07-10T14:43:35+03:00https://health-pharma.ro/question/pentru-fabricarea-peretilor-capsulelor-in-amestecul-gelatina-apa-se-adauga-diversi-adjuvanti-cu-exceptia/2022-07-10T14:44:13+03:00https://health-pharma.ro/question/alegeti-mecanismele-prin-care-de-agregantii-isi-exercita-actiunea/2022-07-10T14:44:58+03:00https://health-pharma.ro/question/alegeti-afirmatiile-adevarate-referitoare-la-avantajele-utilizarii-comprimatelor/2022-07-10T14:45:31+03:00https://health-pharma.ro/question/referitor-la-invelisul-capsulelor-moi-fr-x-supl-2004-prevede/2022-07-10T14:46:02+03:00https://health-pharma.ro/question/agentii-de-curgere-in-formularea-capsulelor-operculate/2022-07-10T14:46:25+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-denumiri-exprima-sorturi-de-polividona-reticulata-utilizate-ca-agenti-superdezagreganti/2022-07-10T14:46:50+03:00https://health-pharma.ro/question/acoperirea-capsulelor-dure-prezinta-urmatoarele-inconveniente-cu-erceptia/2022-07-10T14:47:20+03:00https://health-pharma.ro/question/mecanismul-de-comprimare-a-granulelor-cuprinde-urmatoarele-procese/2022-07-10T14:47:42+03:00https://health-pharma.ro/question/sub-forma-de-comprimate-orale-se-formuleaza-in-doze-mai-mari-decat-cele-administrate-intravenos-substantele-active-care/2022-07-10T14:48:19+03:00https://health-pharma.ro/question/se-utilizeaza-ca-aglutinant-pentru-granularea-uscata/2022-07-10T14:48:45+03:00https://health-pharma.ro/question/cerinte-pe-care-trebuie-sa-le-inde-plineasca-excipienti-pentru-comprimarea-directa-sunt-urmatoarele-cu-exceptia/2022-05-06T13:11:39+03:00https://health-pharma.ro/question/alegeti-afirmatiile-corecte-referitoare-la-proprietatile-de-curgere-ale-unui-material-supus-comprimarii/2022-07-10T15:21:30+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-umplerea-capsulelor-operculate-cu-comprimate-sunt-adevarate-cu-exceptia/2022-07-10T15:21:53+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-ciclul-de-compactare-sunt-adevarate-cu-exceptia/2022-07-10T15:22:14+03:00https://health-pharma.ro/question/capsulele-tip-v-caps/2022-07-10T15:22:32+03:00https://health-pharma.ro/question/despre-lactoza-spray-dried-este-falsa-urmatoarea-afirmatie/2022-07-10T15:23:09+03:00https://health-pharma.ro/question/conform-fr-x-supl-2004-din-categoria-comprimatelor-cu-eliberare-modificata-fac-parte/2022-07-10T15:23:39+03:00https://health-pharma.ro/question/identificati-afirmatia-falsa-referitoare-la-celuloza-microcristalina-excipient-utilizat-la-fabricarea-comprimatelor/2022-07-10T15:24:02+03:00https://health-pharma.ro/question/granularea-in-pat-fluidizat/2022-07-10T15:24:24+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-conditii-experimentale-corespund-prevederilor-oficiale-referitoare-la-testul-de-dizolvare-a-comprimatelor/2022-07-10T15:24:50+03:00https://health-pharma.ro/question/in-functie-de-procedeul-de-fabricare-comprimatele-neacoperite-pot-fi/2022-07-10T15:25:14+03:00https://health-pharma.ro/question/pentru-determinarea-rezistentei-la-rupere-a-comprimatelor-se-utilizeaza-urmatoarele-tipuri-de-aparate/2022-07-10T15:25:36+03:00https://health-pharma.ro/question/pentru-umplerea-capsulelor-operculate-formularile-de-pulberi-trebuie-sa-prezinte-urmatoarele-calitati/2022-07-10T15:26:37+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa-referitoare-la-celuloza-microcristalina-ca-excipient-la-fabricarea-comprimatelor/2022-07-10T15:27:20+03:00https://health-pharma.ro/question/precizati-care-dintre-testele-aplicate-in-cadrul-controlului-produsului-finit-al-comprimatelor-sunt-incadrate-ca-determinari-farmacotehnice/2022-07-10T15:27:48+03:00https://health-pharma.ro/question/densitatea-unei-mase-de-pulberi-folosita-pentru-procesul-de-formulare-si-fabricare-a-comprimatelor/2022-07-10T15:28:30+03:00https://health-pharma.ro/question/gelatina-ca-materie-prima-la-fabricarea-invelisului-capsulelor-dure/2022-07-10T15:28:47+03:00https://health-pharma.ro/question/analiza-imaginil-este-o-tehnica-moderna-utilizata-in-tehnologia-farmaceutica-pentru-urmatoarele-scopuri/2022-07-10T15:29:25+03:00https://health-pharma.ro/question/factorii-dependenti-de-medicament-care-influenteaza-viteza-de-dizolvare-a-comprimatului-sunt/2022-07-10T15:30:03+03:00https://health-pharma.ro/question/gelatina-obtinuta-prin-hidroliza-acida/2022-07-10T15:30:21+03:00https://health-pharma.ro/question/capacitatea-de-absorbtie-a-apel-de-catre-comprimate-poate-fi-determimata-prin/2022-07-10T15:30:43+03:00https://health-pharma.ro/question/referitor-la-dispozitivele-propuse-de-firma-erweka-pentru-testarea-dizolvarii-comprimatelor-si-capsulelor-sunt-adevarate-urmatoarele-afirmatii/2022-07-10T15:31:19+03:00https://health-pharma.ro/question/conform-fr-x-comprimatele-acoperite-trebuie-sa-se-dezagrege-in-pepsina-solutie-acida-in-cel-mult/2022-07-10T15:31:54+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa-referitoare-la-agentii-antifrictionali-utilizati-la-fabricarea-comprimatelor/2022-07-10T15:32:31+03:00https://health-pharma.ro/question/precizati-afirmatiile-adevarate-referitoare-la-substantele-auxiliare-utilizate-la-fabricarea-peretilor-capsulelor/2022-07-10T15:32:58+03:00https://health-pharma.ro/question/precizati-informatiile-adevarate-referitoare-la-masinile-de-umplere-a-capsulelor-dure-cu-sistem-de-dozare-independent/2022-07-10T15:33:20+03:00https://health-pharma.ro/question/conform-fr-x-supl-2004-capsulele-se-conserva-la-o-temperatura-de-cel-mult/2022-07-10T15:33:43+03:00https://health-pharma.ro/question/fata-de-metoda-agitatorului-cu-paleta-si-cea-a-cosuletului-rotativ-metoda-celulei-cu-flux-continuu-folosita-pentru-testarea-dizolvarii-comprimatelor-prezinta-urmatoarele-avantaje/2022-07-10T15:34:00+03:00https://health-pharma.ro/question/precizati-care-sunt-lubrifiantii-din-formularile-de-capsule-cu-pulberi/2022-07-10T15:34:22+03:00https://health-pharma.ro/question/referitor-la-dezagregarea-capsulelor-gelatinoase-gastrosolubile-fr-x-prevede-ca-acestea-trebuie-sa-se-dezagrege-in-apa-in-cel-mult/2022-07-10T15:34:43+03:00https://health-pharma.ro/question/etapele-folosite-in-fabricarea-comprimatelor-prin-granulare-uscata-sunt/2022-07-10T15:34:59+03:00https://health-pharma.ro/question/despre-peretii-capsulelor-moi-sunt-adevarate-urmatoarele/2022-07-10T15:35:19+03:00https://health-pharma.ro/question/densitatea-granulelor-poate-influenta-urmatoarele-proprietati-ale-comprimatelor/2022-07-10T15:35:37+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-inchiderea-capsulelor-operculate-sunt-adevarate-cu-exceptia/2022-07-10T15:35:55+03:00https://health-pharma.ro/question/proprietatile-fizice-ale-granulelor-care-influenteaza-procesul-de-compactibilitate-sunt/2022-07-10T15:36:19+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-cu-privire-la-aglutinanti-in-procesul-de-granulare-umeda-sunt-false/2022-07-10T15:37:07+03:00https://health-pharma.ro/question/granulele-mici/2022-07-10T15:37:24+03:00https://health-pharma.ro/question/selectati-care-dintre-urmatoarele-afirmatii-se-refera-la-etapa-de-dezagregare-microparticulara-a-comprimatelor/2022-07-10T15:37:44+03:00https://health-pharma.ro/question/din-punct-de-vedere-fizic-comprimatele-sunt-incluse-in-categoria/2022-07-10T15:38:04+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-comprimatele-stratificate-sunt-adevarate-cu-exceptia/2022-07-10T15:38:27+03:00https://health-pharma.ro/question/alegeti-excipientul-diluant-utilizat-in-comprimarea-directa/2022-07-10T15:38:45+03:00https://health-pharma.ro/question/aria-medie-a-suprafetei-plate-a-comprimatului-se-calculeaza-pe-baza-urmatorilor-parametri/2022-07-10T15:39:02+03:00https://health-pharma.ro/question/alegeti-excipientul-superdezagregant-utilizat-la-fabricarea-comprimatelor/2022-07-10T15:39:26+03:00https://health-pharma.ro/question/despre-metoda-imersiei-la-prepararea-capsulelor-moi-sunt-adevarate-urmatoarele-cu-exceptia/2022-07-10T15:39:40+03:00https://health-pharma.ro/question/alegeti-afirmatia-falsa-despre-tablettose70/2022-07-10T15:40:01+03:00https://health-pharma.ro/question/precizati-primul-proces-care-trebuie-sa-aiba-loc-inainte-ca-o-substanta-activa-dintr-un-comprimat-sa-devina-disponibila-pentru-absorbtie/2022-07-10T15:40:29+03:00https://health-pharma.ro/question/solubilitatea-substantei-medicamentoase-si-viteza-ei-de-dizolvare-din-comprimate-pot-fi-influentate-de-diferiti-factori-printre-care/2022-07-10T15:40:47+03:00https://health-pharma.ro/question/peretele-capsulelor-moi-poate-contine-urmatoarele-componente-cu-exceptia/2022-07-10T15:41:08+03:00https://health-pharma.ro/question/capsulele-gelatinoase-moi-acoperite-enteric/2022-07-10T15:41:35+03:00https://health-pharma.ro/question/fosfatul-de-calciu-ca-excipient-pentru-comprimate/2022-07-10T15:41:54+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-corecte-privind-parametrul-friabilitate/2022-07-10T15:42:52+03:00https://health-pharma.ro/question/lactoza-direct-compresibila/2022-07-10T15:43:07+03:00https://health-pharma.ro/question/selectati-afirmatiile-corecte-referitoare-la-substantele-medicamentoase-din-clasa-i-a-sistemului-de-clasificare-biofarmaceutica/2022-07-10T15:43:37+03:00https://health-pharma.ro/question/alegeti-dispozitivul-care-poate-fi-utilizat-pentru-determinarea-capacitatii-comprimatelor-de-a-absorbi-apa-prin-masurarea-timpului-si-volumului-de-lichid-absorbit/2022-07-10T15:43:59+03:00https://health-pharma.ro/question/despre-dezagregantii-care-au-ca-mecanism-de-actiune-favorizarea-fortelor-capilare-de-patrundere-a-apei-in-comprimat-este-falsa-urmatoarea-afirmatie/2022-07-10T15:44:15+03:00https://health-pharma.ro/question/selectati-secventa-corecta-de-operatii-la-fabricarea-capsulelor-dure-capsule-goale/2022-07-10T15:44:37+03:00https://health-pharma.ro/question/cresterea-fortei-de-comprimare-influenteaza-absorbtia-substantei-active-din-comprimatele-orale-prin/2022-07-10T15:44:54+03:00https://health-pharma.ro/question/croscarmeloza-sodica/2022-07-10T15:45:10+03:00https://health-pharma.ro/question/dezavantaje-ale-granularii-umede-sunt/2022-07-10T15:45:39+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-fenomenul-de-laminare-a-comprimatelor-sunt-false-cu-exceptia/2022-07-10T15:45:57+03:00https://health-pharma.ro/question/despre-dezagregarea-comprimatelor-acoperite-enterosolubile-fr-x-prevede/2022-05-06T13:25:48+03:00https://health-pharma.ro/question/referitor-la-dispozitivele-de-testare-a-timpului-de-dezagregare-a-comprimatelor-bazate-pe-principiul-magnetic-sunt-adevarate-urmatoarele-afirmatii/2022-07-10T15:46:41+03:00https://health-pharma.ro/question/la-umplerea-capsulelor-in-farmacii-si-laboratoare-se-executa-urmatoarele-operatii-cu-exceptia/2022-07-10T10:53:17+03:00https://health-pharma.ro/question/despre-masele-semisolide-de-tip-formulari-tixotrope-din-continutul-capsulelor-moi-este-adevarata-afirmatia/2022-07-10T15:48:22+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privitoare-la-procedeul-de-comprimare-directa-sunt-adevarate/2022-07-10T15:49:02+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-cu-privire-la-modul-de-operare-la-masina-de-comprimat-rotativa-sunt-adevarate-cu-exceptia/2022-07-10T15:49:24+03:00https://health-pharma.ro/question/masini-de-comprimat-actionate-mecanic-sunt-urmatoarele-cu-exceptia/2022-07-10T15:51:56+03:00https://health-pharma.ro/question/alegeti-afirmatiile-adevarate-referitoare-la-dezavantajele-utilizarii-capsulelor-gelatinoase-moi/2022-07-10T15:52:28+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-capsulele-cu-eliberare-modificata-sunt-adevarate-cu-exceptia/2022-07-10T15:52:56+03:00https://health-pharma.ro/question/la-masinile-de-umplere-a-capsulelor-operculate-cu-tub-dozator-se-executa-urmatoarele-operatii-cu-exceptia/2022-05-06T13:34:38+03:00https://health-pharma.ro/question/factorii-chimici-care-influenteaza-absorbtia-substantei-active-din-comprimatele-orale-sunt/2022-07-10T15:53:45+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-cu-privire-la-granularea-uscata-sunt-adevarate-cu-exceptia/2022-07-10T15:54:36+03:00https://health-pharma.ro/question/umplerea-capsulelor-operculate-cu-pelete-implica-in-functie-de-metoda/2022-07-10T15:55:03+03:00https://health-pharma.ro/question/despre-evaluarea-bioadezivitatii-comprimatelor-sunt-adevarate-urmatoarele-afirmatii/2022-07-10T15:55:26+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-prevederi-ale-fr-x-supl-2004-nu-se-refera-la-comprimatele-utilizate-in-cavitatea-orala/2022-07-10T15:55:45+03:00https://health-pharma.ro/question/in-procedeul-de-comprimare-directa/2022-07-10T15:56:10+03:00https://health-pharma.ro/question/cellactoza/2022-07-10T15:56:24+03:00https://health-pharma.ro/question/umectarea-masei-de-pulbere-compusa-in-procesul-de-granulare-umeda/2022-07-10T15:56:46+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-despre-capsulele-operculate-sunt-corecte-cu-exceptia/2022-07-10T15:57:23+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-prevederi-ale-fr-x-supl-2004-nu-se-refera-la-comprimatele-orodispersabile/2022-07-10T15:57:50+03:00https://health-pharma.ro/question/daca-nu-se-prevede-altfel-timpul-maxim-de-dezagregare-in-apa-admis-de-fr-x-pentru-comprimatele-neacoperite-este/2022-07-10T15:58:07+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-chitozanul-ca-excipient-pentru-fabricarea-peretilor-capsulelor-dure-sunt-adevarate-cu-exceptia/2022-07-10T15:58:26+03:00https://health-pharma.ro/question/copolimerul-alcool-polivinilic-acrilmetilmetacrilat-ca-excipient-pentru-fabricarea-peretilor-capsulelor-operculate/2022-07-10T15:58:41+03:00https://health-pharma.ro/question/excipienti-diluanti-care-actioneaza-ca-dezagreganti-sunt/2022-07-10T15:59:00+03:00https://health-pharma.ro/question/alegeti-proprietatile-fizico-mecanice-ale-materiilor-prime-importante-pentru-procesul-de-formulare-a-comprimatelor/2022-07-10T16:02:14+03:00https://health-pharma.ro/question/la-inscriptionarea-comprimatelor-urmatoarele-afirmatii-sunt-adevarate-cu-exceptia/2022-07-10T16:02:31+03:00https://health-pharma.ro/question/selectati-afirmatia-falsa-despre-lubrifianti/2022-07-10T16:02:52+03:00https://health-pharma.ro/question/pentru-procedeul-de-fabricatie-a-comprimatelor-sunt-adevarate-urmatoarele-afirmatii/2022-07-10T16:03:35+03:00https://health-pharma.ro/question/urmatoarele-substante-sunt-formatori-de-film-enterosolubili-in-peretele-capsulelor/2022-07-10T16:03:53+03:00https://health-pharma.ro/question/selectati-formele-farmaceutice-orale-pentru-care-timpul-de-rezidenta-intestinal-este-foarte-important/2022-07-10T16:04:24+03:00https://health-pharma.ro/question/precizati-pentru-care-dintre-urmatoarele-categorii-de-comprimate-orale-supl-2004-al-fr-x-prevede-la-determinari-finetea-de-dispersare/2022-07-10T16:04:48+03:00https://health-pharma.ro/question/alegeti-afirmatiile-adevarate-despre-excipientii-antifrictionali/2022-07-10T16:05:11+03:00https://health-pharma.ro/question/alegeti-afirmatiile-corecte-referitoare-la-comprimatele-vaginale/2022-07-10T16:05:29+03:00https://health-pharma.ro/question/urmatoarele-substante-sunt-plasticizanti-in-peretele-capsulelor-cu-exceptia/2022-07-10T16:08:23+03:00https://health-pharma.ro/question/micronizarea-substantei-active-in-procesul-de-comprimare-directa/2022-07-10T16:08:42+03:00https://health-pharma.ro/question/continut-multiplu-in-capsulele-operculate-sunt-urmatoarele-cu-exceptia/2022-07-10T16:09:29+03:00https://health-pharma.ro/question/fr-x-prevede-ca-la-prepararea-invelisului-capsulelor-se-pot-folosi-urmatoarele-substante-auxiliare-cu-exceptia/2022-07-10T16:09:50+03:00https://health-pharma.ro/question/un-dezagregant-trebuie-sa-aiba-urmatoarele-proprietati/2022-07-10T16:10:12+03:00https://health-pharma.ro/question/supl-2004-al-fr-x-prevede-pentru-testul-de-dezagregare-a-comprimatelor-acoperite-altele-decat-comprimatele-filmate-urmatoarele-conditii-experimentale/2022-07-10T16:12:53+03:00https://health-pharma.ro/question/in-ceea-ce-priveste-perlele-ca-forma-farmaceutica-alegeti-afirmatia-corecta/2022-07-10T16:13:14+03:00https://health-pharma.ro/question/la-aparatul-de-incapsulat-feton/2022-07-10T16:13:34+03:00https://health-pharma.ro/question/dispozitivele-de-testare-a-dizolvarii-comprimatelor-si-capsulelor-bazate-pe-convectia-fortata-in-conditii-non-sink-folosesc-urmatoarele-metode/2022-07-10T16:13:56+03:00https://health-pharma.ro/question/pentru-urmatoarele-substante-active-poate-fi-necesara-o-acoperire-enterica-a-capsulelor-dure/2022-07-10T16:14:18+03:00https://health-pharma.ro/question/conform-sistemului-de-clasificare-biofarmaceutica-scb-a-substantelor-medicamentoase/2022-07-10T16:14:46+03:00https://health-pharma.ro/question/urmatoarele-substante-active-incluse-in-capsulele-operculate-sunt-degradate-in-stomac-de-ph-ul-acid-al-sucului-gastric-si-de-enzime-cu-exceptia/2022-07-10T16:15:05+03:00https://health-pharma.ro/question/dezavantaje-ale-granularii-uscate-sunt-urmatoarele-cu-exceptia/2022-07-10T16:15:31+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-dezagregantii-in-formularea-pulberilor-pentru-introduceren-in-capsulele-oper-culate-sunt-adevarate/2022-05-06T13:44:09+03:00https://health-pharma.ro/question/selectati-afirmatiile-adevarate-referitoare-la-aglutinanti/2022-07-10T16:16:35+03:00https://health-pharma.ro/question/selectati-afirmatia-falsa-privind-functiile-pe-care-le-indeplinesc-agentii-antifrictionali-in-procesul-de-fabricare-a-comprimatelor/2022-07-10T16:17:02+03:00https://health-pharma.ro/question/procesul-de-comprimare-cuprinde-urmatoarele-etape/2022-07-10T16:17:36+03:00https://health-pharma.ro/question/urmatoarele-determinari-sunt-prevazute-de-supl-2004-al-fr-x-pentru-controlul-calitatii-capsulelor-cu-o-exceptia/2022-07-10T16:18:08+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-sunt-adevarate-cu-exceptia/2022-05-06T13:44:13+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-granularea-uscata-sunt-adevarate-cu-exceptia/2022-07-10T16:20:25+03:00https://health-pharma.ro/question/comprimarea-cu-ajutorul-ultrasunetelor/2022-07-10T16:20:42+03:00https://health-pharma.ro/question/urmatoarele-formulari-sunt-folosite-la-umplerea-capsulelor-dure/2022-07-10T16:21:14+03:00https://health-pharma.ro/question/sunt-cerinte-pentru-excipientii-pentru-comprimare-directa-urmatoarele-cu-exceptia/2022-07-10T16:21:30+03:00https://health-pharma.ro/question/precizati-care-dintre-urmatoarele-substante-medicamentoase-sunt-incluse-in-clasa-ii-a-sistemului-de-clasificare-biofarmaceutica/2022-07-10T16:22:25+03:00https://health-pharma.ro/question/factorii-care-favorizeaza-coeziunea-particulelor-in-comprimarea-directa-sunt/2022-07-10T16:22:47+03:00https://health-pharma.ro/question/pentru-testarea-eliberarii-in-vitro-din-comprimate-a-substantelor-medicamentoase-a-caror-solubilitate-este-putin-influentata-de-ph-se-utilizeaza-ca-mediu-de-dizolvare/2022-07-10T16:23:14+03:00https://health-pharma.ro/question/sunt-comprimate-retard-care-se-fabrica-prin-procedee-specifice-sau-cu-substante-auxiliare-speciale-urmatoarele-tipuri-cu-exceptia/2022-07-10T16:23:32+03:00https://health-pharma.ro/question/precizati-in-cate-etape-are-loc-procesul-de-dezagregare-a-comprimatelor/2022-07-10T16:23:56+03:00https://health-pharma.ro/question/in-functie-de-metoda-de-preparare-se-disting-urmatoarele-tipuri-de-capsule-moi/2022-07-10T16:24:12+03:00https://health-pharma.ro/question/in-ceea-ce-priveste-capsulele-gelatinoase-moi-urmatoarele-substante-pot-indeplini-rol-de-plasticizant-cu-exceptia/2022-07-10T16:24:38+03:00https://health-pharma.ro/question/materialele-de-umplere-a-capsulelor-gelatinoase-moi-includ-urmatoarele-cu-exceptia/2022-07-10T16:24:58+03:00https://health-pharma.ro/question/alegeti-excipientii-antiaderenti-hidrofobi-utilizati-in-fabricarea-comprimatelor/2022-07-10T16:25:19+03:00https://health-pharma.ro/question/alegeti-afirmatia-corecta-despre-excipientii-utilizati-la-fabricarea-comprimatelor/2022-07-10T16:25:48+03:00https://health-pharma.ro/question/alegeti-afirmatiile-adevarate-referitoare-la-comprimate/2022-07-10T16:26:15+03:00https://health-pharma.ro/question/conform-criteriului-de-clasificare-biofarmaceutica-comprimatele-pot-fi-de-urmatoarele-categorii-cu-exceptia/2022-07-10T16:26:38+03:00https://health-pharma.ro/question/nu-este-excipient-coprocesat/2022-07-10T16:27:00+03:00https://health-pharma.ro/question/scopurile-pentru-care-se-folosesc-colorantii-in-unele-formulari-de-comprimate-sunt-2/2022-07-10T16:27:21+03:00https://health-pharma.ro/question/cel-o-cal-este/2022-07-10T16:27:40+03:00https://health-pharma.ro/question/la-masina-de-comprimat-cu-excentric-2/2022-07-10T16:28:04+03:00https://health-pharma.ro/question/etapele-unui-ciclu-de-comprimare-la-presa-rotativa-sunt-urmatoarele-cu-exceptia/2022-07-10T16:28:21+03:00https://health-pharma.ro/question/masinile-de-comprimat-cu-sistem-de-umplere-prin-forta-centrifugala/2022-07-10T16:28:45+03:00https://health-pharma.ro/question/masinile-de-comprimat-cu-ultrasunete/2022-07-10T16:29:16+03:00https://health-pharma.ro/question/comprimarea-cu-ultrasunete/2022-07-10T16:29:49+03:00https://health-pharma.ro/question/o-rezistenta-mecanica-scazuta-a-comprimatelor-poate-fi-cauzata-de-urmatorii-factori-cu-exceptia/2022-07-10T16:30:27+03:00https://health-pharma.ro/question/urmatoarele-sunt-etape-ale-fabricarii-comprimatelor-prin-granulare-in-pat-fluidizat-cu-exceptia/2022-07-10T16:30:50+03:00https://health-pharma.ro/question/schema-de-fabricare-a-comprimatelor-prin-presare-directa-cuprinde-urmatoarele-elemente-cu-exceptia/2022-07-10T16:31:07+03:00https://health-pharma.ro/question/urmatorii-excipienti-se-amesteca-cu-granulele-in-procesul-de-fabricare-a-comprimatelor-prin-granulare-umeda/2022-07-10T16:31:42+03:00https://health-pharma.ro/question/blisterele-obtinute-prin-sudare-cross-net/2022-07-10T16:32:01+03:00https://health-pharma.ro/question/urmatoarele-substante-sunt-materii-prime-la-formularea-invelisului-casetelor-cu-exceptia/2022-07-10T16:32:20+03:00https://health-pharma.ro/question/capsulele-cu-dezagregare-in-colon/2022-07-10T16:32:39+03:00https://health-pharma.ro/question/formulari-pentru-umplerea-capsulelor-dure-sunt-urmatoarele-cu-exceptia/2022-07-10T16:33:02+03:00https://health-pharma.ro/question/capsulele-operculate-pot-fi-umplute-cu-urmatoarele-forme-farmaceutice-solide-asociate-cu-exceptia/2022-07-10T16:33:25+03:00https://health-pharma.ro/question/urmatoarele-afirmatii-privind-casetele-sunt-false/2022-07-10T16:33:51+03:00https://health-pharma.ro/question/selectati-enuntul-adevarat-referitor-la-spansule/2022-07-10T16:34:07+03:00https://health-pharma.ro/question/micronizarea-substantelor-medicamentoase-care-se-umplu-in-capsulele-operculate-determina/2022-07-10T16:34:26+03:00https://health-pharma.ro/question/urmatorii-diluanti-cresc-proprietatile-de-curgere-in-dezvoltarea-de-formulari-pentru-masinile-de-umplere-automata-a-capsulelor-cu-exceptia/2022-07-10T16:34:47+03:00https://health-pharma.ro/question/granularea-pulberilor-pentru-incapsulare-in-capsulele-operculate-conduce-la/2022-07-10T16:35:04+03:00https://health-pharma.ro/question/gelatina-de-tip-a-folosita-pentru-fabricarea-peretilor-capsulelor/2022-07-10T16:35:20+03:00https://health-pharma.ro/question/conform-fr-x-perlele-contin/2022-07-10T16:35:40+03:00https://health-pharma.ro/question/dezagregarea-lenta-a-unui-comprimat-neacoperit-poate-avea-ca-rezultat/2022-07-10T16:35:56+03:00https://health-pharma.ro/question/mecanismul-prin-care-nu-se-efectueaza-transportul-substantelor-active-prin-epiteliul-absorbtiv-gastrointestinal-este/2022-07-10T16:36:19+03:00https://health-pharma.ro/question/timpul-de-rezidenta-gastrica-al-unui-comprimat-poate-fi-scurtat-prin-administrarea-acestuia/2022-07-10T16:36:42+03:00https://health-pharma.ro/question/in-cazul-stomacului-fara-alimente-tranzitul-formei-farmaceutice-solide-este-guvernat-de-complexul-mioelectric-migrant-caracterizat-de/2022-07-10T16:36:58+03:00https://health-pharma.ro/question/care-dintre-urmatoarele-substante-medicamentoase-sunt-transportate-paracelular-prin-epiteliul-absorbtiv-gastrointestinal/2022-07-10T16:37:17+03:00https://health-pharma.ro/question/care-dintre-urmatoarele-substante-medicamentoase-sunt-transportate-transcelular-carrier-mediat-prin-epiteliul-absorbtiv-gastrointestinal/2022-07-10T16:37:38+03:00https://health-pharma.ro/question/conform-fr-x-capsulele-operculate-au-forma/2022-07-10T16:37:58+03:00https://health-pharma.ro/question/tehnica-de-baza-utilizata-pentru-investigarea-structurii-comprimatelor-este/2022-07-10T16:38:13+03:00https://health-pharma.ro/question/sunt-incluse-in-clasa-iii-a-sistemului-de-clasificare-biofarmaceutica-urmatoarele-substante-medicamentoase-cu-exceptia/2022-07-10T16:38:33+03:00https://health-pharma.ro/question/terapia-cvadrupla-fara-bismut-pentru-eradicarea-infectiei-cu-helicobacter-pylori-contine-urmatoarele-substate-active-cu-exceptia/2022-07-10T16:47:42+03:00https://health-pharma.ro/question/doza-initiala-zilnica-de-omeprazol-utilizat-ca-antiulceros-este/2022-11-15T15:56:28+02:00https://health-pharma.ro/question/doza-uzuala-zilnica-de-lansoprazol-administrat-in-ulcer-gastro-duodenal-este/2022-11-15T15:58:22+02:00https://health-pharma.ro/question/doza-uzuala-de-misoprostol-administrat-in-ulcer-gastro-duodenal-este/2022-11-15T15:59:01+02:00https://health-pharma.ro/question/in-terapia-tripla-pentru-tratamentul-ulcerului-gastro-duodenal-helicobacter-pylori-pozitiv-nu-este-inclusa/2022-11-15T16:00:03+02:00https://health-pharma.ro/question/terapia-de-linia-a-doua-de-salvare-pentru-infectii-persistente-cu-helicobacter-pylori-nu-include/2022-11-15T16:00:51+02:00https://health-pharma.ro/question/alegeti-schema-de-terapie-hibrida-utilizata-pentru-tratamentul-ulcerului-gastro-duodenal-helicobacter-pylori-pozitiv/2022-11-15T16:03:18+02:00https://health-pharma.ro/question/nu-este-inclusa-in-terapia-secventiala-a-ulcerului-gastro-duodenal-helicobacter-pylori-pozitiv-substanta/2022-11-15T16:04:06+02:00https://health-pharma.ro/question/terapia-de-linia-a-doua-de-salvare-pentru-infectii-persistente-cu-helicobacter-pylori-nu-include-2/2022-11-15T16:05:10+02:00https://health-pharma.ro/question/alegeti-enuntul-corect-referitor-la-terapia-cvadrupla-fara-bismut-utilizata-in-tratamentul-ulcerului-gastro-duodenal-helicobacter-pylori-pozitiv/2022-07-10T16:58:33+03:00https://health-pharma.ro/question/este-o-caracteristica-a-terapiei-secventiale-aplicata-in-ulcerul-gastro-duodenal-helicobacter-pylori-pozitiv/2022-11-15T16:06:03+02:00https://health-pharma.ro/question/o-alternativa-mai-bine-tolerata-a-terapiei-cvadruple-cu-ipp-si-sare-de-bismut-de-a-doua-linie-este-schema-care-include/2022-11-15T16:07:00+02:00https://health-pharma.ro/question/nu-este-relevanta-pentru-stabilirea-diagnosticului-de-ulcer-gastro-duodenal-determinarea/2022-11-15T16:08:13+02:00https://health-pharma.ro/question/testul-respirator-cu-uree-si-cel-de-determinare-a-antigenului-hp-din-materiile-fecale-pentru-verificarea-eradicarii-infectiei-cu-hp-se-efectueaza/2022-11-15T16:08:56+02:00https://health-pharma.ro/question/rezultatele-fals-negative-in-cazul-verificarii-eradicarii-infectiei-cu-hp-pot-fi-datorate/2022-11-15T16:09:37+02:00https://health-pharma.ro/question/alternativa-de-tratament-antiulceros-la-pacientii-alergici-la-peniciline-este/2022-11-15T16:10:25+02:00https://health-pharma.ro/question/alegeti-inhibitorul-pompei-de-protoni-a-carui-doza-uzuala-in-ulcerul-gastro-duodenal-este-40-80-mg/2022-11-15T16:11:09+02:00https://health-pharma.ro/question/alegeti-inhibitorul-pompei-de-protoni-a-carui-doza-uzuala-in-ulcerul-gastro-duodenal-este-15-30-mg/2022-11-15T16:12:05+02:00https://health-pharma.ro/question/alegeti-inhibitorul-pompei-de-protoni-a-carui-doza-uzuala-in-ulcerul-gastro-duodenal-este-30-60-mg/2022-11-15T16:12:40+02:00https://health-pharma.ro/question/alegeti-inhibitorul-pompei-de-protoni-a-carui-doza-initiala-in-ulcerul-gastro-duodenal-este-20-mg/2022-11-15T16:13:26+02:00https://health-pharma.ro/question/terapia-antiulceroasa-pentru-eradicarea-infectiei-cu-helicobacter-pylori-care-poate-utiliza-un-antihistaminic-hzeste/2022-11-15T16:14:07+02:00https://health-pharma.ro/question/posologia-levofloxacinei-utilizata-pentru-eradicarea-infectiei-cu-helicobacter-pylori-este/2022-11-15T16:14:43+02:00https://health-pharma.ro/question/nu-este-necesara-endoscopia-de-control-pentru-pacientii-cu-ulcer-tratat-in-urmatoarea-situatie/2022-11-15T16:15:28+02:00https://health-pharma.ro/question/metronidazolul-se-administreaza-in-doza-de-250-500-mg-x-4-ziin-cadrul-terapiei-antiulceroase/2022-11-15T16:16:06+02:00https://health-pharma.ro/question/selectati-medicamentul-utilizat-in-ulcer-gastro-duodenal-care-se-utilizeaza-in-doza-de-1-g-x-4-zi/2022-11-15T16:16:48+02:00https://health-pharma.ro/question/sunt-simptome-ale-stenozei-pilorice/2022-11-15T16:17:28+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-referitoare-la-ulcerul-gastro-duodenal/2022-11-15T16:18:28+02:00https://health-pharma.ro/question/evidentierea-infectiei-cu-helicobacter-pylori-se-poate-face-prin/2022-11-15T16:19:53+02:00https://health-pharma.ro/question/metodele-non-endoscopice-de-electie-pentru-evidentierea-eradicarii-infectiei-cu-hp-sunt/2022-11-15T16:20:39+02:00https://health-pharma.ro/question/alegeti-inhibitorii-pompei-de-protoni-a-caror-doza-initiala-zilnica-este-de-40-mg/2022-11-15T16:21:20+02:00https://health-pharma.ro/question/pacientii-cu-ulcer-tratat-dar-care-utilizeaza-ains-trebuie-monitorizati-atent-pentru-detectarea/2022-11-15T16:21:54+02:00https://health-pharma.ro/question/selectati-antiulceroasele-a-caror-doza-uzuala-in-ulcerul-gastro-duodenal-este-20-40-mg-zi/2022-11-15T16:22:42+02:00https://health-pharma.ro/question/selectati-enunturile-corecte-referitoare-la-terapia-pacientilor-cu-ulcere-ains-induse/2022-11-15T16:23:59+02:00https://health-pharma.ro/question/selectati-schemele-terapeutice-antiulceroase-care-includ-claritromicina-in-doza-de-250-500-mg-x-2-zi/2022-11-15T16:24:54+02:00https://health-pharma.ro/question/alegeti-schemele-terapeutice-antiulceroase-care-includ-metronidazolul-in-doza-de-250-500-mg-x-2-zi/2022-11-15T16:25:37+02:00https://health-pharma.ro/question/simptomele-persistente-sau-recurente-in-urmatoarele-14-zile-dupa-incheierea-tratamentului-antiulceros-sugereaza/2022-11-15T16:26:20+02:00https://health-pharma.ro/question/selectati-schemele-terapeutice-antiulceroase-cvadruple-corecte-bazate-pe-saruri-de-bismut/2022-11-15T16:27:10+02:00https://health-pharma.ro/question/terapia-antiulceroasa-hibrida-include-administrarea-medicamentelor/2022-11-15T16:27:47+02:00https://health-pharma.ro/question/terapia-antiulceroasa-secventiala-include-administrarea-medicamentelor/2022-11-15T16:28:33+02:00https://health-pharma.ro/question/schemele-terapeutice-antiulceroase-care-recomanda-utilizarea-amoxicilinei-in-doza-de-1-g-x-2-zi-sunt/2022-11-15T16:29:12+02:00https://health-pharma.ro/question/sunt-scheme-de-terapie-tripla-antiulceroasa-bazata-pe-ipp/2022-11-15T16:29:52+02:00https://health-pharma.ro/question/caracteristicile-durerii-in-cadrul-perforatiei-care-poate-sa-apara-in-ulcerul-gastro-duodenal-sunt/2022-11-15T16:30:41+02:00https://health-pharma.ro/question/in-cazul-ulcerelor-in-care-se-impune-reluarea-terapiei-regimulde-salvare-ar-trebui-sa-includa/2022-11-15T16:31:21+02:00https://health-pharma.ro/question/indicatiile-pentru-tratamentul-helicobacter-pylori-includ/2022-11-15T16:31:57+02:00https://health-pharma.ro/question/rationamentul-pentru-administrarea-succesiva-a-antibioticelorin-cadrul-terapiei-secventiale-presupune/2022-11-15T16:32:41+02:00https://health-pharma.ro/question/sunt-caracteristici-ale-terapiei-cvadruple-fara-bismut/2022-11-15T16:33:19+02:00https://health-pharma.ro/question/daca-tratamentul-initial-esueaza-in-eradicarea-infectiei-cu-helicobacter-pylori-terapia-de-a-doua-linie-de-salvare-ar-trebui/2022-11-15T16:34:29+02:00https://health-pharma.ro/question/la-pacientii-cu-ulcere-ains-induse-si-test-helicobacter-pylori-negativ-se-pot-utiliza-antiulceroasele/2022-11-15T16:35:09+02:00https://health-pharma.ro/question/se-utilizeaza-in-doza-uzuala-de-20-40-mg-zi/2022-11-15T16:35:48+02:00https://health-pharma.ro/question/schemele-posologice-corecte-pentru-sucralfat-in-ulcerul-gastro-duodenal-sunt/2022-11-15T16:36:45+02:00https://health-pharma.ro/question/alegeti-medicamentul-care-poate-fi-util-in-tratamentulesofagitei-cu-reflux-non-acid/2022-11-15T16:37:31+02:00https://health-pharma.ro/question/pentru-pacientii-care-utilizeaza-antiacide-cu-hidroxid-de-magneziu-hidroxid-de-aluminiu-si-simeticona-numarul-maxim-de-lingurite-administrate-pe-zi-este/2022-11-15T16:38:08+02:00https://health-pharma.ro/question/regimul-alimentar-in-brge-include/2022-11-15T16:38:33+02:00https://health-pharma.ro/question/formeaza-o-bariera-protectoare-pentru-esofag-in-brge/2022-11-15T16:39:10+02:00https://health-pharma.ro/question/este-un-medicament-prokinetic/2022-11-15T16:39:49+02:00https://health-pharma.ro/question/cel-mai-eficient-tratament-pentru-pacientii-cu-brge-eroziva-este-reprezentat-de/2022-11-15T16:40:28+02:00https://health-pharma.ro/question/pentru-pacientii-cu-brge-se-efectueaza-biopsie-daca-acestia-prezinta/2022-11-15T16:41:14+02:00https://health-pharma.ro/question/alegeti-enuntul-corect-pentru-antiacide/2022-11-15T16:42:38+02:00https://health-pharma.ro/question/nu-este-un-efect-advers-al-ipp/2022-11-15T16:43:14+02:00https://health-pharma.ro/question/alegeti-medicamentul-cu-care-interactioneaza-toate-substantele-active-din-clasa-ipp/2022-11-15T16:43:55+02:00https://health-pharma.ro/question/ipp-administrati-pe-termen-lung-pot-produce/2022-11-15T16:44:34+02:00https://health-pharma.ro/question/in-cazul-tratamentului-prelungit-cu-ipp-poate-sa-apara-hipovitaminoza/2022-07-10T18:21:56+03:00https://health-pharma.ro/question/alegeti-medicamentul-ipp-care-nu-poate-fi-administrat-fara-prescriptie-medicala/2022-11-15T16:45:28+02:00https://health-pharma.ro/question/are-utilizare-off-label-in-brge/2022-11-15T16:46:16+02:00https://health-pharma.ro/question/selectati-raspunsul-incorect-pentru-acidul-alginic/2022-11-15T16:46:57+02:00https://health-pharma.ro/question/selectati-posologia-considerata-off-label-pentru-medicamentele-eliberate-pe-prescriptie-medicala-in-tratamentul-brge/2022-11-15T16:47:39+02:00https://health-pharma.ro/question/chirurgia-bariatrica-bypass-ul-gastric-roux-en-y-ar-trebui-avuta-in-vedere-la-pacientii/2022-11-15T16:48:15+02:00https://health-pharma.ro/question/in-esofagul-barrett-cu-grad-inalt-de-displazie-se-ia-in-considerare-urmatoarea-interventie-non-farmacologica/2022-11-15T16:49:02+02:00https://health-pharma.ro/question/nu-este-efect-advers-al-metoclopramidului/2022-11-15T16:49:48+02:00https://health-pharma.ro/question/in-cazul-pacientilor-adulti-alimentati-pe-sonda-nazogastrica-o-alternativa-de-tratament-a-capsulelor-cu-eliberare-intarziata-pulberilor-pentru-suspensii-sau-a-preparatelor-injectabile-i-v-este-repr/2022-11-15T16:50:23+02:00https://health-pharma.ro/question/in-cazul-pacientilor-alimentati-pe-sonda-nazogastrica-continutul-capsulelor-cu-ipp-poate-fi-amestecat-cu/2022-11-15T16:51:09+02:00https://health-pharma.ro/question/este-conditionat-sub-forma-de-comprimate-orodispersabile-cu-eliberare-intarziata/2022-11-15T16:51:39+02:00https://health-pharma.ro/question/este-disponibil-sub-forma-de-capsule-cu-eliberare-secventiala-modificata/2022-11-15T16:52:13+02:00https://health-pharma.ro/question/inhibarea-cyp2c19-de-catre-ipp-in-special-omeprazol-poate-reduce-eficacitatea-pentru/2022-11-15T16:52:41+02:00https://health-pharma.ro/question/pentru-ipp-la-utilizarea-de-scurta-durata-s-a-raportat-ca-reactie-adversa/2022-11-15T16:53:25+02:00https://health-pharma.ro/question/sunt-efecte-adverse-ale-ipp/2022-11-15T17:05:21+02:00https://health-pharma.ro/question/sunt-efecte-adverse-posibile-ale-ipp-utilizate-pe-termen-lung/2022-11-15T17:05:47+02:00https://health-pharma.ro/question/prin-cresterea-ph-ului-ipp-scad-absorbtia-pentru/2022-11-15T17:06:25+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-pentru-ipp/2022-11-15T17:07:23+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-referitoare-la-dexlansoprazol/2022-11-15T17:09:09+02:00https://health-pharma.ro/question/alegeti-raspunsurile-corecte/2022-11-15T17:10:30+02:00https://health-pharma.ro/question/selectati-enunturile-corecte-pentru-antiacide/2022-11-15T17:13:04+02:00https://health-pharma.ro/question/pentru-antiacidele-utilizate-in-brge-sunt-corecte-enunturile/2022-11-15T17:14:43+02:00https://health-pharma.ro/question/acidul-alginic-administrat-in-asociere-cu-antiacide/2022-11-15T17:15:35+02:00https://health-pharma.ro/question/selectati-enunturile-corecte-pentru-antihistaminicele-h2-utilizate-in-brge/2022-11-15T17:17:52+02:00https://health-pharma.ro/question/alegeti-variantele-de-raspuns-corecte-pentru-agentii-prokinetici-utilizati-in-brge/2022-11-15T17:18:33+02:00https://health-pharma.ro/question/37-metoclopramidul/2022-11-15T17:19:01+02:00https://health-pharma.ro/question/reactiile-adverse-comune-ale-metoclopramidului-la-nivel-sn-includ/2022-11-15T17:20:27+02:00https://health-pharma.ro/question/prokineticele-administrate-in-brge-nu-au-efect-asupra/2022-11-15T17:21:26+02:00https://health-pharma.ro/question/sucralfatul/2022-11-15T17:22:01+02:00https://health-pharma.ro/question/sunt-antihistaminice-h2-folosite-ca-automedicatie/2022-11-15T17:22:43+02:00https://health-pharma.ro/question/se-pot-utiliza-ca-automedicatie-la-pacienti-cu-varsta-peste-18-ani-urmatoarele-inhibitoare-ale-pompei-de-protoni/2022-11-15T17:23:19+02:00https://health-pharma.ro/question/la-pacientii-cu-brge-tratati-cu-ipp-timp-de-8-saptamani-si-care-prezinta-simptome-extraesofagiene-se-efectueaza/2022-11-15T17:23:52+02:00https://health-pharma.ro/question/sunt-simptome-extraesofagiene-ale-brge/2022-11-15T17:24:23+02:00https://health-pharma.ro/question/sunt-metode-ne-farmacologice-pentru-tratamentul-brge/2022-11-15T17:24:59+02:00https://health-pharma.ro/question/modificarea-stilului-de-viata-in-brge-include/2022-11-15T17:25:34+02:00https://health-pharma.ro/question/alegeti-variantele-de-raspuns-corecte/2022-11-15T17:26:15+02:00https://health-pharma.ro/question/cel-mai-eficient-tratament-pentru-pacientii-care-prezinta-simptome-extraesofagiene-este-reprezentat-de/2022-11-15T17:27:20+02:00https://health-pharma.ro/question/pentru-tratamentul-de-intretinere-al-esofagitei-moderate-spre-severe-dozele-uzuale-de-ipp-sunt/2022-07-10T18:39:15+03:00https://health-pharma.ro/question/selectati-enunturile-corecte/2022-07-10T18:39:51+03:00https://health-pharma.ro/question/selectati-laxativul-care-inmoaie-materiile-fecale-in-1-3-zile/2022-11-15T19:58:35+02:00https://health-pharma.ro/question/produce-un-scaun-moale-sau-semilichid-in-6-12-ore/2022-11-15T19:59:08+02:00https://health-pharma.ro/question/inmoaie-materiile-fecale-in-1-3-zile/2022-11-15T19:59:54+02:00https://health-pharma.ro/question/este-laxativul-care-determina-eliminarea-unor-scaune-lichide-in-1-6-ore/2022-11-15T20:00:33+02:00https://health-pharma.ro/question/este-activator-al-canalelor-de-clor/2022-11-15T20:01:15+02:00https://health-pharma.ro/question/este-agonist-de-guanilat-ciclaza-c-utilizat-in-tratamentul-constipatiei/2022-11-15T20:01:50+02:00https://health-pharma.ro/question/este-un-antagonist-al-receptorilor-opioizi-utilizat-in-tratamentul-constipatiei/2022-11-15T20:02:31+02:00https://health-pharma.ro/question/se-utilizeaza-pentru-recuperarea-functiei-intestinale-dupa-rezectia-intestinului-subtire-sau-gros/2022-11-15T20:03:34+02:00https://health-pharma.ro/question/este-antagonist-al-receptorilor-u-indicat-in-constipatia-indusa-de-opioide/2022-07-10T18:51:32+03:00https://health-pharma.ro/question/este-indicat-in-constipatie-cronica-idiopatica-si-sindromul-colonului-iritabil-in-care-predomina-constipatia/2022-11-15T20:07:15+02:00https://health-pharma.ro/question/se-utilizeaza-pentrie-acuarea-rapida-a-intestinului-inainte-de-diagnostice/2022-11-15T20:09:41+02:00https://health-pharma.ro/question/tratamentul-de-prima-linie-la-adulti-cu-functie-cognitiva-intacta-si-constipatie-functionala-este-reprezentat-de/2022-11-15T20:10:42+02:00https://health-pharma.ro/question/doza-de-linaclotida-utilizata-in-tratamentul-constipatiei-este/2022-11-15T20:11:24+02:00https://health-pharma.ro/question/doza-de-lubiprostona-utilizata-in-tratamentul-constipatiei-este/2022-11-15T20:12:08+02:00https://health-pharma.ro/question/doza-pentru-administrarea-bisacodilului-sub-forma-de-supozitoare-in-tratamentul-constipatiei-este/2022-11-15T20:12:46+02:00https://health-pharma.ro/question/se-administreaza-in-doza-de-50-360-mg-zi-pentru-tratamentul-constipatiei/2022-11-15T20:13:35+02:00https://health-pharma.ro/question/se-administreaza-in-doza-de-100-300-mg-zi-pentru-tratamentul-constipatiei/2022-11-15T20:14:07+02:00https://health-pharma.ro/question/este-un-purgativ-salin/2022-11-15T20:14:35+02:00https://health-pharma.ro/question/nu-este-un-efect-advers-al-lactulozei/2022-11-15T20:15:14+02:00https://health-pharma.ro/question/este-un-agent-tensioactiv-care-creste-secretia-de-apa-si-electroliti-in-intestin/2022-11-15T20:15:47+02:00https://health-pharma.ro/question/se-utilizeaza-pentru-prevenirea-constipatiei/2022-11-15T20:17:25+02:00https://health-pharma.ro/question/este-un-simptom-de-alarma-in-constipatie/2022-11-15T20:18:15+02:00https://health-pharma.ro/question/in-cazul-consumului-crescut-de-tarate-poate-sa-apara-in-primasaptamana-de-tratament/2022-11-15T20:18:52+02:00https://health-pharma.ro/question/glicerina-administrata-local-actioneaza-la-nivelul-rectului-prin-mecanism/2022-11-15T20:19:33+02:00https://health-pharma.ro/question/selectati-agentul-care-determina-aparitia-unor-scaune-lichide-in-1-6-ore-dupa-administrare-a-carui-doza-recomandata-variaza-in-functie-de-sarea-utilizata/2022-11-15T20:20:04+02:00https://health-pharma.ro/question/pot-induce-constipatie-urmatoarele-medicamente-cu-actiune-anticolinergica/2022-11-15T20:20:39+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-referitoare-la-tratamentul-constipatiei/2022-11-15T20:21:36+02:00https://health-pharma.ro/question/sunt-laxative-care-produc-un-scaun-moale-sau-semilichid-in-6-12-ore/2022-11-15T20:22:13+02:00https://health-pharma.ro/question/sunt-laxative-care-determina-inmuierea-materiilor-fecale-in-1-3-zile/2022-11-15T20:22:48+02:00https://health-pharma.ro/question/sunt-laxative-care-determina-eliminarea-unor-scaune-lichide-in-1-6-ore/2022-11-15T20:23:20+02:00https://health-pharma.ro/question/sunt-antagonisti-ai-receptorilor-opioizi/2022-11-15T20:24:05+02:00https://health-pharma.ro/question/pentru-laxativele-emoliente-sunt-corecte-enunturile/2022-11-15T20:25:01+02:00https://health-pharma.ro/question/sunt-reactii-adverse-ale-lactulozei/2022-11-15T20:25:32+02:00https://health-pharma.ro/question/selectati-raspunsurile-corecte-pentru-sorbitol/2022-11-15T20:26:21+02:00https://health-pharma.ro/question/utilizarea-purgativelor-saline-ar-trebui-facuta-in-urmatoarele-situatii/2022-11-15T20:27:05+02:00https://health-pharma.ro/question/alvimopan/2022-11-15T20:28:04+02:00https://health-pharma.ro/question/glicerina/2022-11-15T20:31:08+02:00https://health-pharma.ro/question/lubiprostona/2022-11-15T20:31:43+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-pentru-purgativele-saline/2022-11-15T20:30:36+02:00https://health-pharma.ro/question/linaclotida/2022-11-15T20:32:40+02:00https://health-pharma.ro/question/se-utilizeaza-in-sindromul-de-intestin-iritabil-in-care-predomina-constipatia/2022-11-15T20:33:15+02:00https://health-pharma.ro/question/se-administreaza-in-doza-de-4-6-g-zi/2022-11-15T20:34:44+02:00https://health-pharma.ro/question/se-administreaza-in-doza-de-50-360-mg-zi/2022-07-10T19:11:43+03:00https://health-pharma.ro/question/alegeti-produsele-cu-actiune-laxativa-purgativaa-caror-doza-administrata-variaza-in-functie-de-produs-de-formulare-sau-de-sarea-administrata/2022-11-15T20:37:11+02:00https://health-pharma.ro/question/induc-constipatie/2022-11-15T20:37:46+02:00https://health-pharma.ro/question/in-constipatie-sunt-prezente-urmatoarele-semne-si-simptome/2022-11-15T20:38:27+02:00https://health-pharma.ro/question/sunt-simptome-de-alarma-in-constipatia-cronica/2022-11-15T20:39:02+02:00https://health-pharma.ro/question/la-pacientii-cu-semne-si-simptome-de-alarma-se-fac-investigatiile/2022-11-15T20:39:49+02:00https://health-pharma.ro/question/laxativele-emoliente-pot-fi-utile-in-caz-de/2022-11-15T20:40:36+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-2/2022-07-10T19:18:16+03:00https://health-pharma.ro/question/episoadele-diareice-acute-intra-in-remisiune-de-obicei-in/2022-11-15T20:43:47+02:00https://health-pharma.ro/question/alegeti-medicamentul-utilizat-in-afectiunile-cardiace-care-nu-produce-diaree/2022-11-15T20:44:26+02:00https://health-pharma.ro/question/nu-produce-diaree/2022-11-15T20:45:00+02:00https://health-pharma.ro/question/utilizarea-opioidelor-in-diaree-este-limitata-de/2022-11-15T20:45:35+02:00https://health-pharma.ro/question/subsalicilatul-de-bismut-este-utilizat-frecvent-in/2022-11-15T20:46:13+02:00https://health-pharma.ro/question/debutul-brusc-al-diareei-poate-fi-insotit-de/2022-11-15T20:47:00+02:00https://health-pharma.ro/question/debutul-brusc-al-diareei-poate-fi-insotit-de-2/2022-11-15T20:47:35+02:00https://health-pharma.ro/question/afectiunile-intestinului-subtire-se-caracterizeaza-prin/2022-11-15T20:48:11+02:00https://health-pharma.ro/question/durerea-prezenta-in-cadrul-diareei-masive-este/2022-11-15T20:48:40+02:00https://health-pharma.ro/question/durerea-prezenta-in-cadrul-diareei-masive-este-localizata-in/2022-11-15T20:48:59+02:00https://health-pharma.ro/question/in-diareea-cronica-sunt-importante-informatiile-privind/2022-11-15T20:49:44+02:00https://health-pharma.ro/question/investigatiile-radiologice-in-diaree-sunt-utile-in/2022-11-15T20:50:15+02:00https://health-pharma.ro/question/sunt-antihipertensive-care-pot-induce-diaree/2022-11-15T20:51:07+02:00https://health-pharma.ro/question/produc-diaree-prin-mecanism-colinergic/2022-11-15T20:51:37+02:00https://health-pharma.ro/question/subsalicilatul-de-bismut-are-urmatoarele-efecte/2022-11-15T20:52:12+02:00https://health-pharma.ro/question/subsalicilatul-de-bismut-are-urmatoarele-efecte-2/2022-07-10T19:25:04+03:00https://health-pharma.ro/question/preparatele-care-contin-microorganismele-din-specia-lactobacillus-pot-avea-efectele/2022-11-15T20:52:49+02:00https://health-pharma.ro/question/octreotida/2022-11-15T20:53:24+02:00https://health-pharma.ro/question/reactiile-adverse-determinate-de-octreotida-sunt/2022-11-15T20:53:53+02:00https://health-pharma.ro/question/in-categoria-medicamentelor-antidiareice-sunt-incluse/2022-11-15T20:54:29+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-referitoare-la-tratamentul-diareei/2022-11-15T20:55:34+02:00https://health-pharma.ro/question/alegeti-inhibitorul-dpp4-care-determina-o-reducere-a-numarului-absolut-de-limfocite-in-functie-de-doza/2022-11-16T14:29:53+02:00https://health-pharma.ro/question/alegeti-antidiabeticul-a-carui-doza-uzuala-orala-este-de-100-mg-zi/2022-11-16T14:31:04+02:00https://health-pharma.ro/question/asocierea-colesevelam-insulina-poate-duce-la-cresterea/2022-11-16T14:37:07+02:00https://health-pharma.ro/question/terapia-cu-pramlintida-in-dz1-se-initiaza-cu-doza/2022-11-16T14:39:55+02:00https://health-pharma.ro/question/pentru-a-scadea-riscul-de-hipoglicemie-severa-care-apare-la-asocierea-dintre-pramlintida-insulina-se-reduce-doza-de-insulina-prandiala-cu/2022-11-16T14:40:45+02:00https://health-pharma.ro/question/este-un-analog-sintetic-de-amilina/2022-11-16T14:41:19+02:00https://health-pharma.ro/question/este-inhibitor-al-alfa-glucozidazei/2022-11-16T14:42:14+02:00https://health-pharma.ro/question/eficacitatea-maxima-a-tiazolidindionelor-apare-dupa/2022-11-16T14:43:17+02:00https://health-pharma.ro/question/alegeti-parametrul-profilului-lipidic-pe-care-il-cresc-ambele-tiazolidindione-pioglitazona-si-rosiglitazona/2022-11-16T14:44:10+02:00https://health-pharma.ro/question/cel-mai-frecvent-inhibitorii-co-transportorului-2-sodiuglucoza-sglt-2-produc/2022-11-16T14:46:10+02:00https://health-pharma.ro/question/eficacitatea-inhibitorilor-sglt-2-este-scazuta-in-insuficienta/2022-11-16T14:47:48+02:00https://health-pharma.ro/question/cel-mai-frecvent-efect-advers-secundar-al-sulfonilureelor-antidiabetice-este/2022-11-16T14:48:27+02:00https://health-pharma.ro/question/selectati-posologia-corecta-pentru-dulaglutid/2022-11-16T14:49:11+02:00https://health-pharma.ro/question/antidiabeticul-care-produce-scadere-in-greutate-este/2022-11-16T14:49:54+02:00https://health-pharma.ro/question/administrarea-metforminului-este-contraindicata-la-pacienticu-rata-filtrarii-glomerulare/2022-11-16T14:50:37+02:00https://health-pharma.ro/question/selectati-insulina-cu-durata-maxima-de-actiune-de-36-ore/2022-11-16T14:51:24+02:00https://health-pharma.ro/question/selectati-insulina-cu-durata-maxima-de-actiune-de-24-ore/2022-11-16T14:52:07+02:00https://health-pharma.ro/question/alegeti-insulina-cu-timpul-de-debut-al-efectului-in-2-4-ore/2022-11-16T14:53:33+02:00https://health-pharma.ro/question/alegeti-insulina-cu-durata-de-actiune-intermediara/2022-11-16T14:54:05+02:00https://health-pharma.ro/question/insulina-regular-se-administreaza/2022-11-16T14:54:31+02:00https://health-pharma.ro/question/insulina-regular-se-administreaza-2/2022-11-16T14:54:55+02:00https://health-pharma.ro/question/insulina-aspart-se-administreaza-inainte-de-masa-cu/2022-11-16T14:56:03+02:00https://health-pharma.ro/question/insulina-cu-actiune-intermediara-administrata-dimineata-asigura/2022-11-16T14:56:55+02:00https://health-pharma.ro/question/daca-apare-hipoglicemia-pacientul-trebuie-sa-consume/2022-11-16T14:57:34+02:00https://health-pharma.ro/question/antrenamentul-de-rezistenta-sau-forta-la-pacientii-diabetici-nu-este-recomandat-la/2022-11-16T14:58:06+02:00https://health-pharma.ro/question/selectati-antidiabeticul-derivat-de-sulfoniluree-care-prin-metabolizare-formeaza-un-metabolit-cu-activitate-egala-cu-a-compusului-parinte/2022-11-16T14:58:45+02:00https://health-pharma.ro/question/scaderea-in-greutate-este-recomandata-la-pacientii-diabetici/2022-11-16T14:59:23+02:00https://health-pharma.ro/question/administrarea-dozei-de-insulina-nph-inainte-de-culcare-are-urmatoarele-avantaje/2022-11-16T15:00:04+02:00https://health-pharma.ro/question/in-regimurile-bazal-bolus-pacientul-isi-stabileste-doza-de-insulina-bolus-in-functie-de/2022-11-16T15:00:38+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-referitoare-la-necesarul-zilnic-mediu-de-insulina-in-dzi/2022-11-16T15:01:20+02:00https://health-pharma.ro/question/pramlintida/2022-11-16T15:02:36+02:00https://health-pharma.ro/question/alegeti-optiunile-terapeutice-corecte-pentru-pacientii-cu-dz-2/2022-11-16T15:03:22+02:00https://health-pharma.ro/question/daca-tinta-individuala-a-hba1c-nu-se-atinge-prin-monoterapie-metforminei-i-se-asociaza/2022-11-16T15:04:03+02:00https://health-pharma.ro/question/alegeti-enuntul-corect-pentru-pacientii-cu-dz-2-la-care-nu-se-atinge-tinta-hba1c-dupa-3-luni-de-dubla-terapie/2022-11-16T15:04:48+02:00https://health-pharma.ro/question/sunt-insuline-cu-actiune-rapida/2022-11-16T15:05:20+02:00https://health-pharma.ro/question/pentru-insulina-regular-sunt-corecte-enuturile/2022-11-16T15:06:06+02:00https://health-pharma.ro/question/deosebirile-insulinei-glulizin-fata-de-insulina-regular-sunt/2022-11-16T15:06:52+02:00https://health-pharma.ro/question/sunt-dezavantaje-ale-insulinelor-nph/2022-11-16T15:07:40+02:00https://health-pharma.ro/question/sunt-insuline-cu-durata-lunga-de-actiune/2022-11-16T15:08:08+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-pentru-insulinele-cu-durata-lunga-deactiune/2022-11-16T15:09:43+02:00https://health-pharma.ro/question/alegeti-insulinele-cu-timp-de-debut-al-efectului-in-15-30-minute/2022-11-16T15:10:17+02:00https://health-pharma.ro/question/metformin/2022-11-16T15:10:54+02:00https://health-pharma.ro/question/efectele-metforminului-asupra-profilului-lipidic-includ/2022-11-16T15:11:20+02:00https://health-pharma.ro/question/sunt-reactii-adverse-gastrointestinale-ale-metforminului/2022-11-16T15:11:54+02:00https://health-pharma.ro/question/reactiile-adverse-gastrointestinale-ale-metforminului-pot-fi-reduse-prin/2022-11-16T15:12:34+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-referitoare-la-posologia-formelor-farmaceutice-de-metformin-500-mg-cu-eliberare-imediata/2022-11-16T15:14:32+02:00https://health-pharma.ro/question/consecintele-administrarii-metforminului-comprimate-cu-eliberare-prelungita-in-2-sau-3-prize-zilnice-sunt/2022-11-16T15:15:19+02:00https://health-pharma.ro/question/riscul-de-acidoza-lactica-indusa-de-metformin-creste-in/2022-11-16T15:15:56+02:00https://health-pharma.ro/question/agonistii-receptorilor-glucagon-like-peptid-1-au-urmatoarele-actiuni/2022-11-16T15:16:50+02:00https://health-pharma.ro/question/in-tratamentul-diabetului-se-poate-utiliza-un-analog-de-gpl-1-in-locul-insulinei-bazale-in-urmatoarele-conditii/2022-11-16T15:17:29+02:00https://health-pharma.ro/question/sulfonilureele-antidiabetice/2022-11-16T15:18:05+02:00https://health-pharma.ro/question/hipoglicemia-indusa-de-sulfonilureele-antidiabetice-este-mai-intensa-in-caz-de/2022-11-16T15:18:29+02:00https://health-pharma.ro/question/inhibitorii-dipeptidilpeptidazei-4-dpp-4/2022-11-16T15:19:35+02:00https://health-pharma.ro/question/inhibitorii-dipeptidilpeptidazei-4-dpp-4-nu-produc/2022-11-16T15:19:55+02:00https://health-pharma.ro/question/reactiile-adverse-frecvente-ale-inhibitorilor-dpp-4-sunt/2022-11-16T15:20:31+02:00https://health-pharma.ro/question/alegeti-antidiabeticele-a-caror-doza-uzuala-este-de-5-mg-zi/2022-11-16T15:21:03+02:00https://health-pharma.ro/question/sunt-caracteristici-ale-inhibitorilor-co-transportorului-2-sodiu-glucoza-sglt-2/2022-11-16T15:21:36+02:00https://health-pharma.ro/question/sunt-caracteristici-ale-inhibitorilor-co-transportorului-2-sodiu-glucoza-sglt-2-2/2022-05-06T13:42:13+03:00https://health-pharma.ro/question/alegeti-variantele-corecte-de-raspuns-pentru-tiazolidindione/2022-11-16T15:22:16+02:00https://health-pharma.ro/question/alegeti-efectele-adverse-ale-tiazolidindionelor/2022-11-16T15:23:02+02:00https://health-pharma.ro/question/selectati-enunturile-corecte-referitoare-la-tratamentul-cu-tiazolidine/2022-11-16T15:24:04+02:00https://health-pharma.ro/question/sunt-reactii-adverse-frecvente-ale-acarbozei/2022-11-16T15:24:47+02:00https://health-pharma.ro/question/actioneaza-ca-antidiabetice-prin-legarea-de-receptorul-activator-al-proliferarii-peroxizomilor-y/2022-11-16T15:25:22+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-pentru-meglitinide/2022-11-16T15:26:09+02:00https://health-pharma.ro/question/alegeti-antidiabeticele-sulfoniluree-care-se-metabolizeaza-la-compusi-inactivi/2022-11-16T15:28:12+02:00https://health-pharma.ro/question/se-metabolizeaza-predominant-cu-cyp2c9/2022-11-16T15:28:54+02:00https://health-pharma.ro/question/se-metabolizeaza-predominant-cu-cyp2c8/2022-11-16T15:29:15+02:00https://health-pharma.ro/question/alegeti-antidiabeticele-care-se-biotransforma-cu-cyp2c8-si-cyp3a4/2022-11-16T18:03:12+02:00https://health-pharma.ro/question/este-inhibitor-al-oligonucleotidei-antisens-care-intervine-in-sinteza-apolipoproteinei-b-100/2022-11-16T18:05:03+02:00https://health-pharma.ro/question/selectati-doza-maxima-zilnica-de-lomitapida/2022-11-16T18:05:40+02:00https://health-pharma.ro/question/inhiba-proteina-de-transfer-microzomal-al-trigliceridelor/2022-11-16T18:07:03+02:00https://health-pharma.ro/question/ezetimib/2022-11-16T18:07:30+02:00https://health-pharma.ro/question/lomitapida-prezinta-risc-crescut-de-inducere-a/2022-11-16T18:08:14+02:00https://health-pharma.ro/question/statinele-produc/2022-11-16T18:08:45+02:00https://health-pharma.ro/question/terapia-de-intensitate-inalta-in-dislipidemie-consta-in/2022-11-16T18:09:24+02:00https://health-pharma.ro/question/terapia-de-intensitate-moderata-in-dislipidemie-consta-in/2022-11-16T18:10:31+02:00https://health-pharma.ro/question/pentru-pacientii-cu-varsta-sub-75-ani-dislipidemie-si-boala-cardiovasculara-in-antecedente-terapia-de-prima-linie-consta-in-administrarea-de/2022-11-16T18:39:19+02:00https://health-pharma.ro/question/sechestrantii-acizilor-biliari-nu-impiedica-absorbtia-vitaminei/2022-11-16T18:40:27+02:00https://health-pharma.ro/question/stimuleaza-sinteza-hepatica-a-acizilor-biliari-din-colesterol/2022-11-16T18:41:24+02:00https://health-pharma.ro/question/asocierea-dintre-statine-si-sechestrantii-acizilor-biliari-este-justificata-prin/2022-11-16T18:42:05+02:00https://health-pharma.ro/question/inrosirea-pielii-si-pruritul-induse-de-niacina-se-pot-amplifica-laadministrarea-concomitenta-cu/2022-11-16T18:42:39+02:00https://health-pharma.ro/question/inhiba-hmg-coa-reductaza/2022-11-16T18:43:28+02:00https://health-pharma.ro/question/terapia-de-intensitate-inalta-cu-statine-consta-in-administrarea-de/2022-11-16T18:45:10+02:00https://health-pharma.ro/question/terapia-cu-statine-de-intensitate-inalta-consta-in-administrarea-de/2022-11-16T18:44:32+02:00https://health-pharma.ro/question/terapia-cu-statine-de-intensitate-moderata-consta-in-administrarea-de/2022-11-16T18:45:51+02:00https://health-pharma.ro/question/terapie-cu-statine-de-intensitate-scazuta-consta-in-administrarea-de/2022-07-10T20:45:28+03:00https://health-pharma.ro/question/in-preventia-primara-la-pacienti-fara-diabet-cu-ldl-c-70-189-mg-dl-si-cu-riscul-score-5-75-este-recomandata-administrarea-de/2022-11-16T18:49:48+02:00https://health-pharma.ro/question/in-preventia-primara-la-pacienti-fara-diabet-cu-ldl-c-70-189-mg-dl-si-cu-riscul-score-5-75-este-recomandata-administrarea-de-2/2022-11-16T18:50:17+02:00https://health-pharma.ro/question/la-pacientii-cu-boala-cardiovasculara-in-antecedente-ldl-c-190-mg-dl-neeligibili-pentru-terapia-de-intensitate-inalta-cu-statine-se-recomanda-administrarea-de/2022-11-16T18:51:01+02:00https://health-pharma.ro/question/sunt-inhibitori-pcsk9/2022-11-16T18:52:41+02:00https://health-pharma.ro/question/aportul-de-carbohidrati-din-totalul-caloriilor-la-un-pacient-cu-dislipidemie-este/2022-11-16T18:53:58+02:00https://health-pharma.ro/question/aportul-de-grasimi-totale-din-totalul-caloriilor-la-un-pacient-cu-dislipidemie-este/2022-11-16T18:54:40+02:00https://health-pharma.ro/question/blocheaza-absorbtia-intestinala-a-colesterolului/2022-11-16T18:55:16+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-pentru-sechestrantii-acizilor-biliari/2022-07-10T21:08:40+03:00https://health-pharma.ro/question/alegeti-enunturile-corecte-pentru-sechestrantii-acizilor-biliari-2/2022-07-10T21:09:17+03:00https://health-pharma.ro/question/sunt-reactii-adverse-ale-sechestrantilor-acizilor-biliari/2022-11-16T18:58:17+02:00https://health-pharma.ro/question/sechestrantii-acizilor-biliari-produc-urmatoarele-efecte-asupra-metabolismului-electrolitic/2022-11-16T18:58:57+02:00https://health-pharma.ro/question/niacina/2022-11-16T18:59:25+02:00https://health-pharma.ro/question/inrosirea-pielii-si-pruritul-induse-de-niacina-pot-fi-reduse-prin/2022-11-16T19:00:24+02:00https://health-pharma.ro/question/sunt-modificari-ale-testelor-de-laborator-induse-de-niacina/2022-11-16T19:02:59+02:00https://health-pharma.ro/question/sunt-reactii-adverse-ale-statinelor/2022-11-16T19:03:38+02:00https://health-pharma.ro/question/sunt-considerate-cele-mai-eficiente-medicamente-hipolipemiante-pentru-reducerea-colesterolul-total-si-a-ldl-colesterolului/2022-11-16T19:04:51+02:00https://health-pharma.ro/question/sunt-actiuni-farmacologice-ale-statinelor/2022-07-10T21:14:00+03:00https://health-pharma.ro/question/ezetimib-2/2022-11-16T19:07:34+02:00https://health-pharma.ro/question/acizii-grasi-polinesaturati-omega-3-scad/2022-11-16T19:08:01+02:00https://health-pharma.ro/question/sunt-considerate-complicatii-ale-administrarii-suplimentelor-cu-ulei-de-peste-in-doze-mari/2022-11-16T19:08:42+02:00https://health-pharma.ro/question/mipomersen/2022-11-16T19:09:13+02:00https://health-pharma.ro/question/mipomersen-scade/2022-11-16T19:09:32+02:00https://health-pharma.ro/question/lomitapida/2022-11-16T19:10:22+02:00https://health-pharma.ro/question/inhibitorii-de-pcsk-9-se-adauga-tratamentului-cu-hipolipemiante-la-doza-maxima-tolerata-la-pacientii-care-necesita-scaderea-suplimentara-a-ldl-colesterolului-in-urmatoarele-patologii/2022-11-16T19:11:40+02:00https://health-pharma.ro/question/inhiba-pcsk9/2022-11-16T19:12:10+02:00https://health-pharma.ro/question/recomandarile-de-tratament-pentru-hipercolesterolemia-primara-includ-administrarea-de/2022-11-16T19:12:42+02:00https://health-pharma.ro/question/recomandarile-de-tratament-pentru-hiperlipoproteinemia-mixta-iib-includ-administrarea-de/2022-11-16T19:13:18+02:00https://health-pharma.ro/question/recomandarile-de-tratament-pentru-hiperlipoproteinemia-de-tipiii-includ-administrarea-de/2022-11-16T19:13:57+02:00https://health-pharma.ro/question/pentru-hiperlipoproteinemia-de-tip-v-se-recomanda-tratament-cu/2022-11-16T19:14:38+02:00https://health-pharma.ro/question/pentru-pacienti-cu-niveluri-foarte-crescute-ale-trigliceridelor-se-recomanda/2022-11-16T19:15:10+02:00https://health-pharma.ro/question/pentru-pacienti-cu-valori-ale-hdl-colesterol-scazut-se-recomanda-administrarea-de/2022-11-16T19:15:53+02:00https://health-pharma.ro/question/pentru-pacientii-cu-diabet-zaharat-si-valori-ale-ldl-colesterol-de-100-129-mg-dl-se-recomanda/2022-11-16T19:16:32+02:00https://health-pharma.ro/question/pentru-diagnosticarea-hta-secundare-data-de-hiperaldosteronism-se-determina/2022-11-17T10:13:16+02:00https://health-pharma.ro/question/se-recomanda-adaugarea-unui-antagonist-aldosteronic-la-farmacoterapia-standard-pentru-pacientii-care-au-hta-asociata-cu/2022-11-17T10:13:52+02:00https://health-pharma.ro/question/nu-exista-risc-de-hiperpotasemie-la-pacientii-tratati-cu-iec-la-care-se-adauga-in-schema-de-terapie/2022-11-17T10:14:32+02:00https://health-pharma.ro/question/nu-exista-risc-de-hiperpotasemie-la-pacientii-tratati-cu-iec-la-care-se-adauga-in-schema-de-terapie-2/2022-11-17T10:15:23+02:00https://health-pharma.ro/question/nu-intervine-in-metabolizarea-bradikininei/2022-11-17T10:15:55+02:00https://health-pharma.ro/question/selectati-diureticul-care-poate-produce-hipocalcemie/2022-11-17T10:16:31+02:00https://health-pharma.ro/question/riscul-crescut-de-hiperkaliemie-este-prezent-la/2022-11-17T10:17:09+02:00https://health-pharma.ro/question/beta-blocantele-reprezinta-medicatie-de-prima-intentie-la-pacienti-cu-hta-asociata-cu/2022-11-17T10:17:49+02:00https://health-pharma.ro/question/pentru-a-mentine-echilibrul-ionului-de-potasiu-hidroclorotiazida-se-asociaza-cu/2022-11-17T10:18:27+02:00https://health-pharma.ro/question/blocheaza-direct-receptorul-de-tip-1-al-angiotensinei-ii/2022-11-17T10:19:11+02:00https://health-pharma.ro/question/poate-produce-hiperpotasemie/2022-11-17T10:20:40+02:00https://health-pharma.ro/question/efectul-advers-care-nu-apare-in-cursul-tratamentului-cu-bra-fata-de-tratamentul-cu-iec-este/2022-11-17T10:21:26+02:00https://health-pharma.ro/question/produce-scaderea-conducerii-atrio-ventriculare-a/2022-11-17T10:22:01+02:00https://health-pharma.ro/question/selectati-diureticul-care-prezinta-un-debut-lent-al-actiunii/2022-11-17T10:22:38+02:00https://health-pharma.ro/question/alegeti-beta-blocantul-cu-activitate-simpatomimetica-intrinseca/2022-11-17T10:28:21+02:00https://health-pharma.ro/question/selectati-antihipertensivul-care-actioneaza-prin-scaderea-debitului-cardiac/2022-11-17T10:29:08+02:00https://health-pharma.ro/question/produce-fenomenul-primei-doze-caracterizat-prin-hipotensiune-ortostatica/2022-11-17T10:29:48+02:00https://health-pharma.ro/question/antihipertensivul-recomandat-la-pacienti-cu-hta-asociata-cu-hiperplazie-benigna-de-prostata-este/2022-11-17T10:30:29+02:00https://health-pharma.ro/question/prin-blocarea-receptorilor-beta2-beta-blocantele-pot-agrava/2022-11-17T10:31:09+02:00https://health-pharma.ro/question/este-inhibitor-direct-al-reninei/2022-11-17T10:31:43+02:00https://health-pharma.ro/question/aliskiren-nu-trebuie-utilizat-in-asociere-cu/2022-11-17T10:32:16+02:00https://health-pharma.ro/question/poate-produce-hiperpotasemie-2/2022-11-17T10:32:49+02:00https://health-pharma.ro/question/selectati-antihipertensivul-agonist-al-receptorilor-02-centrali/2022-11-17T10:33:23+02:00https://health-pharma.ro/question/produce-hipertensiune-de-rebound-la-oprirea-brusca-a-tratamentului/2022-11-17T10:33:53+02:00https://health-pharma.ro/question/goleste-veziculele-de-noradrenalina-din-terminatiile-nervoase-simpatice/2022-11-17T10:34:24+02:00https://health-pharma.ro/question/selectati-efectul-advers-produs-de-rezerpina-datorat-activarii-parasimpatice/2022-11-17T10:37:42+02:00https://health-pharma.ro/question/antihipertensivul-care-produce-sindrom-de-tip-lupus-doza-dependent-si-reversibil-este/2022-11-17T10:38:30+02:00https://health-pharma.ro/question/poate-produce-hipertricoza-reversibila/2022-11-17T10:39:10+02:00https://health-pharma.ro/question/beta-blocantul-nerecomandat-post-infarct-de-miocard-este/2022-11-17T10:39:40+02:00https://health-pharma.ro/question/selectati-antihipertensivul-care-nu-produce-retentie-hidrosalina/2022-11-17T10:40:13+02:00https://health-pharma.ro/question/testele-de-laborator-pentru-diagnosticarea-hta-secundare-bolii-renovasculare-sunt/2022-11-17T10:41:25+02:00https://health-pharma.ro/question/testele-de-laborator-pentru-diagnosticarea-hta-secundare-data-de-feocromocitom-sunt/2022-11-17T10:41:51+02:00https://health-pharma.ro/question/pentru-pacientii-fara-alte-comorbiditati-si-hta-stadiul-1-este-recomandata-monoterapia-cu/2022-11-17T10:42:26+02:00https://health-pharma.ro/question/pentru-pacientii-cu-hta-stadiul-2-fara-boala-arteriala-coronariana-sau-infarct-de-miocard-in-antecedente-sunt-recomandate-asocierile-de-medicamente/2022-11-17T10:42:58+02:00https://health-pharma.ro/question/pentru-pacientii-cu-hta-si-insuficienta-cardiaca-cu-fractie-de-ejectie-redusa-tripla-terapie-standard-include/2022-11-17T10:43:36+02:00https://health-pharma.ro/question/pentru-pacientii-cu-hta-post-infarct-de-miocard-farmacoterapia-standard-include/2022-11-17T10:44:45+02:00https://health-pharma.ro/question/se-recomanda-adaugarea-unui-bcc-la-farmacoterapia-standard-pentru-pacientii-care-au-hta-asociata-cu/2022-11-17T10:45:20+02:00https://health-pharma.ro/question/farmacoterapia-standard-recomandata-la-pacientii-cu-hta-si-boala-arteriala-coronariana-include/2022-11-17T10:46:14+02:00https://health-pharma.ro/question/farmacoterapia-standard-recomandata-la-pacientii-cu-hta-si-diabet-include-ca-prima-linie-de-tratament/2022-11-17T10:47:24+02:00https://health-pharma.ro/question/la-farmacoterapia-standard-pentru-pacientii-cu-hta-si-diabetse-pot-adauga/2022-11-17T10:48:24+02:00https://health-pharma.ro/question/farmacoterapia-standard-recomandata-la-pacientii-cu-hta-siboala-cronica-de-rinichi-include/2022-11-17T10:49:22+02:00https://health-pharma.ro/question/farmacoterapia-standard-recomandata-la-pacientii-hipertensivi-pentru-preventia-recurentei-accidentului-vascular-cerebral-include/2022-11-17T10:50:30+02:00https://health-pharma.ro/question/sunt-mecanisme-de-actiune-ale-iec/2022-11-17T10:51:21+02:00https://health-pharma.ro/question/in-cadrul-tratamentului-cu-iec-poate-aparea-hipotensiune-acuta-in-special-la-pacientii/2022-11-17T10:52:23+02:00https://health-pharma.ro/question/sunt-blocante-ale-receptorilor-alfa-1/2022-11-17T10:52:59+02:00https://health-pharma.ro/question/riscul-de-a-dezvolta-insuficienta-renala-acuta-in-urma-tratamentului-cu-iec-este-mai-mare-la-pacientii-cu/2022-11-17T10:53:58+02:00https://health-pharma.ro/question/bra-sunt-utilizati-ca-alternativa-de-tratament-la-pacientii-care-prezinta-urmatoarele-reactii-adverse-la-iec/2022-11-17T10:54:50+02:00https://health-pharma.ro/question/nu-scad-conducerea-atrio-ventriculara/2022-11-17T10:55:29+02:00https://health-pharma.ro/question/nu-sunt-eficiente-tratamentul-tahiaritmiilor-pentru-ventriculare/2022-11-17T10:56:26+02:00https://health-pharma.ro/question/dintre-blocantele-canalelor-de-calciu-dihidropiridine-nu-prezinta-efect-inotrop-negativ/2022-11-17T10:57:08+02:00https://health-pharma.ro/question/sunt-beta-blocante-cardioselective-la-doze-mici/2022-11-17T10:57:49+02:00https://health-pharma.ro/question/sunt-beta-blocante-cu-actiune-simpatomimetica-intrinseca/2022-11-17T11:01:53+02:00https://health-pharma.ro/question/sunt-mecanisme-de-actiune-antihipertensiva-ale-beta-blocantelor/2022-11-17T11:02:28+02:00https://health-pharma.ro/question/oprirea-brusca-a-tratamentului-cu-beta-blocante-la-pacienti-cu-boala-coronariana-poate-determina/2022-11-17T11:03:25+02:00https://health-pharma.ro/question/sunt-beta-blocante-cu-t1-2-relativ-lung-care-se-administreaza-intr-o-singura-priza-zilnica/2022-07-11T20:02:09+03:00https://health-pharma.ro/question/sunt-efecte-adverse-cardiace-ale-beta-blocantelor/2022-11-17T11:06:02+02:00https://health-pharma.ro/question/caracterizeaza-ai-blocantele/2022-07-11T20:03:09+03:00https://health-pharma.ro/question/aliskiren/2022-11-17T11:07:53+02:00https://health-pharma.ro/question/sunt-antihipertensive-agonisti-ai-receptorilor-alfa2-adrenergici-centrali/2022-11-17T11:08:35+02:00https://health-pharma.ro/question/stimularea-receptorilor-alfa-2-presinaptici-periferici-produsa-de-clonidina-determina/2022-11-17T11:09:20+02:00https://health-pharma.ro/question/prin-stimularea-receptorilor-alfa-2-adrenergici-din-creier-guanabenz-produce/2022-11-17T11:09:59+02:00https://health-pharma.ro/question/poate-determina-hipertensiune-de-rebound-oprirea-brusca-a-tratamentului-cu/2022-11-17T11:10:26+02:00https://health-pharma.ro/question/rezerpina/2022-11-17T11:10:52+02:00https://health-pharma.ro/question/hidralazina/2022-11-17T11:11:48+02:00https://health-pharma.ro/question/cresterea-activitatii-reflexe-a-baroreceptorilor-determinata-de-hidralazina-produce/2022-11-17T11:12:23+02:00https://health-pharma.ro/question/minoxidil/2022-11-17T11:13:04+02:00https://health-pharma.ro/question/b-blocantele-cu-eliberare-sustinuta-care-au-beneficii-dovedite-in-insuficienta-cardiaca-cu-fractie-de-ejectie-scazuta-sunt/2022-07-11T20:17:25+03:00https://health-pharma.ro/question/beta-blocantele-administrate-post-infarct-de-miocard-reduc/2022-11-17T11:15:06+02:00https://health-pharma.ro/question/sunt-recomandate-post-infarct-de-miocard/2022-11-17T11:15:43+02:00https://health-pharma.ro/question/selectati-raspunsurile-corecte-referitoare-la-terapia-hta-asociata-cu-insuficienta-cardiaca-cu-fractie-de-ejectie-scazuta/2022-11-17T12:56:15+02:00https://health-pharma.ro/question/se-utilizeaza-in-boala-cardiaca-ischemica-deoarece-inhiba-competitiv-efectele-catecolaminelor-neuronale-circulante/2022-11-17T12:57:08+02:00https://health-pharma.ro/question/este-blocant-al-receptorilor-alfa-1-beta-1si-beta-2/2022-11-17T12:59:56+02:00https://health-pharma.ro/question/este-blocant-al-receptorilor-alfa-1-beta-1si-beta-2-2/2022-11-17T13:00:23+02:00https://health-pharma.ro/question/reduce-concentratia-citosolica-de-calciu/2022-11-17T13:01:05+02:00https://health-pharma.ro/question/creste-concentratia-de-guanozin-monofosfat-ciclic-in-endoteliul-vascular/2022-11-17T13:01:45+02:00https://health-pharma.ro/question/inhiba-curentul-tardiv-de-sodiu-cu-reducerea-concentratiei-intracitoplasmatice-a-acestuia/2022-11-17T13:02:16+02:00https://health-pharma.ro/question/selectati-medicamentul-antianginos-care-scade-rata-cardiaca-si-nu-produce-tahicardie-reflexa/2022-11-17T13:02:52+02:00https://health-pharma.ro/question/hiperplazia-gingivala-este-o-reactie-adversa-specifica-pentru/2022-11-17T13:03:20+02:00https://health-pharma.ro/question/poate-provoca-constipatie-semnificativa-la-pana-la-8-dintre-pacienti/2022-11-17T13:03:49+02:00https://health-pharma.ro/question/inhiba-glicoproteina-p-si-creste-concentratia-plasmaticia-ciclosporinei/2022-11-17T13:04:18+02:00https://health-pharma.ro/question/prin-inhibitia-glicoproteinei-p-verapamilul-creste-concentratia-plasmatica-a/2022-11-17T13:04:56+02:00https://health-pharma.ro/question/selectati-beta-blocantul-care-ar-trebui-folosit-la-pacientii-cu-disfunctii-ale-ventriculului-stang/2022-11-17T13:05:38+02:00https://health-pharma.ro/question/dupa-infarct-de-miocard-sau-sindrom-coronarian-acut-la-pacientii-cu-functie-normala-a-ventriculului-terapia-cu-b-blocante-trebuie-initiata-si-urmata-timp-de/2022-11-17T13:06:04+02:00https://health-pharma.ro/question/produce-vasodilatatie-predominant-in-teritoriul-venos/2022-11-17T13:06:28+02:00https://health-pharma.ro/question/pentru-reducerea-riscului-de-aparitie-a-tolerantei-cronice-la-nitrati-pacientul-trebuie-sa-includa-o-perioada-de-pauza-zilnica-de/2022-11-17T13:07:04+02:00https://health-pharma.ro/question/alegeti-varianta-corecta-de-raspuns-pentru-nitratiiantianginosi/2022-11-17T13:08:29+02:00https://health-pharma.ro/question/creste-semnificativ-concentratia-plasmatica-ranolazinei/2022-11-17T13:09:22+02:00https://health-pharma.ro/question/scade-semnificativ-concentratia-plasmatica-ranolazinei/2022-11-17T13:09:57+02:00https://health-pharma.ro/question/poate-prelungi-intervalul-qtc/2022-11-17T13:10:47+02:00https://health-pharma.ro/question/nu-este-indicat-ca-terapie-antiagreganta-plachetara-in-boala-cardiaca-ischemica/2022-11-17T13:11:19+02:00https://health-pharma.ro/question/alegeti-blocantul-canalelor-de-calciu-care-se-administreaza-in-boala-cardiaca-ischemica-in-doza-de-5-10-mg-zi/2022-11-17T13:12:11+02:00https://health-pharma.ro/question/alegeti-blocantul-canalelor-de-calciu-care-se-administreaza-in-boala-cardiaca-ischemica-in-doza-de-5-10-mg-zi-2/2022-07-11T20:29:01+03:00https://health-pharma.ro/question/nitratii-organici-nu-produc/2022-11-17T13:13:17+02:00https://health-pharma.ro/question/acetaminofenul-este-utilizat-pentru-combaterea-urmatorului-efect-advers-al-nitratilor/2022-11-17T13:13:47+02:00https://health-pharma.ro/question/nu-reprezinta-o-terapie-adecvata-pentru-vasospasm/2022-11-17T13:14:13+02:00https://health-pharma.ro/question/sunt-beta-blocante-neselective-b1-si-b2/2022-11-17T13:14:46+02:00https://health-pharma.ro/question/este-preferata-administrarea-si-blocantelor-selective-la-pacienti-cu/2022-11-17T13:15:16+02:00https://health-pharma.ro/question/sunt-beta-blocante-care-ar-trebui-folosite-la-pacienti-cu-fractie-de-ejectie-40/2022-11-17T13:15:52+02:00https://health-pharma.ro/question/sunt-reactii-adverse-comune-ale-beta-blocantelor/2022-11-17T13:16:28+02:00https://health-pharma.ro/question/selectati-enunturile-corecte-referitoare-la-intreruperea-terapiei-cu-beta-blocante/2022-07-11T20:35:13+03:00https://health-pharma.ro/question/blocantele-canalelor-de-calciu/2022-11-17T13:18:31+02:00https://health-pharma.ro/question/sunt-efecte-secundare-ale-bcc-dihidropiridine/2022-11-17T13:19:10+02:00https://health-pharma.ro/question/reactiile-adverse-frecvente-ale-bcc-nondihidropiridine-includ/2022-11-17T13:19:49+02:00https://health-pharma.ro/question/sunt-bcc-care-actioneaza-in-principal-la-nivelul-muschiului-neted-vascular/2022-11-17T13:20:23+02:00https://health-pharma.ro/question/diltiazem-inhiba-clearance-ul-pentru/2022-11-17T13:21:31+02:00https://health-pharma.ro/question/verapamil-inhiba-clearance-ul-pentru/2022-11-17T13:22:14+02:00https://health-pharma.ro/question/inhibitia-glicoproteinei-p-de-catre-verapamil-creste-concentratia-plasmatica-pentru/2022-11-17T13:22:58+02:00https://health-pharma.ro/question/actioneaza-prin-reducerea-calciului-citoplasmatic/2022-11-17T13:23:33+02:00https://health-pharma.ro/question/nitratii-organici/2022-11-17T13:24:03+02:00https://health-pharma.ro/question/alegeti-enunturile-corecte-referitoare-la-nitrati/2022-11-17T13:25:05+02:00https://health-pharma.ro/question/pot-preveni-ischemia-de-rebound-din-timpul-intervalului-fara-nitrati/2022-11-17T13:25:34+02:00https://health-pharma.ro/question/efectele-secundare-asociate-cu-administrarea-nitratilor-sunt/2022-11-17T13:26:18+02:00https://health-pharma.ro/question/ranolazina/2022-11-17T13:26:57+02:00https://health-pharma.ro/question/ranolazina-2/2022-11-17T13:27:26+02:00https://health-pharma.ro/question/este-contraindicata-asocierea-ranolazinei-cu-urmatorii-inhibitori-ai-cyp3a4/2022-11-17T13:28:06+02:00https://health-pharma.ro/question/ranolazina-se-poate-asocia-in-doza-de-500-mg-x-2-zi-cu/2022-11-17T13:28:47+02:00https://health-pharma.ro/question/este-contraindicata-asocierea-ranolazinei-cu-urmatoarele-substante-care-produc-inductie-enzimatica-pentru-cyp3a4-si-glicoproteina-p/2022-11-17T13:29:48+02:00https://health-pharma.ro/question/sunt-eficiente-ca-agentii-unici-pentru-managementul-initial-al-vasospasmului-in-boala-cardiaca-ischemica/2022-11-17T13:30:16+02:00https://health-pharma.ro/question/beta-blocantele-sunt-contraindicate-la-pacienti-cu/2022-11-17T13:30:45+02:00https://health-pharma.ro/question/beta-blocantele-sunt-contraindicate-la-pacienti-cu-2/2022-11-17T13:31:12+02:00https://health-pharma.ro/question/concentratia-serica-tinta-a-digoxinului-este-cuprinsa-intre/2022-11-17T13:51:56+02:00https://health-pharma.ro/question/inhiba-excretia-potasiului/2022-11-17T13:52:34+02:00https://health-pharma.ro/question/reducerea-nivelului-de-angiotensina-ii-si-aldosteron-produse-de-iec-nu-scade/2022-11-17T13:53:11+02:00https://health-pharma.ro/question/dozele-de-b-blocant-utilizate-in-insuficienta-cardiaca-necesita-titrare-ascendenta-lenta-pentru-a-evita/2022-07-11T20:46:51+03:00https://health-pharma.ro/question/nu-se-evita-utilizarea-antagonistilor-aldosteronului-la-pacienti-cu/2022-11-17T13:55:16+02:00https://health-pharma.ro/question/alegeti-varianta-de-raspuns-incorecta-referitoare-la-utilizarea-digoxinei-in-insuficienta-cardiaca/2022-11-17T13:55:55+02:00https://health-pharma.ro/question/doza-tinta-de-carvedilol-la-pacientii-care-au-greutatea-corporala-peste-85-kg-este/2022-11-17T13:56:26+02:00https://health-pharma.ro/question/in-tratamentul-insuficientei-cardiace-se-ajusteaza-doza-in-functie-de-greutatea-corporala-pentru/2022-11-17T13:57:25+02:00https://health-pharma.ro/question/este-un-dilatator-arterial-direct-utilizat-in-insuficienta-cardiaca/2022-11-17T13:57:54+02:00https://health-pharma.ro/question/doza-tinta-pentru-asocierea-sacubitril-valsartan-este/2022-11-17T13:58:38+02:00https://health-pharma.ro/question/scade-depolarizarea-spontam-a-nodului-sinoatrial/2022-11-17T13:59:33+02:00https://health-pharma.ro/question/alegeti-medicamentul-indicat-pentru-reducerea-riscului-de-spitalizare-la-pacienti-cu-ic-agravata-si-fevs-s-35-in-ritm-sinusal-cu-frecventa-cardiaca-de-repaus-70-bpm-si-care-prezinta-contraindica/2022-11-17T14:00:24+02:00https://health-pharma.ro/question/neprilizina-degradeaza/2022-11-17T14:00:49+02:00https://health-pharma.ro/question/administrata-in-insuficienta-cardiaca-digoxina-nuimbunatateste/2022-11-17T14:01:44+02:00https://health-pharma.ro/question/inhiba-curentul-if-din-nodul-sinoatrial/2022-11-17T14:02:10+02:00https://health-pharma.ro/question/sacubitril-inhiba-activitatea/2022-11-17T14:02:46+02:00https://health-pharma.ro/question/este-un-prodrog/2022-11-17T14:03:18+02:00https://health-pharma.ro/question/este-inhibitor-al-neprilizinei/2022-11-17T14:03:56+02:00https://health-pharma.ro/question/diureticul-utilizat-pentru-mentinerea-starii-de-euvolemie-in-insuficienta-cardiaca-este/2022-11-17T14:04:28+02:00https://health-pharma.ro/question/prezinta-efect-venodilatator-si-vasodilatator-arterial-direct-asocierile/2022-11-17T14:05:20+02:00https://health-pharma.ro/question/nu-este-un-efect-al-antagonistilor-aldosteronului/2022-11-17T14:06:30+02:00https://health-pharma.ro/question/se-evita-utilizarea-spironolactonei-la-pacienti-cu-potasemie-mai-mare-de/2022-11-17T14:06:57+02:00https://health-pharma.ro/question/decompensarea-acuta-pe-care-o-pot-produce-beta-blocantele-in-insuficienta-cardiaca-este-datorata/2022-11-17T14:07:35+02:00https://health-pharma.ro/question/in-insuficienta-cardiaca-dozele-de-beta-blocant-ar-trebui-dublate/2022-11-17T14:09:57+02:00https://health-pharma.ro/question/este-diuretic-tiazidic-like/2022-07-11T21:02:05+03:00https://health-pharma.ro/question/selectati-variantele-corecte-de-raspuns-referitoare-la-tratamentul-diuretic-in-insuficienta-cardiaca/2022-11-17T14:18:33+02:00https://health-pharma.ro/question/diureticele-recomandate-pentru-restaurarea-si-mentinerea-starii-de-euvolemie-in-insuficienta-cardiacasunt/2022-11-17T14:19:00+02:00https://health-pharma.ro/question/pentru-diureticele-de-ansa-administrate-in-insuficienta-cardiaca-sunt-corecte-enunturile/2022-11-17T14:19:35+02:00https://health-pharma.ro/question/inhibitoarele-enzimei-de-conversie-a-angiotensinei-scad/2022-11-17T14:19:59+02:00https://health-pharma.ro/question/la-debutul-terapiei-cu-iec-ar-trebui-evaluate/2022-11-17T14:20:27+02:00https://health-pharma.ro/question/iec-sunt-indicate-pacientilor-post-infarct-de-miocard-apartinand-urmatoarelor-categorii/2022-11-17T14:21:06+02:00https://health-pharma.ro/question/blocantii-receptorilor-angiotensinei-prezinta-urmatoarele-efecte-adverse-generate-de-excesul-de-bradikinina/2022-11-17T14:21:45+02:00https://health-pharma.ro/question/prezinta-risc-de-hiperpotasemie-asocierile/2022-11-17T14:22:22+02:00https://health-pharma.ro/question/se-poate-adauga-un-bra-la-pacienti-cu-icfer-care-raman-simptomatici-in-urma-tratamentului-cu-iec-si-b-blocant-doar-daca-nu-se-pot-utiliza/2022-11-17T14:22:51+02:00https://health-pharma.ro/question/in-cursul-tratamentului-cu-bra-se-monitorizeaza-la-1-2-saptamani/2022-11-17T14:23:41+02:00https://health-pharma.ro/question/selectati-enunturile-corecte-referitoare-la-recomandarile-ghidurilor-privind-utilizarea-beta-blocantelor-in-insuficienta-cardiaca/2022-11-17T14:24:34+02:00https://health-pharma.ro/question/singurele-b-blocante-care-au-dovedit-reducerea-mortalitatii-in-studii-clinice-dedicate-insuficientei-cardiace-sunt/2022-07-11T21:10:12+03:00https://health-pharma.ro/question/eplerenona-se-evita-la-pacientii-cu/2022-11-17T14:26:31+02:00https://health-pharma.ro/question/dozele-mici-de-antagonisti-ai-aldosteronului-pot-fi-potrivite-pentru/2022-11-17T14:27:10+02:00https://health-pharma.ro/question/reactiile-adverse-ale-spironolactonei-datorate-interactiunii-cu-receptorii-androgenici-si-progesteronici-sunt/2022-11-17T14:27:41+02:00https://health-pharma.ro/question/mecanismele-benefice-ale-asocierii-hidralazina-isosorbid-dinitrat-in-insuficienta-cardiaca-par-a-fi-datorate/2022-11-17T14:28:58+02:00https://health-pharma.ro/question/combinatia-sacubitril-valsartan-utilizata-in-insuficienta-cardiaca-are-urmatoarele-mecanisme-de-actiune/2022-11-17T14:29:29+02:00https://health-pharma.ro/question/peptidele-natriuretice-endogene-produc/2022-11-17T14:30:06+02:00https://health-pharma.ro/question/sunt-indicatii-terapeutice-ale-asocierii-sacubitril-valsartan/2022-11-17T14:30:35+02:00https://health-pharma.ro/question/ivabradina/2022-11-17T14:31:16+02:00https://health-pharma.ro/question/cele-mai-frecvente-reactii-adverse-ale-ivabradinei-sunt/2022-11-17T14:31:46+02:00https://health-pharma.ro/question/ivabradina-este-indicata-pentru-reducerea-riscului-de-spitalizare-in-urma-agravarii-insuficientei-cardiace-la-pacienti-cu-fevs-35-care/2022-11-17T14:32:22+02:00https://health-pharma.ro/question/hidralazina-2/2022-11-17T14:32:50+02:00https://health-pharma.ro/question/intreruperea-tratamentului-cu-digoxinx-in-insuficienta-cardiaca-se-ia-in-considerare-la-pacientii-asimptomatici-care-prezinta/2022-11-17T14:34:07+02:00https://health-pharma.ro/question/necesita-administrarea-unei-doze-de-0125-mg-digoxina-la-doua-zile-pacientii/2022-11-17T14:34:35+02:00https://health-pharma.ro/question/este-inhibitor-direct-al-factorulul-xa-liber-si-legat-de-trombina/2022-07-11T21:19:51+03:00https://health-pharma.ro/question/este-inhibitor-direct-al-factorului-xa-liber-sl-legat-de-trombina/2022-11-17T14:36:18+02:00https://health-pharma.ro/question/inhiba-direct-selectiv-si-reversibil-factorul-ii-al-coagularii/2022-11-17T14:37:15+02:00https://health-pharma.ro/question/pentru-a-neutraliza-rapid-efectul-dabigatranulul-so-utilizeaza/2022-11-17T14:37:49+02:00https://health-pharma.ro/question/cea-mai-utilizata-metoda-de-monitorizare-a-hmmm-consta-in-determinarea/2022-11-17T14:38:24+02:00https://health-pharma.ro/question/la-pacientil-fir-cancer-tratamentul-acut-cu-hmmm-este-continuat-dupa-o-pauzi-de-5-10-zilecu/2022-05-06T13:34:41+03:00https://health-pharma.ro/question/hemoragiile-majore-date-de-fimmm-se-trateazi-cu/2022-11-17T14:39:55+02:00https://health-pharma.ro/question/inhiba-forma-redusa-a-vitamine-k-si-procesul-de-formare-al-factorilor-de-coagulare-dependenti-de-vitamina-k/2022-11-17T14:58:03+02:00https://health-pharma.ro/question/previne-generarea-trombilor-si-formarea-cheagurilor-prin-inhibarea-indirecta-a-activitatiifactorului-xa/2022-11-17T14:58:46+02:00https://health-pharma.ro/question/heparina-mefractionata-nu-inhiba-activitatea-factorului-coagularii/2022-11-17T14:59:26+02:00https://health-pharma.ro/question/este-o-reactie-imunologica-indusa-de-heparinane-fractionata/2022-11-17T15:01:22+02:00https://health-pharma.ro/question/este-utilizat-ca-trombolitie/2022-11-17T15:01:54+02:00https://health-pharma.ro/question/tratamentul-trombolitie-este-indicat/2022-11-17T15:02:40+02:00https://health-pharma.ro/question/pentru-diagnostical-trombocitopeniei-indusa-de-heparina-este-necesara-determinarea/2022-07-11T21:29:00+03:00https://health-pharma.ro/question/doza-de-rivaroxaban-administrata-oral-postchirurgie-ortopedica-este/2022-11-17T15:05:01+02:00https://health-pharma.ro/question/doza-de-rivaroxaban-administrata-oral-pentru-tratamentul-tev-acut-este/2022-11-17T15:05:28+02:00https://health-pharma.ro/question/doza-de-dabigatran-pentru-tratamentul-tev-acut-este/2022-11-17T15:05:51+02:00https://health-pharma.ro/question/doza-de-edoxaban-pentru-tratamentul-tev-acut-este/2022-11-17T15:06:14+02:00https://health-pharma.ro/question/sindromul-degetelor-rosii-de-la-picioare-este-reactie-adversa-specifica-pentru/2022-11-17T15:06:44+02:00https://health-pharma.ro/question/nu-exista-antidot-specific-pentru/2022-11-17T15:07:18+02:00https://health-pharma.ro/question/favorizeaza-conversia-plasminogenului-in-plasmina/2022-11-17T15:07:45+02:00https://health-pharma.ro/question/la-pacientii-fara-tromboembolism-venos-si-cancer-tratamentul-acut-cu-hmmm-este-continuat-cu-warfarina-dupa-o-pauza-de/2022-11-17T15:08:18+02:00https://health-pharma.ro/question/riscul-de-hemoragii-majore-pentru-dabigatran-este-comparabil-cu-cel-produs-de/2022-11-17T15:08:58+02:00https://health-pharma.ro/question/durata-tratamentului-initial-cu-anticoagulante-pentru-primul-episod-acut-de-tromboembolism-venos-in-cazul-tuturor-pacientilor-este/2022-11-17T15:09:28+02:00https://health-pharma.ro/question/studiile-clinice-sustin-profilaxia-tromboembolismului-venos-in-cazul-operatiel-pentru-inlocuirea-completa-de-sold-timp-de/2022-11-17T15:09:57+02:00https://health-pharma.ro/question/recomandarile-pentru-profilaxia-tromboembolismul-venos-ulterioare-operatiei-de-inlocuire-a-articulatiei-pot-include/2022-11-17T15:10:38+02:00https://health-pharma.ro/question/nu-necesita-monitorizarea-anticoagularii/2022-11-17T15:11:07+02:00https://health-pharma.ro/question/sunt-avantaje-ale-heparinelor-cu-masa-moleculara-mica-fata-de-heparina-nefractionata/2022-11-17T15:11:41+02:00https://health-pharma.ro/question/sunt-avantaje-ale-heparinelor-cu-masl-moleculara-micafata-de-heparina-nefractionati/2022-11-17T15:13:05+02:00https://health-pharma.ro/question/alegeti-variantele-de-raspuns-corecte-2/2022-11-17T15:14:37+02:00https://health-pharma.ro/question/salfatul-de-protamina-este-utilizat-pentru-tratamentul-hemoragiilor-produse-de/2022-07-11T21:44:41+03:00https://health-pharma.ro/question/selectati-derele-corecte-pentru-fondaparinux/2022-07-11T21:45:33+03:00https://health-pharma.ro/question/heparinele-cu-masd-moleculara-mici/2022-11-17T15:17:07+02:00https://health-pharma.ro/question/initierea-terapiel-cu-hmmm-se-face-dupa-determinarea-parametrilor/2022-07-11T21:47:30+03:00https://health-pharma.ro/question/fondaparinux/2022-11-17T15:18:41+02:00https://health-pharma.ro/question/heparina-nefractionata/2022-11-17T15:19:41+02:00https://health-pharma.ro/question/warfarina/2022-11-17T15:20:52+02:00https://health-pharma.ro/question/au-indicatie-terapeutica-pentru-tratamentul-tev-post-chirurgie-ortopedica/2022-11-17T15:21:24+02:00https://health-pharma.ro/question/au-indicatii-aprobate-pentru-tratamentul-tev-post-chirurgie-ortopedica-urmatoarele-anticoagulante-orale-directe-aod/2022-11-17T15:21:56+02:00https://health-pharma.ro/question/anticoagulantele-orale-directe-utilizate-pentru-tratamentul-tev-acut-sunt/2022-11-17T15:22:30+02:00https://health-pharma.ro/question/anticoagulantele-orale-directe-indicate-in-tratamentul-extins-al-tev-dupa-primele-6-luni-de-terapie-anticoagulanta-sunt/2022-11-17T15:22:51+02:00https://health-pharma.ro/question/dabigatranul-are-urmatoarele-indicatii-aprobate/2022-11-17T15:23:19+02:00https://health-pharma.ro/question/apixaban-se-utilizeaza-in-doza-de-25-mg-x-2-zi-pentru/2022-11-17T15:23:43+02:00https://health-pharma.ro/question/dozele-recomandate-de-rivaroxaban-pentru-tratamentul-tev-acut-sunt/2022-11-17T15:24:20+02:00https://health-pharma.ro/question/dozele-recomandate-de-apixaban-pentru-tratamentul-tev-acut-sunt/2022-11-17T15:24:50+02:00https://health-pharma.ro/question/alegeti-variantele-corecte-de-raspuns-referitoare-lahmmm-utilizate-in-tratamentul-tev/2022-07-11T21:52:59+03:00https://health-pharma.ro/question/nu-sunt-anticoagulante-orale-directe/2022-11-17T15:25:41+02:00https://health-pharma.ro/question/monitorizarea-terapiei-cu-hmmm-este-necesara-la-pacientii-cu/2022-11-17T15:26:08+02:00https://health-pharma.ro/question/sunt-reactii-adverse-ale-heparinei-nefractionate/2022-11-17T15:26:36+02:00https://health-pharma.ro/question/pentru-tratamentul-sangerarilor-majore-induse-de-warfarina-se-administreaza/2022-11-17T15:27:12+02:00https://health-pharma.ro/question/este-agonist-b2-adrenergic-inhalator-cu-durata-scurta-deactiune-utilizat-in-astmul-bronsic/2022-11-20T09:46:00+02:00https://health-pharma.ro/question/este-agonist-b2-adrenergic-inhalator-cu-durata-lunga-deactiune-utilizat-in-astmul-bronsic/2022-11-20T09:45:15+02:00https://health-pharma.ro/question/este-agonist-b2-adrenergic-inhalator-cu-durata-ultra-lunga-deactiune-utilizat-in-astmul-bronsic/2022-11-20T09:46:15+02:00https://health-pharma.ro/question/tratamentul-intermitent-cu-agonisti-b2-adrenergici-inhalatori-cu-durata-scurta-de-actiune-consta-in-administrareaurmatoarelor-doze/2022-11-20T09:47:02+02:00https://health-pharma.ro/question/pentru-perioadele-intermitente-de-bronhospasm-este-preferata-administrarea-de/2022-11-20T09:48:28+02:00https://health-pharma.ro/question/este-un-corticosteroid-inhalator-utilizat-in-astmul-bronsic/2022-11-20T09:49:43+02:00https://health-pharma.ro/question/este-un-corticosteroid-sistemic-utilizat-in-astmul-bronsic/2022-11-20T09:50:09+02:00https://health-pharma.ro/question/inhiba-5-lipooxigenaza/2022-11-20T09:50:39+02:00https://health-pharma.ro/question/stimuleaza-clearance-ul-teofilinei/2022-11-20T09:52:11+02:00https://health-pharma.ro/question/inhiba-clearance-ul-teofilinei/2022-11-20T09:53:38+02:00https://health-pharma.ro/question/produce-bronhodilatatie-numai-in-cazul-bronhoconstrictiei-mediate-colinergic/2022-11-20T09:54:23+02:00https://health-pharma.ro/question/este-antagonist-oral-al-receptorilor-pentru-leucotriene/2022-11-20T09:55:14+02:00https://health-pharma.ro/question/este-anticorp-anti-ige/2022-11-20T09:56:02+02:00https://health-pharma.ro/question/simptomele-astmului-bronsic-se-amelioreaza-dupa-1-2saptamani-de-tratament-cu/2022-11-20T09:56:39+02:00https://health-pharma.ro/question/are-metabolizare-predominant-hepatica-cu-cyp1a2-sicyp3a4/2022-11-20T09:57:16+02:00https://health-pharma.ro/question/sunt-agonisti-b2-adrenergici-cu-durata-ultralunga-de-actiune-efect-24-ore/2022-11-20T09:58:15+02:00https://health-pharma.ro/question/selectati-enunturile-corecte-pentru-agonistii-b2-adrenergici-utilizati-in-astmul-bronsic/2022-11-20T09:59:21+02:00https://health-pharma.ro/question/agonistii-b2-adrenergici-inhalatori-cu-durata-scurta-de-actiune-sunt-indicati-pentru/2022-11-20T10:00:04+02:00https://health-pharma.ro/question/sunt-agonisti-b2-adrenergici-cu-durata-lunga-de-actiune-durata-12-ore/2022-11-20T10:00:40+02:00https://health-pharma.ro/question/in-astmul-nocturn-se-prefera-administrarea-de/2022-11-20T10:01:18+02:00https://health-pharma.ro/question/sunt-corticosteroizi-inhalatori-utilizati-in-astmul-bronsic/2022-11-20T10:02:28+02:00https://health-pharma.ro/question/sunt-corticosteroizi-inhalatori-utilizati-in-astmul-bronsic-2/2022-11-20T10:02:49+02:00https://health-pharma.ro/question/sunt-corticosteroizi-sistemici-utilizati-in-astmul-bronsic/2022-11-20T10:03:21+02:00https://health-pharma.ro/question/terapia-de-electie-pentru-controlul-pe-termen-lung-al-astmului-bronsic-persistent-consta-in-administrarea-de/2022-11-20T10:04:02+02:00https://health-pharma.ro/question/sunt-efecte-adverse-ale-sulfatului-de-magneziu-administrat-in-perfuzie-i-v-in-astmul-bronsic/2022-11-20T10:04:47+02:00https://health-pharma.ro/question/sulfatul-de-magneziu/2022-11-20T10:05:38+02:00https://health-pharma.ro/question/selectati-raspunsurile-corecte-pentru-anticolinergicele-utilizate-in-astm-bronsle/2022-11-20T10:06:46+02:00https://health-pharma.ro/question/reduce-clearance-ul-teofilinci/2022-11-20T10:07:19+02:00https://health-pharma.ro/question/redue-clearance-ul-teofilinei/2022-07-11T22:31:27+03:00https://health-pharma.ro/question/crese-clearance-al-teofilinei/2022-05-06T13:12:17+03:00https://health-pharma.ro/question/teofillna-se-blotransforma-cu/2022-05-06T13:43:01+03:00https://health-pharma.ro/question/metilxantinele/2022-11-20T10:12:14+02:00https://health-pharma.ro/question/sunt-antagonisti-orali-ai-receptorilor-pentru-leucotriene/2022-11-20T10:12:48+02:00https://health-pharma.ro/question/pot-produce-sindrom-idiosincrazie-similar-sindromului-churg-strauss/2022-11-20T10:13:52+02:00https://health-pharma.ro/question/antileucotrienele-administrate-in-astm/2022-11-20T10:14:58+02:00https://health-pharma.ro/question/zileuton-are-utilizare-limitata-din-cauza/2022-11-20T10:16:15+02:00https://health-pharma.ro/question/posologia-omalizumabului-se-stabileste-in-functie-de/2022-11-20T10:16:49+02:00https://health-pharma.ro/question/sunt-efecte-adverse-locale-ale-corticosteroizilor-inhalatori/2022-11-20T10:17:24+02:00https://health-pharma.ro/question/selectati-variantele-corecte-de-raspuns-pentru-corticosteroiziiinhalatori-utilizati-in-astm/2022-11-20T10:18:38+02:00https://health-pharma.ro/question/administrarea-agonistilor-b2-adrenergici-sub-forma-de-aerosoli-potenteaza/2022-11-20T10:19:16+02:00https://health-pharma.ro/question/sunt-corticosteroizi-utilizati-sistemic-in-astm/2022-11-20T10:19:58+02:00https://health-pharma.ro/question/ghidurile-cold-recomanda-vaccinul-antipneumococie-pacientilor-cu-bpoc-si-varsta-sub-65-ani-doar-daci/2022-11-20T10:22:15+02:00https://health-pharma.ro/question/terapia-farmacologica-in-bpoc-pentru-pacientii-cu-simptome-intermitente-si-risc-scazut-de-exacerbare-include/2022-11-20T10:23:12+02:00https://health-pharma.ro/question/este-agonist-bz-adrenergic-cu-durata-scurta-de-actiune/2022-11-20T10:23:53+02:00https://health-pharma.ro/question/inhiba-competitiv-receptorii-colinergici-de-la-nivelul-musculaturii-netede-bronsice/2022-11-20T10:24:26+02:00https://health-pharma.ro/question/este-anticolinergic-cu-durata-scurta-de-actiune-utilizat-in-bpoc/2022-11-20T10:25:13+02:00https://health-pharma.ro/question/poate-fi-necesara-cresterea-dozei-de-teofilina-la/2022-11-20T10:26:28+02:00https://health-pharma.ro/question/inhiba-selectiv-fosfodiesteraza-4/2022-11-20T10:27:46+02:00https://health-pharma.ro/question/este-o-reactie-adversa-sistemica-severa-a-corticosteroizilor-utilizati-in-bpoc/2022-11-20T10:28:30+02:00https://health-pharma.ro/question/selectati-patologia-care-creste-clearance-ul-teofilinei/2022-11-20T10:29:06+02:00https://health-pharma.ro/question/intervalul-terapeutic-optim-al-teofilinei-este/2022-11-20T10:30:26+02:00https://health-pharma.ro/question/sunt-b2-adrenomimetice-cu-durata-scurta-de-actiune-utilizatein-bpoc/2022-11-20T10:31:02+02:00https://health-pharma.ro/question/selectati-enunturile-corecte-referitoare-la-agonistii-selectivi-b2-adrenergici-utilizati-in-bpoc/2022-11-20T10:31:52+02:00https://health-pharma.ro/question/sunt-b2-adrenomimetice-cu-durata-lunga-de-actiune-utilizate-in-bpoc/2022-11-20T10:32:28+02:00https://health-pharma.ro/question/pentru-pacientii-din-categoria-a-cu-putine-simptome-si-riscuri-medicatia-de-prima-intentie-in-bpoc-stabila-include/2022-11-20T10:33:08+02:00https://health-pharma.ro/question/pentru-pacientii-din-categoria-b-cu-mai-multe-simptome-si-putine-riscuri-medicatia-de-prima-intentie-in-bpoc-stabila-include/2022-11-20T10:33:41+02:00https://health-pharma.ro/question/anticolinergicele-administrate-inhalator-in-bpoc-pot-produce-urmatoarele-reactii-adverse/2022-11-20T10:34:07+02:00https://health-pharma.ro/question/bromura-de-ipratropiu/2022-11-20T10:35:03+02:00https://health-pharma.ro/question/sunt-anticolinergice-cu-durata-lunga-de-actiune-utilizate-inbpoc/2022-11-20T10:35:38+02:00https://health-pharma.ro/question/utilizarea-cronica-a-teofilinei-in-bpoc-produce/2022-11-20T10:36:10+02:00https://health-pharma.ro/question/clearance-ul-teofilinei-scade-la-pacientii/2022-11-20T10:36:47+02:00https://health-pharma.ro/question/corticosteroizii-administrati-in-bpoc-produc/2022-11-20T10:38:03+02:00https://health-pharma.ro/question/situatii-adecvate-corticoterapiei-in-bpoc-sunt/2022-11-20T10:38:58+02:00https://health-pharma.ro/question/reactiile-adverse-ale-corticosteroizilor-inhalatori-administrati-in-bpoc-sunt/2022-11-20T10:39:41+02:00https://health-pharma.ro/question/reactiile-adverse-severe-produse-de-corticosteroizii-inhalatori-includ/2022-11-20T10:40:34+02:00https://health-pharma.ro/question/roflumilast/2022-11-20T10:41:32+02:00https://health-pharma.ro/question/antibioticele-recomandate-in-exacerbarile-bpoc-fara-complicatii-sunt/2022-11-20T10:42:20+02:00https://health-pharma.ro/question/antibioticele-nerecomandate-in-exacerbarile-bpoc-fara-complicatii-sunt/2022-11-20T10:42:49+02:00https://health-pharma.ro/question/selectati-variantele-corecte-de-raspuns-referitoare-la-corticoterapia-sistemica-in-bpoc-cu-exacerbari-acute/2022-11-20T10:43:21+02:00https://health-pharma.ro/question/oxigenoterapia-de-lunga-durata-se-aplica-pacientilor-cu-bpoc-daca/2022-11-20T10:43:49+02:00https://health-pharma.ro/question/metilxantinele-au-rol-limitat-in-bpoc-din-cauza/2022-11-20T12:19:36+02:00https://health-pharma.ro/question/selectati-doza-peste-care-pseudoefedrina-poate-produce-cresteri-ale-tensiunii-arteriale/2022-11-20T12:20:22+02:00https://health-pharma.ro/question/durata-terapiei-cu-decongestionante-nazale-nu-trebuie-sa-depaseasca/2022-11-20T12:20:45+02:00https://health-pharma.ro/question/prezinta-efect-sedativ-crescut-antihistaminicul/2022-11-20T12:21:24+02:00https://health-pharma.ro/question/prezinta-efect-anticolinergic-crescut-anthistaminicul/2022-11-20T12:21:59+02:00https://health-pharma.ro/question/este-antihistaminic-oftalmic-utilizat-in-conjunctivita-asociata-rinitei-alergice/2022-11-20T12:22:49+02:00https://health-pharma.ro/question/este-antihistaminic-oftalmic-utilizat-in-conjunctivita-asociata-rinitei-alergice-2/2022-11-20T12:23:25+02:00https://health-pharma.ro/question/prezinta-efect-sedativ-si-efect-anticolinergic-scazut-spre-absent-antihistaminicul/2022-11-20T12:24:22+02:00https://health-pharma.ro/question/inhiba-eliberarea-mediatorilor-inflamatiei/2022-11-20T12:24:55+02:00https://health-pharma.ro/question/poate-produce-rinita-medicamentoasa-la-administrare-prelungita-mai-mult-de-3-5-zile/2022-11-20T12:25:21+02:00https://health-pharma.ro/question/alegeti-decongestivul-care-se-poate-utiliza-atat-topic-cat-si-sistemic/2022-11-20T12:25:53+02:00https://health-pharma.ro/question/alegeti-decongestivul-care-poate-duce-la-aparitia-de-episoade-hipertensive-severe-la-asocierea-cu-inhibitori-de-monoaminooxidaza/2022-11-20T12:29:48+02:00https://health-pharma.ro/question/prezinta-efect-sedativ-scazut-antihistaminicele/2022-11-20T12:30:50+02:00https://health-pharma.ro/question/prezinta-efect-sedatiy-crescut-antihistaminicele/2022-11-20T12:32:37+02:00https://health-pharma.ro/question/prezinta-efect-anticolinergic-crescut-antihistaminicele/2022-11-20T12:33:13+02:00https://health-pharma.ro/question/prezinta-efect-anticolinergic-scazut-spre-absent-urmatoarele-clase-chimice-de-antihistaminice/2022-11-20T12:34:03+02:00https://health-pharma.ro/question/din-clasa-piperidinelor-periferic-selective-fac-parte-antihistaminicele/2022-11-20T12:34:39+02:00https://health-pharma.ro/question/sunt-antihistaminice-oftalmice/2022-11-20T12:35:07+02:00https://health-pharma.ro/question/azelastina/2022-11-20T12:35:30+02:00https://health-pharma.ro/question/sunt-antihistaminice-cu-administrare-intranazala/2022-11-20T12:36:03+02:00https://health-pharma.ro/question/efectele-anticolinergice-care-stau-la-baza-diminuarii-simptomelor-rinitei-alergice-prezente-la-unele-antihistaminice-sunt/2022-11-20T12:36:54+02:00https://health-pharma.ro/question/administrate-in-rinita-alergica-antihistaminicele-impiedica/2022-11-20T12:39:15+02:00https://health-pharma.ro/question/sunt-efecte-adverse-anticolinergice-ale-antihistaminicelor/2022-11-20T12:39:55+02:00https://health-pharma.ro/question/simpatomimeticele-administrate-in-rinita-alergica-produc/2022-11-20T12:40:36+02:00https://health-pharma.ro/question/reactiile-adverse-ale-decongestivelor-topice-sunt/2022-11-20T12:41:36+02:00https://health-pharma.ro/question/caracteristicile-farmacologice-ale-pseudoefedrinei-comparativ-cu-decongestivele-topice-sunt/2022-11-20T12:43:09+02:00https://health-pharma.ro/question/corticosteroizii-administrati-intranazal-in-rinita-alergica-produc/2022-11-20T12:44:30+02:00https://health-pharma.ro/question/in-cazul-rinitelor-persistente-ameliorarea-simptomelor-poate-sa-apara-dupa-2-4-saptamani-de-tratament-cu/2022-11-20T12:45:01+02:00https://health-pharma.ro/question/in-cazul-rinitelor-persistente-ameliorarea-simptomelor-poate-sa-apara-dupa-2-4-saptamani-de-tratament-cu-2/2022-11-20T12:45:28+02:00https://health-pharma.ro/question/sunt-mecanisme-de-actiune-ale-cromoglicatului-de-sodiu/2022-11-20T12:46:06+02:00https://health-pharma.ro/question/selectati-variantele-corecte-de-raspuns-referitoare-laimunoterapie/2022-11-20T12:46:54+02:00https://health-pharma.ro/question/scade-absorbtia-tetraciclinelor/2022-11-20T12:53:07+02:00https://health-pharma.ro/question/managementul-clinic-pentru-evitarea-interactiunii-dintre-antiacide-si-tetracicline-consta-in/2022-11-20T12:53:32+02:00https://health-pharma.ro/question/stimuleaza-metabolizarea-azolilor/2022-11-20T12:53:54+02:00https://health-pharma.ro/question/creste-ototoxicitatea-data-de-aminoglicozide-la-asociere-cu/2022-11-20T12:54:18+02:00https://health-pharma.ro/question/creste-ototoxicitatea-si-nefrotoxicitatea-aminoglicozidelor-la-asociere-cu/2022-11-20T12:54:48+02:00https://health-pharma.ro/question/se-monitorizeaza-functia-renala-la-asocierea-amfotericinei-b-cu/2022-11-20T12:55:16+02:00https://health-pharma.ro/question/apare-reactie-de-tip-disulfiram-la-asocierea-alcoolului-cu/2022-11-20T12:55:40+02:00https://health-pharma.ro/question/produce-prelungirea-intervalului-qtc-asocierea/2022-11-20T12:56:13+02:00https://health-pharma.ro/question/macrolidele-reduc-metabolizarea-pentru/2022-11-20T12:56:34+02:00https://health-pharma.ro/question/blocheaza-excretia-penicilinelor-si-cefalosporinelor/2022-11-20T12:56:56+02:00https://health-pharma.ro/question/medicamentul-de-prima-alegere-in-infectia-cu-bacteroides-fragilis-este/2022-11-20T12:57:36+02:00https://health-pharma.ro/question/in-meningita-data-de-escherichia-coli-tratamentul-de-prima-alegere-este/2022-11-20T12:57:59+02:00https://health-pharma.ro/question/in-infectia-cu-streptococ-din-grupurile-a-b-c-sau-gtratamentul-de-prima-alegere-este-reprezentat-de/2022-11-20T12:58:26+02:00https://health-pharma.ro/question/in-infectia-cu-neisseria-meningitidis-tratamentul-de-prima-alegere-este-reprezentat-de/2022-11-20T12:59:00+02:00https://health-pharma.ro/question/in-infectia-cu-moraxella-branhamella-catarrhalis-tratamentul-de-prima-alegere-este-reprezentat-de/2022-11-20T12:59:28+02:00https://health-pharma.ro/question/in-infectiile-cu-enterococcus-faecalis-tratamentul-de-prima-alegere-este-reprezentat-de-asocierea/2022-11-20T13:00:10+02:00https://health-pharma.ro/question/in-infectia-data-de-clostridium-difficile-tratamentul-de-prima-alegere-consta-in-administrarea-de/2022-11-20T13:00:37+02:00https://health-pharma.ro/question/in-infectiile-date-de-acinetobacter-spp-recomandarea-de-electie-prevede-administrarea-de-meropenem-asociat-cu/2022-11-20T13:01:06+02:00https://health-pharma.ro/question/este-recomandata-administrarea-tigeciclinei-in-infectiile-date-de/2022-11-20T13:01:37+02:00https://health-pharma.ro/question/in-infectiile-date-de-gardnerella-vaginalis-tratamentul-de-prima-alegere-consta-in-administrarea-de/2022-11-20T13:02:03+02:00https://health-pharma.ro/question/tratamentul-de-electie-in-infectiile-produse-de-stenotrophomonas-xanthomonas-maltophilia-include-administrarea-de/2022-11-20T13:02:37+02:00https://health-pharma.ro/question/tratamentul-de-electie-in-infectiile-produse-de-chlamydia-pneumoniae-include-administrarea-de/2022-11-20T13:03:08+02:00https://health-pharma.ro/question/tratamentul-de-electie-in-infectiile-produse-de-treponema-pallidum-include-administrarea-de/2022-11-20T13:03:37+02:00https://health-pharma.ro/question/tratamentul-de-alternativa-in-neurosifilisul-produs-de-treponema-pallidum-include-administrarea-de/2022-11-20T13:04:10+02:00https://health-pharma.ro/question/tratamentul-de-alternativa-in-infectia-produsa-de-mycoplasma-pneumoniae-include-administrarea-de/2022-11-20T13:04:35+02:00https://health-pharma.ro/question/selectati-fluorochinolonele-teofilinei/2022-05-06T13:40:56+03:00https://health-pharma.ro/question/tratamentele-de-electie-in-infectiile-date-de-enterococcus-faecalis-sunt/2022-11-20T13:36:02+02:00https://health-pharma.ro/question/reprezinta-tratamente-de-alternativa-in-infectiile-date-de-enterococcus-faecalis-administrarea-de/2022-11-20T13:36:30+02:00https://health-pharma.ro/question/asocierea-vancomicinei-in-infectiile-date-de-enterococcus-faecalis-se-face-cu/2022-11-20T13:36:56+02:00https://health-pharma.ro/question/pot-fi-active-in-infectiile-date-de-enterococcus-faecium/2022-11-20T13:37:40+02:00https://health-pharma.ro/question/quinupristin-dalfopristin-este-indicat-in-infectiile-produse-de/2022-11-20T13:38:23+02:00https://health-pharma.ro/question/in-infectiile-urinare-date-de-enterococcus-faecalis-tratamentul-se-face-cu/2022-11-20T13:39:27+02:00https://health-pharma.ro/question/in-infectiile-date-de-staphylococcus-aureus-meticilino-oxacilina-sensibil-se-recomanda-administrarea-de/2022-11-20T13:40:10+02:00https://health-pharma.ro/question/medicatia-de-prima-alegere-la-adulti-femei-in-afara-sarcinii-pentru-infectiile-date-de-staphylococcus-epidermidis-meticilino-oxacilina-rezistent-dobandit-in-comunitate-este-reprezentata-de/2022-11-20T13:40:41+02:00https://health-pharma.ro/question/nu-se-administreaza-copiilor-si-femeilor-insarcinate-cu-infectii-date-de-s-aureus-si-s-epidermidis-meticilino-oxacilinarezistent-dobandit-in-spital-sau-in-comunitate/2022-11-20T13:41:33+02:00https://health-pharma.ro/question/in-infectiile-date-de-streptococcus-grupurile-a-b-c-g-bovis-reprezinta-tratament-de-prima-alegere/2022-11-20T13:42:11+02:00https://health-pharma.ro/question/antibioticele-recomandate-pentru-infectiile-produse-de-streptococcus-viridans-sunt/2022-11-20T13:42:35+02:00https://health-pharma.ro/question/nu-se-administreaza-pacientilor-alergici-la-peniciline-cu-infectii-produse-de-streptococcus-viridans/2022-11-20T13:43:10+02:00https://health-pharma.ro/question/nu-se-administreaza-copiilor-si-femeilor-insarcinate-cu-infectii-produse-de-streptococcus-pneumoniae-penicilinorezistent/2022-11-20T13:43:55+02:00https://health-pharma.ro/question/se-administreaza-in-infectiile-branhamella-catarrhalis/2022-11-20T13:44:37+02:00https://health-pharma.ro/question/sunt-cefalosporine-orale-de-generatia-a-ii-a-administrate-in-infectiile-produse-de-moraxella-branhamella-catarrhalis/2022-11-20T13:45:26+02:00https://health-pharma.ro/question/sunt-cefalosporine-orale-de-generatia-a-ii-a-administrate-in-infectiile-produse-de-moraxella-branhamella-catarrhalis-2/2022-11-20T13:45:49+02:00https://health-pharma.ro/question/sunt-cefalosporine-orale-de-generatia-a-iii-a-administrate-in-infectiile-produse-de-moraxella-branhamella-catarrhalis/2022-11-20T13:46:22+02:00https://health-pharma.ro/question/sunt-cefalosporine-orale-de-generatia-a-iii-a-administrate-in-infectiile-produse-de-moraxella-branhamella-catarrhalis-2/2022-11-20T13:46:42+02:00https://health-pharma.ro/question/sunt-cefalosporine-orale-de-generatia-i-administrate-in-infectiile-produse-de-streptococcus-grupurile-a-b-c-g-bovis/2022-11-20T13:47:07+02:00https://health-pharma.ro/question/infectia-gonococica-diseminata-data-de-neisseria-gonorrhoeae-are-ca-tratament-de-electie-cefalosporinele/2022-11-20T13:47:50+02:00https://health-pharma.ro/question/in-infectiile-produse-de-neisseria-meningitidis-la-pacientii-fara-alergie-la-b-lactamine-se-recomanda-administrarea-de/2022-11-20T13:48:34+02:00https://health-pharma.ro/question/in-infectiile-produse-de-clostridium-difficile-se-recomanda-administrarea-de/2022-11-20T13:49:09+02:00https://health-pharma.ro/question/in-infectiile-produse-de-clostridium-perfringens-serecomanda-administrarea-de/2022-11-20T13:49:47+02:00https://health-pharma.ro/question/tratamentul-de-prima-alegere-in-infectiile-produse-de-clostridium-perfringens-consta-in-administrarea-de/2022-11-20T13:50:14+02:00https://health-pharma.ro/question/in-infectiile-date-de-acinetobacter-spp-se-recomanda-asocierea-amikacinei-cu/2022-11-20T13:50:55+02:00https://health-pharma.ro/question/metronidazolul-este-considerat-tratament-de-prima-alegere-in-infectiile-produse-de/2022-11-20T13:51:34+02:00https://health-pharma.ro/question/medicatia-de-prima-alegere-in-meningitele-date-de-escherichia-coli-este-reprezentata-de/2022-11-20T13:52:07+02:00https://health-pharma.ro/question/in-infectiile-severe-date-de-enterobacter-spp-se-recomanda-asocierea-aminoglicozidelor-cu/2022-11-20T13:52:31+02:00https://health-pharma.ro/question/tratamentul-de-prima-alegere-recomandat-in-infectiile-urinare-produse-de-escherichia-coli-consta-in-administrarea-de/2022-11-20T13:53:22+02:00https://health-pharma.ro/question/in-infectiile-date-de-gardnerella-vaginalis-este-recomandat-tratamentul-cu/2022-11-20T13:53:53+02:00https://health-pharma.ro/question/in-meningita-data-de-haemophilus-influenzae-tratamentul-de-electie-recomanda-la-pacientii-fara-alergie-la-b-lactamineadministrarea-de/2022-11-20T13:54:30+02:00https://health-pharma.ro/question/fluorochinolonele-recomandate-in-infectiile-produse-de-klebsiella-pneumoniae-sunt/2022-11-20T13:55:14+02:00https://health-pharma.ro/question/in-infectiile-date-de-legionella-spp-tratamentul-de-electie-recomanda-asocierea-eritromicinei-cu/2022-11-20T13:56:43+02:00https://health-pharma.ro/question/asocierea-trimetoprim-sulfametoxazol-este-recomandata-in-infectiile-produse-de/2022-11-20T13:57:47+02:00https://health-pharma.ro/question/in-infectiile-date-de-enterobacter-spp-sunt-recomandate-asocierile/2022-11-20T13:58:33+02:00https://health-pharma.ro/question/in-infectiile-produse-de-klebsiella-pneumoniae-sunt-de-electie-cefalosporinele/2022-11-20T13:59:06+02:00https://health-pharma.ro/question/in-infectiile-produse-de-klebsiella-pneumoniae-sunt-recomandate-antibioticele/2022-11-20T13:59:26+02:00https://health-pharma.ro/question/medicatia-de-prima-alegere-in-infectiile-produse-de-pasteurella-multocida-consta-in-administrarea-de/2022-11-20T13:59:59+02:00https://health-pharma.ro/question/in-infectiile-produse-de-pasteurella-multocida-se-recomandaadministrarea-antibioticelor/2022-11-20T14:00:25+02:00https://health-pharma.ro/question/in-infectiile-produse-de-proteus-mirabilis-sunt-recomandate-antibioticele/2022-11-20T14:00:58+02:00https://health-pharma.ro/question/in-infectiile-produse-de-proteus-indol-pozitiv-tratamentul-deprima-alegere-komanda-cefalosporinele/2022-11-20T14:01:40+02:00https://health-pharma.ro/question/in-infectiile-produse-de-proteus-vulgaris-sunt-recomandate-ca-tratament-de-alternativa/2022-11-20T14:01:57+02:00https://health-pharma.ro/question/in-infectiile-produse-de-morganellamorganii-suntrecomandate-ca-tratament-de-alternativa/2022-11-20T14:02:48+02:00https://health-pharma.ro/question/aztreonamul-este-indicat-in-infectiile-date-de/2022-11-20T14:03:15+02:00https://health-pharma.ro/question/sunt-recomandate-ca-tratament-de-electie-exclusiv-in-infectiile-urinare-produse-de-pseudomonas-aeruginosa/2022-11-20T14:03:44+02:00https://health-pharma.ro/question/in-infectiile-sistemice-produse-de-pseudomonas-aeruginosa-cefalosporinele-recomandate-ca-tratament-de-prima-alegere-sunt/2022-11-20T14:04:58+02:00https://health-pharma.ro/question/in-infectiile-sistemice-produse-de-pseylomonas-aeruginosa-ca-tratament-de-prima-alegere-sunt-recomandate-antibioticele/2022-05-06T13:33:35+03:00https://health-pharma.ro/question/n-infectiile-sistemice-produse-de-pseudomonas-aeruginosa-ca-tratament-de-prima-alegere-sunt-recomandate-antibioticele/2022-11-20T14:08:12+02:00https://health-pharma.ro/question/tratamentul-de-electie-in-infectiile-produse-de-salmonella-typhi-include/2022-11-20T14:08:35+02:00https://health-pharma.ro/question/tratamentul-de-electie-in-infectiile-produse-de-serratia-marcescens-include-cefalosporinele/2022-11-20T14:09:12+02:00https://health-pharma.ro/question/tratamentul-de-electie-in-infectiile-produse-de-serratia-marcescens-include-fluorochinolonele/2022-11-20T14:09:31+02:00https://health-pharma.ro/question/in-infectiile-produse-de-chlamydia-pneumoniae-sunt-recomandate-antibioticele/2022-11-20T14:10:12+02:00https://health-pharma.ro/question/in-infectiile-produse-de-chlamydia-pneumoniae-sunt-recomandate-fluorochinolonele/2022-11-20T14:10:41+02:00https://health-pharma.ro/question/tratamentul-de-prima-alegere-in-infectiile-produse-de-chlamidia-trachomatis-include-administrarea-de/2022-11-20T14:11:57+02:00https://health-pharma.ro/question/tratamentul-de-alternativa-in-infectiile-produse-de-chlamidia-trachomatis-include-administrarea-de/2022-11-20T14:12:18+02:00https://health-pharma.ro/question/in-sifilisul-primar-sau-secundar-produs-de-treponema-pallidum-tratamentul-de-alternativa-include-administrarea-de/2022-11-20T14:12:55+02:00https://health-pharma.ro/question/tratamentul-de-electie-in-infectiile-produse-de-borrelia-burgdorferi-recomanda-administrarea-de/2022-11-20T14:13:25+02:00https://health-pharma.ro/question/este-necesara-monitorizarea-concentratilor-plasmatice-ale-aminoglicozidelor-si-a-functiei-renale-la-asocierea-acestora-cu/2022-11-20T14:14:04+02:00https://health-pharma.ro/question/este-necesara-monitorizarea-concentratiilor-plasmatice-ale-aminoglicozidelor-si-a-functiei-renale-la-asocierea-acestora-cu/2022-11-20T14:14:25+02:00https://health-pharma.ro/question/este-necesara-monitorizarea-functiei-renale-la-asocierea-amfotericinei-b-cu/2022-11-20T14:14:57+02:00https://health-pharma.ro/question/este-necesara-monitorizarea-functiei-renale-la-asocierea-amfotericinei-b-cu-2/2022-11-20T14:15:14+02:00https://health-pharma.ro/question/cloramfenicol-reduce-metabolizarea-pentru/2022-11-20T14:15:40+02:00https://health-pharma.ro/question/macrolidele-reduc-metabolizarea-pentru-2/2022-11-20T14:16:06+02:00https://health-pharma.ro/question/izoniazida-reduce-metabolizarea-pentru/2022-11-20T14:16:41+02:00https://health-pharma.ro/question/blocheaza-excretia-b-lactaminelor/2022-11-20T14:17:07+02:00https://health-pharma.ro/question/fluorochinolonele-care-reduc-metabolizarea-teofilinei/2022-11-20T14:18:34+02:00https://health-pharma.ro/question/reduc-absorbtia-chinolonelor-antimicrobiene/2022-11-20T14:19:35+02:00https://health-pharma.ro/question/reduc-absorbtia-tetraciclinei/2022-11-20T14:19:56+02:00https://health-pharma.ro/question/are-loc-prelungirea-intervalului-qt-la-asocierea-chinolonelor-antibacteriene-cu/2022-11-20T14:20:37+02:00https://health-pharma.ro/question/rifampicina-creste-metabolizarea-pentru/2022-11-20T14:21:11+02:00https://health-pharma.ro/question/rifampicina-creste-metabolizarea-pentru-antiviralele/2022-11-20T14:21:33+02:00https://health-pharma.ro/question/rifampicina-creste-metabolizarea-pentru-2/2022-11-20T14:21:52+02:00https://health-pharma.ro/question/rifampicina-creste-metabolizarea-pentru-3/2022-11-20T14:23:09+02:00https://health-pharma.ro/question/sulfamidele-antibacteriene-reduc-metabolizarea-pentru/2022-11-20T14:23:40+02:00https://health-pharma.ro/question/terapia-empirica-initiala-de-electie-pentru-tratamentul-rinosinuzitei-acute-bacteriene-la-copii-presupune-administrarea-de/2022-11-20T15:07:38+02:00https://health-pharma.ro/question/terapia-insectiilor-severe-ce-necesita-spitalizare-in-cazul-rinosinuzitei-acute-bacteriene-la-copii-presupune-administrarea-de/2022-07-12T10:48:18+03:00https://health-pharma.ro/question/in-cazul-alergiei-de-tip-1-la-beta-lactamine-pentru-tratamentul-rinosinuzitei-acute-bacteriene-la-copii-se-administreaza/2022-11-20T15:10:03+02:00https://health-pharma.ro/question/terapia-empirica-initiala-de-electie-pentru-tratamentul-rinosinuzitei-acute-bacteriene-la-adulti-presupune-administrarea-de/2022-11-20T15:10:41+02:00https://health-pharma.ro/question/terapia-empirica-initiala-de-electie-pentru-tratamentul-rinosinuzitei-acute-bacteriene-la-adulti-presupune-administrarea-de-2/2022-11-20T15:11:17+02:00https://health-pharma.ro/question/in-cazul-alergiei-la-beta-lactamine-pentru-tratamentul-rinosinuzitei-acute-bacteriene-la-adulti-se-administreaza/2022-11-20T15:11:45+02:00https://health-pharma.ro/question/antibioticul-preferat-in-faringita-acuta-sbhga-este/2022-11-20T15:12:17+02:00https://health-pharma.ro/question/durata-tratamentului-cu-benzatin-penicilina-g-in-faringita-acuta-sbhga-la-copil-este/2022-11-20T15:12:47+02:00https://health-pharma.ro/question/durata-tratamentului-cu-penicilina-v-in-faringita-acuta-sbhga-la-adult-si-copil-este/2022-11-20T15:13:31+02:00https://health-pharma.ro/question/tratamentul-antibiotic-de-electie-in-otita-medie-acuta-este-reprezentat-de/2022-11-20T15:14:07+02:00https://health-pharma.ro/question/daca-tratamentul-cu-amoxicilina-in-otita-medie-esueaza-ar-trebui-sa-se-aleaga/2022-11-20T15:14:31+02:00https://health-pharma.ro/question/nu-reprezinta-tratament-de-a-doua-linie-sau-la-pacienti-cu-alergie-non-severa-la-peniciline-in-otita-medie-cefalosporina/2022-11-20T15:14:51+02:00https://health-pharma.ro/question/daca-pacientul-a-primit-amoxicilina-in-ultimele-30-de-zile-si-are-conjunctivita-purulenta-concomitenta-tratamentul-de-electie-in-otita-medie-acuta-include-administrarea-de/2022-11-20T15:15:12+02:00https://health-pharma.ro/question/se-utilizeaza-pentru-eradicarea-infectiei-cu-sbhga-la-purtatorii-cronici/2022-11-20T15:16:24+02:00https://health-pharma.ro/question/doza-unica-de-benzatin-penicilina-g-recomandata-in-faringita-acuta-sbhga-la-copii-cu-greutatea-sub-27-kg-este/2022-11-20T15:16:59+02:00https://health-pharma.ro/question/doza-unica-de-benzatin-penicilina-g-recomandata-in-faringita-acuta-sbhga-la-copii-cu-greutatea-peste-27-kg-este/2022-11-20T15:17:25+02:00https://health-pharma.ro/question/selectati-schema-corecta-de-tratament-pentru-eradicarea-infectiei-cu-sbhga-la-purtatorii-cronici/2022-11-20T15:18:18+02:00https://health-pharma.ro/question/pentru-eradicarea-infectiei-cu-sbhga-la-purtatorii-cronici-penicilina-v-si-benzatin-penicilina-g-se-asociazi-cu/2022-11-20T15:19:49+02:00https://health-pharma.ro/question/pentru-tratamentul-rinosinuzitei-bacteriene-acute-la-copiiclindamicina-se-poate-asocia-cu-cefalosporina/2022-11-20T15:21:04+02:00https://health-pharma.ro/question/pentru-tratamentul-rinosinuzitei-acute-la-copii-nu-sunt-necesare-doze-mai-mari-amoxicilina-clavulanat-in-situatia/2022-11-20T15:23:09+02:00https://health-pharma.ro/question/terapia-empirica-initiala-de-electie-si-de-a-doua-linie-in-rinosinuzita-bacteriana-acuta-la-adulti-include/2022-11-21T18:55:16+02:00https://health-pharma.ro/question/tratamentul-infectiilor-severe-care-necesita-spitalizare-din-rinosinuzita-bacteriana-acuta-la-adulti-include-antibioticele/2022-11-21T18:55:44+02:00https://health-pharma.ro/question/tratamentul-infectiilor-severe-care-necesita-spitalizare-din-rinosinuzita-bacteriana-acuta-la-adulti-include-antibioticele-2/2022-11-21T18:55:58+02:00https://health-pharma.ro/question/in-cazul-alergiei-la-beta-lactamine-tratamentul-rinosinuzitei-acute-bacteriene-la-adulti-se-face-cu/2022-11-21T18:56:38+02:00https://health-pharma.ro/question/selectati-posologia-corecta-pentru-antibioticele-utilizate-in-infectiile-severe-care-necesita-spitalizare-din-rinosinuzita-bacteriana-acuta-la-adulti/2022-11-21T18:57:25+02:00https://health-pharma.ro/question/asocierea-amoxicilina-clavulanat-se-utilizeaza-pentru-tratamentul-rinosinuzitei-bacteriene-acute-la-adulti-in-doza-de-2000-mg-125-mg-de-2-ori-zi-oral-in-urmatoarele-situatii/2022-11-21T18:58:06+02:00https://health-pharma.ro/question/in-tratamentul-rinosinuzitei-acute-la-adulti-posologia-doxiciclinei-este/2022-11-21T18:58:52+02:00https://health-pharma.ro/question/selectati-schemele-posologice-corecte-pentru-asocierea-amoxicilina-clavulanat-ce-pot-fi-utilizate-in-tratamentul-rinosinuzitei-acute-la-adulti/2022-11-21T18:59:46+02:00https://health-pharma.ro/question/selectati-schemele-posologice-corecte-pentru-asocierea-amoxicilina-clavulanat-ce-pot-fi-utilizate-in-tratamentul-rinosinuzitei-acute-la-copii/2022-11-21T19:00:08+02:00https://health-pharma.ro/question/asocierea-dintre-clindamicina-si-cefixima-sau-cefpodoxima-pentru-tratamentul-rinosinuzitei-acute-la-copii-se-face-inurmatoarele-situatii/2022-11-21T19:00:53+02:00https://health-pharma.ro/question/pentru-tratamentul-rinosinuzitei-acute-bacteriene-la-copil-in-cazul-riscului-de-rezistenta-la-antibiotice-sau-esec-al-terapiei-initiale-se-utilizeaza/2022-11-21T19:01:38+02:00https://health-pharma.ro/question/selectati-posologia-corecta-pentru-antibioticele-utilizate-in-infectiile-severe-care-necesita-spitalizare-din-rinosinuzita-bacteriana-acuta-la-copii/2022-11-21T19:02:19+02:00https://health-pharma.ro/question/sunt-necesare-doze-mai-mari-de-amoxicilina-clavulanat-pentru-tratamentul-rinosinuzitei-acute-in-urmatoarele-situatii/2022-11-21T19:03:09+02:00https://health-pharma.ro/question/sunt-necesare-doze-mai-mari-de-amoxicilina-clavulanat-pentru-tratamentul-rinosinuzitei-acute-la-urmatoarele-categorii-de-populatie/2022-11-21T19:03:48+02:00https://health-pharma.ro/question/levofloxacina-se-administreaza-oral-in-doza-de-10-20-mg-kg-zi-la-12-24-ore-in-tratamentul-rinosinuzitel-acute-la-copii-in-urmatoarele-situatii/2022-11-21T19:04:34+02:00https://health-pharma.ro/question/decongestionantele-nazale-utilizate-in-tratamentul-rinosinuzitei-nebacteriene-administrate-pentru-o-perioada-mai-mare-de-3-zile-pot-duce-la-aparitia-urmatoarelor-efecte-adverse/2022-11-21T19:05:08+02:00https://health-pharma.ro/question/alegeti-schemele-posologice-corecte-utilizate-la-copii-pentru-eradicarea-infectiei-cu-sbhga-la-purtatorii-cronici/2022-11-21T19:05:52+02:00https://health-pharma.ro/question/pentru-eradicarea-infectiei-cu-sbhga-la-copii-purtatori-cronici-rifampicina-se-asociaza-cu/2022-11-21T19:06:14+02:00https://health-pharma.ro/question/selectati-dozele-maxime-de-antibiotice-utilizate-pentru-eradicarea-infectiei-cu-sbhga-la-copii-purtatori-cronici/2022-11-21T19:06:44+02:00https://health-pharma.ro/question/alegeti-schemele-posologice-corecte-utilizate-la-copii-pentrueradicarea-infectiei-cu-sbhga-la-purtatorii-cronici/2022-11-21T19:07:38+02:00https://health-pharma.ro/question/majoritatea-cazurilor-de-faringita-acuta-sunt-determinate-de/2022-11-21T19:08:07+02:00https://health-pharma.ro/question/tratamentul-otitei-medii-acute-in-cazul-alergiei-non-severe-la-peniciline-include-cefalosporinele/2022-11-21T19:08:51+02:00https://health-pharma.ro/question/amoxicilina-clavulanat-in-doza-de-90-mg-kg-zi-amoxicilina-cu-64-mg-kg-zi-clavulanat-divizat-in-doua-doze-este-recomandata-la-copii-cu-otita-medie-in-urmatoarele-situatii/2022-11-21T19:09:50+02:00https://health-pharma.ro/question/pentru-eradicarea-infectiei-cu-sbhga-la-copii-purtatori-cronici-durata-tratamentului-este-de-10-zile-in-cazul-administrarii-antibioticelor/2022-05-06T13:36:53+03:00https://health-pharma.ro/question/pentru-eradicarea-infectiei-cu-sbhga-la-copii-purtatori-cronici-durata-tratamentului-este-de-10-zile-in-cazul-administrarii-antibioticelor-2/2022-07-12T11:13:17+03:00https://health-pharma.ro/question/cefalosporinele-administrate-oral-ca-tratament-de-a-doua-linie-sau-la-pacienti-cu-alergie-non-severa-la-peniciline-in-otita-medie-acuta-sunt/2022-07-12T11:15:24+03:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-antibioticul-utilizat-oral-in-doza-de-100-mg-x-2-zi-este/2022-11-21T19:11:53+02:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-antibioticul-utilizat-oral-in-doza-de-100-mg-x-2-zi-este-2/2022-07-12T11:32:07+03:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-moxifloxacina-se-utilizeaza-in-doza-de/2022-11-21T19:12:54+02:00https://health-pharma.ro/question/in-cazul-pacientilor-cu-bronsita-cronica-si-limitare-clinica-persistenta-a-debitului-respirator-ar-trebui-luat-in-considerare-un-test-terapeutic-cu/2022-11-21T19:13:28+02:00https://health-pharma.ro/question/nu-este-izolata-frecvent-din-sputa-pacientilor-cu-exacerbari-ale-bronsitei-cronice-bacteria/2022-07-12T11:33:47+03:00https://health-pharma.ro/question/in-bronsiolita-determinata-de-virusul-sincitial-respirator-poate-fi-luata-in-considerare-administrarea-de/2022-07-12T11:34:36+03:00https://health-pharma.ro/question/la-pacienti-cu-pneumonie-virala-si-comorbiditati-diabet-afectiuni-cardiace-pulmonare-hepatice-renale-sau-alcoolism-terapia-empirica-include-in-primele-48-de-ore/2022-11-21T19:14:43+02:00https://health-pharma.ro/question/in-pneumonia-atipica-data-de-virusul-gripal-h1n1-sau-de-virusul-gripei-aviare-terapia-empirica-presupune-administrarea-de/2022-07-12T11:35:41+03:00https://health-pharma.ro/question/doza-de-ampicilina-sulbactam-utilizata-in-tratamentul-pneumoniei-bacteriene-la-copii-este/2022-11-21T19:15:53+02:00https://health-pharma.ro/question/posologia-corecta-a-gentamicinei-sau-tobramicinei-utilizate-la-copil-pentru-tratamentul-pneumoniei-bacteriene-este/2022-11-21T19:16:18+02:00https://health-pharma.ro/question/doza-de-claritromicina-utilizata-in-tratamentul-pneumoniei-bacteriene-la-copii-este/2022-05-06T13:29:13+03:00https://health-pharma.ro/question/alegeti-antibioticul-care-este-rareori-utilizat-la-copii-in-special-cu-varsta-sub-8-ani-din-cauza-inducerii-pigmentarii-permanente-a-dintilor/2022-11-21T19:18:03+02:00https://health-pharma.ro/question/doza-maxima-pe-zi-de-gentamicina-administrata-la-adulti-pentru-tratamentul-pneumoniei-bacteriene-este/2022-11-21T19:18:23+02:00https://health-pharma.ro/question/doza-maxima-pe-zi-de-claritromicina-administrata-la-adulti-pentru-tratamentul-pneumoniei-bacteriene-este/2022-07-12T11:39:29+03:00https://health-pharma.ro/question/alegeti-antibioticul-care-nu-este-indicat-pentru-tratamentul-pneumonici-bacteriene-la-adulti/2022-11-21T19:20:14+02:00https://health-pharma.ro/question/posologia-corecta-pentru-azitromicina-administrata-pentru-tratamentul-pneumoniei-bacteriene-la-copii-este/2022-07-12T11:41:22+03:00https://health-pharma.ro/question/alegeti-doza-maxima-zi-de-gemifloxacina-utilizata-pentru-tratamentul-pneumoniei-bacteriene-la-adulti/2022-11-21T19:21:42+02:00https://health-pharma.ro/question/la-sugari-si-prescolari-anterior-sanatosi-cu-imunizare-completa-si-cu-suspiciune-de-pneumonie-comunitara-bacteriana-usoara-moderata-data-de-s-pneumoniae-se-recomanda-administrarea-cefalosporinei/2022-11-21T19:22:11+02:00https://health-pharma.ro/question/la-sugari-si-prescolari-anterior-sanatosi-cu-imunizare-completa-si-cu-suspiciune-de-pneumonie-comunitara-bacteriana-usoara-moderata-data-de-s-pneumoniae-se-recomanda-administrarea-cefalosporinei-2/2022-11-21T19:22:31+02:00https://health-pharma.ro/question/nu-sunt-active-pe-listeria/2022-07-12T11:54:40+03:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-antibioticul-utilizat-oral-in-doza-de-100-mg-x-2-zi-este-3/2022-05-06T13:34:03+03:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-antibioticul-utilizat-oral-in-doza-de-100-mg-x-2-zi-este-4/2022-11-21T19:12:10+02:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-moxifloxacina-se-utilizeaza-in-doza-de-2/2022-05-06T13:34:03+03:00https://health-pharma.ro/question/option-in-cazul-pacientilor-cu-bronsita-cronica-si-limitare-clinica-persistenta-a-debitului-respirator-ar-trebui-luat-in-considerare-un-test-terapeutic-cu/2022-05-06T13:36:17+03:00https://health-pharma.ro/question/nu-este-izolata-frecvent-din-sputa-pacientilor-cu-exacerbari-ale-bronsitei-cronice-bacteria-2/2022-11-21T19:13:58+02:00https://health-pharma.ro/question/in-bronsiolita-determinata-de-virusul-sincitial-respirator-poate-fi-luata-in-considerare-administrarea-de-2/2022-11-21T19:14:20+02:00https://health-pharma.ro/question/la-pacienti-cu-pneumonie-virala-si-comorbiditati-diabet-afectiuni-cardiace-pulmonare-hepatice-renale-sau-alcoolism-terapia-empirica-include-in-primele-48-de-ore-2/2022-05-06T13:34:39+03:00https://health-pharma.ro/question/in-pneumonia-atipica-data-de-virusul-gripal-h1n1-sau-de-virusul-gripei-aviare-terapia-empirica-presupune-administrarea-de-2/2022-11-21T19:15:27+02:00https://health-pharma.ro/question/doza-de-ampicilina-sulbactam-utilizata-in-tratamentul-pneumoniei-bacteriene-la-copii-este-2/2022-05-06T13:29:13+03:00https://health-pharma.ro/question/posologia-corecta-a-gentamicinei-sau-tobramicinei-utilizate-la-copil-pentru-tratamentul-pneumoniei-bacteriene-este-2/2022-05-06T13:37:32+03:00https://health-pharma.ro/question/doza-de-claritromicina-utilizata-in-tratamentul-pneumoniei-bacteriene-la-copii-este-2/2022-11-21T19:16:46+02:00https://health-pharma.ro/question/alegeti-antibioticul-care-este-rareori-utilizat-la-copii-in-special-cu-varsta-sub-8-ani-din-cauza-inducerii-pigmentarii-permanente-a-dintilor-2/2022-05-06T13:09:53+03:00https://health-pharma.ro/question/doza-maxima-pe-zi-de-gentamicina-administrata-la-adulti-pentru-tratamentul-pneumoniei-bacteriene-este-2/2022-05-06T13:29:17+03:00https://health-pharma.ro/question/doza-maxima-pe-zi-de-claritromicina-administrata-la-adulti-pentru-tratamentul-pneumoniei-bacteriene-este-2/2022-11-21T19:19:16+02:00https://health-pharma.ro/question/alegeti-antibioticul-care-nu-este-indicat-pentru-tratamentul-pneumonici-bacteriene-la-adulti-2/2022-05-06T13:09:53+03:00https://health-pharma.ro/question/posologia-corecta-pentru-azitromicina-administrata-pentru-tratamentul-pneumoniei-bacteriene-la-copii-este-2/2022-11-21T19:21:15+02:00https://health-pharma.ro/question/alegeti-doza-maxima-zi-de-gemifloxacina-utilizata-pentru-tratamentul-pneumoniei-bacteriene-la-adulti-2/2022-05-06T13:09:55+03:00https://health-pharma.ro/question/la-sugari-si-prescolari-anterior-sanatosi-cu-imunizare-completa-si-cu-suspiciune-de-pneumonie-comunitara-bacteriana-usoara-moderata-data-de-s-pneumoniae-se-recomanda-administrarea-cefalosporinei-3/2022-05-06T13:34:44+03:00https://health-pharma.ro/question/la-sugari-si-prescolari-anterior-sanatosi-cu-imunizare-completa-si-cu-suspiciune-de-pneumonie-comunitara-bacteriana-usoara-moderata-data-de-s-pneumoniae-se-recomanda-administrarea-cefalosporinei-4/2022-05-06T13:34:44+03:00https://health-pharma.ro/question/nu-sunt-active-pe-listeria-2/2022-11-21T19:23:17+02:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-levofloxacinase-utilizeaza-in-dozele/2022-11-21T19:23:47+02:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-azitromicina-se-utilizeaza-in-dozele/2022-11-21T19:24:09+02:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-ciprofloxacina-se-utilizeaza-in-dozele/2022-11-21T19:24:46+02:00https://health-pharma.ro/question/in-tratamentul-exacerbarilor-bronsitei-cronice-se-utilizeaza-in-doza-de-500-mg-x-4-zi/2022-11-21T19:25:21+02:00https://health-pharma.ro/question/in-bronsita-cronica-aduc-beneficii-in-utilizarea-pe-termen-lung/2022-11-21T19:25:49+02:00https://health-pharma.ro/question/la-pacientul-anterior-sanatos-cu-pneumonie-comunitara-data-de-s-pneumoniac-m-pneumoniae-h-influenzac-c-pneumoniac-m-catarrhalis-tratamentul-empiric-include/2022-11-21T19:26:19+02:00https://health-pharma.ro/question/terapia-antimicrobiana-empirica-a-pneumoniei-data-de-s-pneumoniae-mdr-la-adulti-cu-comorbiditati-diabet-afectiuni-cardiace-pulmonare-hepatice-renale-sau-alcoolism-include/2022-11-21T19:26:56+02:00